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Facial Eczema (FE) is a disease of ruminants that was first reported in New Zealand at the 
beginning of this century. Today this disease is considered the most important mycotoxin 
affecting the sheep industry, causing an estimated 75 million dollars per year in lost 
revenue. 
FE is a secondary photosensitisation disease arising from liver dysfunction. The liver 
damage is caused by a mycotoxin, sporidesmin, produced in the spores of the saprophytic 
fungus Pithomyces chartarum. The cytotoxicity of sporidesmin is postulated to arise from 
its production of free radicals. The reduced (dithiol) form of sporidesmin undergoes 
autoxidation in a reaction that generates superoxide radicals (02} It is the increased 
generation of these free radicals, overwhelming the ability of the cellular enzymes to reduce 
and detoxify them, that is the cause of sporidesmin toxicity. 
Differences among Romney sheep in their response to sporidesmin has been used to select 
lines which vary markedly in their resistance to the toxin. The biochemical and genetic 
basis of these differences is not known. The main research focus thus far has been on the 
study of antioxidant enzymes and their role in resistance to FE. A further candidate, the 
multiple drug resistant (MDRl) protein, has been implicated in cross resistance to many 
lipophilic cytotoxic compounds. Studies have indicated this phenomenon is due to 
decreased drug accumulation in resistant cells. 
This research was aimed at studying the role of .MDRl in resistance to sporidesmin. With 
the discovery of a biological or genetic marker for FE resistance current selection 
techniques could be replaced by marker assisted selection. 
The sheep .MDRl gene was cloned and sequenced which enabled the design of both sheep 
specific probes and primers for the mapping of .MDRl and analysis of its segregation with 
FE resistance. The sheep .MDRl gene showed high sequence and structural homology to 
other .MDR family members, including 12 potential transmembrane spanning domains and 
consensus sequence for 2 nucleotide binding domains. 
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The :MDRl gene was placed on the sheep genetic linkage map using RFLP analysis. Its 
localisation on sheep chromosome 4 is orthologous to the mapping of the human :MDR 
genes on chromosome 7 and the mouse mdr family on chromosome 5. 
To analyse :MDRl segregation a highly polymorphic :MDRl-linked microsatellite marker 
was isolated and screened across pedigrees in which resistance to FE was segregating. 
Results showed no linkage of the :MDRl marker with resistance or susceptibility to FE, 
suggesting that a structural change in the :MDRl gene per se was not linked to resistance. 
The amplification in this analysis of up to six allelic bands, segregating as two haplotypes, 
suggested the presence of at least three members in the sheep :MDR family. Fragments were 
amplified from a second, l\1DR2, family member and used to map the gene adjacent to 
:MDRl on sheep chromosome 4. 
Promoter elements have previously been documented that differentially regulate :MDRl. 
:MDRl mRNA levels were therefore studied in both resistant and susceptible animals using 
quantitative RT-PCR. Variation was detected in the level of :MDRl expression between 
resistant and susceptible animal samples from both hepatic and leukocyte cells. An increase 
in :MDRl expression was recorded in resistant cells exposed to sporidesmin, wheras 
susceptible cells showed no significant change in :MDRl expression on exposure to the 
toxin. These results suggest that resistant cells are able to induce the overexpression of 
:MDRl on exposure to sporidesmin. The mechanism by which this occurs or the proteins 
involved in the interaction are yet to be determined. 
In conclusion this research has demonstrated the sheep :MDR family is composed of at least 
two gene members with high sequence homology to characterised :MDR genes from other 
mammals. Hepatic overexpression of at least one of these, MDRl, is associated with 
resistance to sporidesmin. The differential expression in leukocyte cells may be exploited in 
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1.1 FACIAL ECZEMA 
There are a number of mycotoxins which produce photosensitisation in animals and many 
are the result of hepatogenous (secondary) photosensitisation (Mortimer and Ronaldson, 
1983). The most commonly occurring of these diseases in New Zealand (N.Z) is facial 
eczema (FE) which is caused by the mycotoxin sporidesmin found in the spores of the 
saprophytic fungus Pithomyces chartarum. In severe cases the liver injury caused by 
sporidesmin results in animal death, while sublethal exposure to the mycotoxin leads to 
production losses such as lower weight gains and poor lambing percentages (Smeaton et 
al., 1985). 
1.1.1 Morphology and Distribution of P. chartarum 
Major outbreaks of the disease occur under environmental conditions of high temperature 
(10-30°C) and high humidity (100%) in which P. chartarum grows rapidly and sporulates 
freely (Brook, 1963). The substrate for the growth of P. chartarum in the field is dead 
vegetative material. In N .Z outbreaks are seen in late summer and autumn in northern 
regions of the South Island and in coastal and low lying areas of the North Island. Areas 
most at risk are Northland, South Auckland and Waikato. 
P. chartarum has been associated with FE in several other countries notably Australia 
(Walsh, 1966), South Africa (Maraas et al., 1972), USA (Hansen et al., 1994) and Europe 
(Bezille et al., 1984). Globally the proportion of P. chartarum strains which produce 
sporidesmin varies from 2% in Brazil to 67% in Australia and 95% in N.Z. (Collin et al., 
1998). Livestock in N.Z. appear to suffer to a greater extent than any other country and this 
may be due to the higher proportion of sporidesmin producing P. chartarum strains found 
in N.Z. pastures (Collin and Towers, 1995b). 
FE has a mean cost to the N.Z sheep industry of 75 million dollars per annum. Susceptible 
animals exposed to sporidesmin show reduced survival, fertility, growth and meat and 
wool production (Towers, 1986). 
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1.1.2 Disease Pathology 
Sporidesmin is rapidly absorbed from the intestine and concentrated in the liver and hepatic 
bile. FE is characterised by necrosis of liver cells (Figure l.IA), bile duct destruction and 
inflammation of hepatic and portal vein branches (Cunningham, 1942). Subsequent 
invasion of the damaged areas by granulation tissue, in the process of cell repair, results in 
cholestasis. Obstruction to bile flow prevents excretion of metabolic products such as 
phylloerythrin. Phylloerythrin is a photodynamic pigment derived from microbial 
breakdown of plant chloropyll in the gut. In susceptible animals phylloerythrin accumulates 
in the blood and is activated on absorption of solar energy leading to characteristic 
inflammation and scabbing of the facial skin (Figure 1.1 B) seen in the later stages of 
disease (Mortimer and Ronaldson, 1983). Once the initial biliary damage by sporidesmin 
has occured the progression of the disease process \Vas immutable. Prolonged recirculation 
is not required for maintenance of liver damage. Photosensitised animals seek shade and 
venture out only in overcast weather or in darkness. Irritation is evident from head shaking, 




Figure 1.1 Facial eczema symptoms. (A) The liver of a moderately susceptible sheep 
infected with sporidesmin. (B) A susceptible animal showing the outward clinical signs of 
facial eczema. Scarring of tissue around the face and ears. 
Peak sporidesmin concentrations are seen at 2-8 hours after oral dosing and by 24 hours 
the toxin is no longer detectable (Mortimer and Stanbridge, 1968). The earliest effects of 
sporidesmin on cultured liver cells are the reorganisation of cytoskeletal microfilaments and 
the loss of cell surface adhesiveness (Jordan and Pedersen, 1986). Other effects such as 
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inhibition of phagocytosis and reduction in bile flow and bile acid secretion are also 
observed (Bullock et al., 1974; Cordiner and Jordan, 1983; Cordiner et al., 1983). 
1.1.3 Variation in Resistance to Sporidesmin 
Sheep, fallow deer and cattle are particularly sensitive to sporidesmin intoxication 
(Mortimer et al., 1978a; Mortimer et al., 1978b; Mortimer and Smith, 1981). Hepatobiliary 
lesions can also be readily induced in rabbits and guinea pigs although rats and mice are 
comparatively resistant to the mycotoxin. (Mortimer and Ronaldson, 1983). Certain sheep 
breeds such as Merinos and Finnish Landrance have shown greater resistance to 
sporidesmin poisoning (Morris et al., 1994b) than the Romney breed (Smith et al., 1980). 
Differences in resistance to sporidesmin may result from variability in: (i) toxin distribution 
and metabolism; (ii) interaction of toxic molecules with cells and (iii) repair and protective 
responses. The biochemical and genetic basis of these differences is not known although 
variation has been detected in a number of liver proteins between Romney flocks selected 
for resistance or susceptibility to FE (Morris et al., 1994a). As the liver and biliary system 
are major targets for sporidesmin action differential presence of such proteins might explain 
some of the variation in disease resistance. 
1.1.4 Control of Facial Eczema 
Earliest control methods involved avoidance of suspected toxic pastures during the high 
risk times of the year, later improved by the advent of spore counting (Towers, 1986) and 
again most recently by the development of immunoassays to detect the mycotoxin in 
pasture (Collins et al., 1995). Determination of pasture toxicity can be used to manage the 
effect of the toxin by moving of stock or reducing grazing on infected fodder by feeding 
uncontaminated supplements. 
The use of fungicides to reduce P. chartarum was a major advance although in recent years 
their expense and growing ineffectiveness has made them less favoured. Keogh (pers. 
comm.) is investigating, as a means of reducing the number of P. chartarum spores present 
in the pasture, alternative pasture species which support lower spore counts. 
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Treatment of livestock with zinc has proven to be popular and effective as a method of 
neutralising sporidesmin and minimising the effects of FE (Munday and Manns, 1989). 
Zinc reduces the amount of copper available in the liver to serve a catalytic role and binds 
with reduced sporidesmin preventing its autoxidation (Munday, 1984b; Munday and 
Manns, 1989). Zinc has traditionally been administered by drenching with a zinc oxide 
slurry or by the addition of zinc sulphate to drinking water. The use of the 'Time Capsule' 
has overcome many of the deficiencies of zinc administration as it allows a consistent 
release of zinc over a long period (Munday et al., 1997). 
An alternative method, currently under trial, is the introduction of an atoxigenic strain of P. 
chartarum to outcompete or displace naturally occurring toxigenic strains thereby reducing 
toxin levels in the pasture. Investigators have found non-producing strains have the ability 
to establish and compete efficiently with sporidesmin producing strains (Collin and 
Towers, 1995a; Fitzgerald et al., 1998). 
Immunisation against sporidesmin has been investigated however being such a small 
molecule sporidesmin is non-antigenic. Attempts have been made to couple sporidesmin to 
certain proteins and inject the complexes formed to stimulate the production of antibodies. 
This method gave little protection against the toxic affects of sporidesmin (Fairclough et al., 
1984). 
A practical long term solution to FE is to breed animals with greater resistance to the 
sporidesmin toxin. Susceptiblity to FE has a heritability of 0.42 (Campbell et al., 1981). 
This can be exploited to create, through selective breeding, resistant flocks. 
1.1.5 Selection Line Breeding 
Two Romney flocks, a resistant (R) and susceptible (S) have been bred and maintained 
since 1975 with the establishment of a control (C) flock in 1982 (Morris et al., 1994d). 
Initially randomly selected ewes were mated with rams which had been identified by 
progeny testing as resistant or susceptible to FE (Campbell et al., 1975). Progeny testing 
involved randomly chosen offspring from each ram that were challenged at four months 
with sporidesmin and a liver damage score assigned upon post mortem examination six 
weeks later. Performance testing replaced progeny testing in 1982 (Morris et al., 1989). 
Rams were then selected on the basis of a performance test in which they were challenged 
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with small doses of sporidesmin and the degree of liver injury was measured by examining 
serum gamma-glutamyltransferase (GOT) levels. GOT is not an enzyme specific to 
spmidesmin but elevation of GOT levels correlate well (r
2>0.75) with severity of liver 
damage (Towers and Stratton, 1978). An elevation of greater than 30 % above pre-dose 
GOT concentration was taken as indicative of liver injury and of susceptibility of that 
animal to that dose rate of sporidesmin. After 20 years of genetic selection the lines have 
diverged so much that nine times more sporidesmin is required to elicit the same GOT 
response in the resistant line compared with the susceptible line (Morris, pers. comm.). 
1.1.6 Toxicity of Sporidesmin 
Sporidesmin toxicity is dependent on the disulphide bond (Taylor, 1971) that chemically 
reacts in a glutathione-linked (Munday, 1982), copper catalysed cycle of reduction and 
oxidation to produce the toxic free radical superoxide and a cascade of other free radical 
species (Figure 1.2) (Munday, 1984a; 1989). 
Disulphide 
........... s 












Figure 1. 2 Redox cycling of oxidised (disulphide) sporidesmin compound. This reaction 
is initiated by reductants such as glutathione. Oxidation of the dithiol back to the disulphide 
form requires a metal catalyst and produces the superoxide free radical. 
Other disulphides show similar activity but at higher concentrations (Cordiner and Jordan, 
1983) indicating the peperazinedione ring of sporidesmin provides a chemically reactive 
environment for the bridge sulphurs (Figure 1.3). In addition to free radicals already 
generated from normal cellular processes it is suggested that the influx of free radicals from 
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sporidesmin-induced production overwhelms the cellular detoxification systems, leading to 
cell death and liver dysfunction. 
N SH 0 
o~N~ 
c~ 
A. Oxidised Sporidesmin B. Reduced Sporidesmin 
Figure 1.3 The disulphide (left) and reduced dithiol (right) forms of sporidesmin. 
Free radical formation requires the presence of a suitable metal catalyst such as copper. 
This perhaps explains the benefit of zinc dosing in inhibiting free radical production 
through mercaptide formation (Munday, 1984b). It may also account for the species 
specific differences in susceptibility to sporidesmin as ruminants absorb and store copper 
more readily and this is reflected in the high levels of copper found in ruminant liver 
(Underwood, 1977). 
Superoxide radical (02-) and hydrogen peroxide (H20 2) are the first two products of the 
reduction of molecular oxygen to water (Munday, 1987). The third is the hydroxyl radical 
(OR) an exceptionally unstable compound and it is likely this is the compound responsible 
for initiating most of the pathological changes (Kappus and Sies, 1981). 
Enzymes which remove toxic free radicals are of great importance in allowing organisms to 
survive in the presence of increased 0 2 concentration. Superoxide dismutase acts to remove 
0 2- wheras catalase and the peroxidases break down H20 2 to water preventing the 
formation of OR. Glutatione peroxidase also catalyses oxidation of GSH to GSSG at the 
expense of ~02 (Halliwell and Gutteridge, 1984). 
Although the favoured view of sporidesmin toxicity is the interaction of the disulphide 
group to produce free radicals other views on the molecular interaction of the disulphide 
moiety concern its involvement in the direct modification of cellular thiols including those 
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of membrane and microfilament proteins (Middleton, 1974; Jordan and Pedersen, 1986; 
Cordiner and Jordan, 1983). 
1.1.7 Genetic Basis of Facial Eczema 
The biochemical and genetic basis of resistance to FE is unknown. The liver is remarkably 
insensitive to a variety of cytotoxins. Transport of nutrients and metabolites from the blood 
to the hepatocytes occurs by distinct transport processes in the sinusoidal membrane. 
Hepatocyte derived metabolites, which need to be excreted, are transported across the 
canalicular membrane by specific transporters. Beside the secretory function of hepatocytes 
for waste products, there is also secretion of bile salts which assists in fat dispersion and 
absorption into the intestinal tract. 
Increased toxin resistance might be explained by the decrease in expression of phase I P-
450 cytochromes that metabolise carcinogenes to cytotoxins (Cowan et al., 1986; Peters et 
al., 1992), an increase in phase II detoxification enzymes (Rushmore et al., 1993; Osada et 
al., 1995) that often promote conjugation reactions with metabolites formed by phase I 
enzymes (Sipes and Gandolfi, 1991) or the overexpression of known drug resistance genes 
(Weinstein et al., 1990; Kuo et al., 1992). 
The primary role of the cytochrome P-450 system is to convert, via oxidative metabolism, 
toxic hydrophobic xenobiotics to innocuous polar products that can be more readily 
excreted (Nebert and Gonzalez, 1987). Although certain subfamilies of the cytochrome P-
450 system are known to oxidise compounds to toxic radicals (Recknagel and Glende, 
1973) sporidesmin is believed to be the intrinsically toxic agent (Bhathal et al., 1990). 
There is no evidence to indicate that metabolism enhances toxicity. 
An understanding of the underlying biophysical mechanisms is necessary in order to 
evaluate the resistance of animals to sporidesmin. The possibility of developing a blood test 
for resistance identification, without the need for toxic challenge, has been examined by 
plasma transferrin typing (Morris et al., 1988) and by characterising the differences in 
physical properties of blood cells (Upreti et al., 1991). Although the latter study 
significantly discriminated between resistant and susceptible animals commercialisation 
requires further optimisation. Research on possible candidate genes for resistance or 
susceptibility has focused on the detoxification enzymes involved in breakdown of free 
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radical species (Phua, 1998). To date only one of the studied antioxidant enzymes, 
catalase, has shown any association with disease resistance. There has been no analysis on 
the involvement of drug resistance proteins although it has been suggested the eo-induction 
of the cytochrome family and the multiple drug resistant (MDR) family may represent a co-
ordinated protective response to harmful compounds (Burt and Thorgeirsson, 1988). 
1.2 MULTIPLE DRUG RESISTANCE 
1.2.1 Multiple Drug Resistance Genes 
P-glycoprotein (pgp) is a membrane glycoprotein, the expression of which was originally 
identified by Juliano and Ling (1976) in cell lines that developed resistance to multiple 
drugs. Subsequently pgp was purified (Riordan and Ling, 1979) and its gene, MDR1, was 
cloned (Ng et al., 1989; Devine et al., 1991). MDR1 is a membrane glycoprotein that 
confers multidrug resistance to mammalian cells by acting as an energy-dependent efflux 
pump (Fojo et al., 1985). The cloning of MDR cDNAs has revealed that they are encoded 
by a small multigene family with two members in humans (MDR1 and MDR2) and three in 
rodents (mdr1, mdr2 and mdr3). Despite a sequence identity of >70% the MDR gene 
products can be divided into three classes. Class I and 11 consist of the drug transporting 
MDR proteins which include the human MDR1 and mouse mdr1 and mdr3 genes (Chen et 
al., 1986; Devault and Gros, 1990). Class Ill includes the non-drug transporting MDR 
genes such as the human MDR2 (van der Bliek et al., 1987; Schinkel and Roelofs, 1991) 
and mouse mdr2 (Gros et al., 1988; Buschman et al., 1992). 
The MDR family members are expressed in a tissue specific pattern in normal mammalian 
tissues (Lum and Gosland, 1995). Their distribution at the apical domain of epithelial cells 
suggests a physiological function in facilitating excretion of xenobiotics and endogenous 
compounds (Buschman et al., 1992; Smit et al., 1993). Monoclonal antibodies against 
MDR genes have been isolated (Kartner et al., 1985) and used to localise the predominant 
expression of each MDR isoform protein (Georges et al., 1990; Bradley et al., 1990). 
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In humans high levels of MDR1 mRNA have been observed in the adrenal gland and on the 
luminal surfaces of the kidney, liver, colon, jejunum and pancreas (Thiebaut et al., 1987). 
MDR2 is found overexpressed in the canalicular membrane of epithelial cells lining the 
lumen of the bile canaliculi and biliary ducts (Croop et al., 1989). 
1.2.2 Function and Structure 
Gene transfer experiments involving MDR cDNAs have clearly demonstrated that the 
expression of class I and II MDR genes confers resistance on sensitive cells (Gros et al., 
1986c; Ueda et al., 1987a; Devault and Gros, 1990) while expression of human and mouse 
class Ill genes has no direct effect on cellular drug resistance (Schinkel and Roelofs, 1991; 
Buschman et al., 1992). Class Ill MDR gene products are predominately expressed in the 
liver bile canaliculi (Buschman et al., 1992) and recently their function in the transport of 
phosphatidylcholine into bile has been reported (van Helvoort et al., 1996). 
Several years ago it was recognised that the MDR family was a subfamily of the ATP-
binding cassette (ABC) transporters (Hyde et al., 1990). ABC transporters are involved in 
a wide range of energy dependent events across cell surfaces. 
The sequence of the human (Chen et al., 1986) and mouse (Gros et al., 1986a) MDR1 
genes led to the current structural model of this protein (Gottesman and Pastan, 1988). The 
MDR1 protein consists of approximately 1280 amino acid residues and is composed of two 
highly homologous halves each of which contains one hydrophobic region encoding six 
potential transmembrane spanning domains (TMDs) followed by a hydrophilic region 
containing a consensus sequence for a nucleotide binding domain (NBD) (Figure 1.4). 
Topology of the human MDR1 protein is based on hydropathy calculations and epitope 
localisation data. According to this model both theN- and C- terminal and the two NBDs 
are located intracellularly (Yoshimura et al., 1989; Cianfriglia et al., 1994). 
Studies with photoactivatable analogues of ATP clearly show that MDR1 binds ATP 
(Schurr et al., 1989) and that mutations into the core consensus motif of either NBD 
abolish protein function (Hamada and Tsuruo, 1988) but do not affect the capacity of the 
mutants to bind photoactivatable analogues of ATP. This suggests a step subsequent to 





Figure 1. 4 Schematic diagram of MDR1. Twelve TMDs and 2 NBDs are shown. The 
first extracellular loop contains three potential glycosylation sites and the linker region 
joining the two homologous halves contains a number of phosphorylation sites (see text). 
The study of chimeric molecules constructed by exchanging homologous domains of 
functionally distinct MDR genes has shown that these regions are functionally identical 
(Buschman and Gros, 1991). However replacement of the C-terminal ATP site of MDR1 
with the N-terminal site allowed only partial functioning of the protein, while substituting 
the C-terminal site in the N-terminal position caused complete loss of function. This 
suggests the two sites serve distinct functions. 
Detailed biochemical analyses using photolabeled drug analogues has shown that the TMDs 
in general, and the regions near TMD 6 and TMD 12 in particular, participate in drug 
interaction (Comwell et al., 1986a; Greenberger, 1993). Genetic analysis of chimeric 
proteins constructed between functionally distinct MDR genes have shown altered substrate 
specificity indicating that the TMDs are important determinants for drug recognition and 
binding. This conclusion is strengthened through studies using inhibitors that compete for 
these binding sites reducing drug transport (Comwell et al., 1987). 
Although exogenous substrates that have been identified for MDR1 are structurally diverse 
(Oude Elferink et al., 1995) three dimensional analysis of more than 120 cytotoxic 
compounds that interact with MDR1 revealed several shared characteristics. It was 
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postulated that the prototype MDR1 substrate is a cationic, hydrophobic, 400-1000 Da 
molecule containing at least two planar rings (Arias et al., 1993). Sporidesmin shares these 
characteristics (White et al., 1977). 
Bissinger and Kuchler (1994) isolated the STS1 gene in yeast which shares high sequence 
and structural homology to ABC proteins and whose overexpression confers resistance to 
sporidesmin and other structurally unrelated drugs. Active removal of sporidesmin from 
hepatic cells would prevent assimilation of excessive toxic free radical species and confer 
resistance to FE in sheep. 
1.2.3 Sequence Homology 
Although the two halves of the MDR1 protein share 40% identity the lack of homologous 
placing of introns (Chen et al., 1990) suggests that the two halves have either evolved 
independently or undergone major intron movement after a duplication event. 
Different MDR gene members show a remarkable degree of sequence homology both 
within and between species (Devine et al., 1991). The human MDR1 and MDR2 genes are 
75% similar at the DNA level despite different functions and the mouse and human MDR1 
genes show 85% similarity despite 50 million years of evolution. The most conserved 
regions are those adjacent to and including the nucleotide binding sites and the first and 
second intraplasmic loops in each half of the molecule. The least conserved regions are the 
first extracytoplasmic loop, the amino and carboxyl termini and the intracellular linker 
region connecting both halves of the molecule. 
Two core consensus motifs, known as Walker A and B motifs are found in many 
nucleotide binding proteins and are directly involved in ATP binding (Endicott et al., 
1987). This linker dodecapeptide (L-S-G-G-(X)3- R -(hydrophobic)-X -(hydrophobic )-A) 
immediately preceding the walker B motif and another short stretch known as the centre 
region are characteristic for ABC transporters only (Shyamala et al., 1991). It has been 
hypothesised these sequences may undergo conformational change upon hydrolysis of 
bound nucleotides and promote contact between the TMDs and NBDs (Mimura et al., 
1991). 
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1.2.5 Post-translational Modification 
Soon after pgp was discovered it was reported to be a phosphoglycoprotein (Carlsen et al., 
1977). Synthesised as a non-glycosylated precursor with molecular size of 120,000 to 
140,000 it is processed into the mature form with a half life of 1-2 hours in humans and 
20-30 minutes in mice (Richert et al., 1988; Greenberger et al., 1988). 
Research groups have attempted to evaluate the significance of N-linked glycosylation with 
respect to the proteins ability to confer multiple drug resistance (Beck and Cirtain, 1982). 
Removal of these sites did not affect the function or substrate specificity of the protein but 
did reduce its effectiveness, possibly by lowering its stability or through less efficient 
targeting of the protein to the plasma membrane (Germann, 1996; Schinkel et al., 1993). 
Phosphorylation has been established as a characteristic of mature MDR1 (Ma et al., 1991, 
Richert et al., 1988). The MDR1 protein has been shown to be phosphorylated by protein 
kinase C (PKC) at several discrete sites in the highly divergent linker region (Chambers et 
al., 1993) (Figure 1.4) 
In analogy with the highly phosphorylated R domain of the cystic fibrosis transmembrane 
conductance regulator (CFTR) (Cheng et al., 1991), it was hypothesised that the linker 
region of MDR1 may act as a regulatory domain to control drug efflux activity (Chambers 
et al., 1993). These initial ideas were challenged by experiments in which serine residues 
were mutated to mimic both the permanently phosphorylated and non-phosphorylated 
states. Neither mutant yielded MDR proteins with altered drug transport activities 
(Goodfellow et al., 1996). A recent study suggested phosphorylation of MDR1 may 
modulate regulation of an endogenous chloride channel whose identity is still obscure 
(Hardy et al., 1995). 
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1.3 OBJECTIVES OF THIS RESEARCH 
The specific aim of this research was to determine if the MDR family, and in particular 
MDRl, was associated with resistance to FE in sheep. To achieve this the study required 
firstly, isolation and characterisation of the full length sheep cDNA encoding MDRl. This 
characterisation included mapping of the MDRl gene onto the sheep genetic linkage map 
using an isolated restriction fragment length polymorphism (RFLP). Secondly, 
determination of whether MDRl segregated with FE resistance or susceptibility using 
families segregating with the trait. Finally quantitative PCR was used to compare MDRl 
expression levels between resistant and susceptible animals both pre- and post-
sporidesmin dosing. 
CHAPTER TWO 




All buffers, salts, acids and bases used were Analar grade unless otherwise stated. All 
solutions, with the exception of those containing SDS, were either autoclaved (15psi, 
121 °C, 20 mins) or filter sterilised where possible. 
Reagents were purchased from the following suppliers: 





P]dATP), each with specific activity 3000 Ci/mmol, Hybond 
N+ membranes and Rediprime DNA labeling system. 
BDH Chemicals Ltd., Poole, UK: Acetic acid, bis-acrylamide, ethanol, formamide, 
tris(hydroxymethyl)methylamine (Tris), chloroform, isopropanol and phenol 
Boehringer Mannheim, Germany: All restriction enzymes used, together with their 
appropriate incubation buffers, Klenow fragment, Proteinase K and T4 DNA polymerase 
with appropriate buffers, ampicillin (sodium salt), deoxynucleoside triphosphates (dATP, 
dCTP, dGTP and dTTP), ethylene diamine tetra-acetic acid (EDTA), ethidium bromide, 
bovine serum albumin (BSA), sodium dodecyl sulphate (SDS), High pure PCR 
purification kit, 5'/3' RACE kit. High fidelity polymerase, Long Template polymerase and 
random prime DNA labeling kit. 
Difco Laboratories, Detroit, M!, USA: agar, Bactopeptone, Bactotryptone and Bactoyeast 
extract 
Eastman Kodak Company, Rochester, NY, USA: X-Omat™ AR-5 film 
FMC BioProducts, Rockland, ME, USA: NuSieve GTG® agarose (low melting 
temperature agarose ). 
Life Technologies, Inc., Gaithersburg, MD, USA: Superscript™ II reverse transcriptase 
and appropriate buffer, T7 RNA polymerase, agarose, yeast extract and Taq DNA 
polymerase (recombinant). 
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New England Biolabs, Beverly, MA, USA: T4 DNA ligase and T4 polynucleotide kinase 
with appropriate buffers and SDS. 
Phannacia Biotech: NICK™column. 
Promega, Madison WI, USA: Wizard™ minipreps and Rnasin Ribonuclease inhibitor. 
Qiagen: RNeasy Mini kit. 
Roussel Phannaceuticals N.S. W: gentomycin 
Sigma Chemical Company, St. Louis, MO, USA: RNase A; acrylamide, BCIG, IPTG and 
PEG. 
For autoradiography, film was processed in an All-Pro 100-L film processor with Kodak 
RP X-Omat developer and fixer. Water was deionised by a Milli-Q reagent water system 
(Millipore Corporation). 
2.2 STOCK SOLUTIONS 
Ampicillin: 
Ethidium bromide: 
Loading dye (5x): 
(for agarose gels) 
A 100 mg/ml stock of ampicillin was made up in sterile Milli-Q 
water and stored at -20°C. Final concentration was 5 mg/ml in 
liquid media, or spread on solid media plates. 
A stock of 5 mg/ml was stored at 4 °C. Working concentration was 
0.5 f.!g/ml. 
0.2 % (w/v) bromophenol blue 
12.5 % (w/v) Ficoll 
20 % (w/v) sucrose 
2.5x TBE 
2 mg/ml ethidium bromide 
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Loading dye (5x): 90% (w/v) deionised formamide 100% 







TAE buffer (I Ox): 
TBE buffer ( 1 Ox): 
TE buffer: 
TfBI 
5% (w/v) xylene cyanol 
5% (w/v) bromophenol blue 
Solid phenol was saturated and equilibrated with TE buffer. 
Paraffin oil was equilibrated with TE buffer. 
25 mM Tris-HCl (pH8), 50 mM glucose, 10 mM EDTA (pH8). 
47.5 ml ddH20, 0.2 mM NaOH, 1 % SDS. 
3 M Potassium acetate, pH adjusted to 4.8 with glacial acetic acid. 
150mMNaCl 
15 mM Na citrate 
Final pH 7.0 
0.4 M Tris-HCl 
50 mM sodium acetate 
10mMEDTA 
Final pH 7.8 
0.9 M Tris-HCl 
0.9 M boric acid 
25mMEDTA 
Final pH 8.3 
10 mM Tris-HCl pH 7.2 
0.1mMEDTA 
2.45 g RbCl, 0.588 g KAc, 1.98 g MnC12, 30 ml glycerol, 
pH adjusted to 5.8 with glacial acetic acid, and made up to 
200 ml. ·Stored in dark at 4 °C. 
TfBII 
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5 ml of 100 mM MOPS (pH7), 0.55 g CaC12, 0.06 g RbCl, 
7.5 ml glycerol. Store in dark at 4°C. 








4 M guanidinium isothiocyanate, 5 mM sodium citrate, pH 
7.0, 0.5% sarkosyl (sodium lauroyl sarcosinate) 
1% tryptone, 0.8% NaCl with 1.5% (w/v) agar 
1 % (w/v) Bacto-tryptone 
0.5 % (w/v) yeast extract 
0.5% (w/v) NaCl 
0.1 % (w/v) glucose 
LB broth with 1.5% (w/v) agar 
5 g Yeast extract, 20 g Bactotryptone, 0.75 g KCl, KOH was used 
to pH the solution to 7.6 and made up to 1litre using ddHzO. The 
mixture was autoclaved for 45 minutes and 34 ml of 1 M MgS04 
added (previously filter sterilised). 
10 g/1 yeast extract 
20 g/1 bacto-peptone 
20 g/1 dextrose 
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2.4 GENERAL METHODS 
2.4.1 Restriction Enzyme digestion 
Restriction enzyme digests were carried out according to the manufacturer's 
recommendations using the buffers provided. 
2.4.2 Gel Electrophoresis 
Agarose 
DNA was electrophoresed in 0.8-2.0% agarose gels in 1xTAE buffer. Ethidium bromide 
was added to a final concentration of 0.5 1-Lg/ml. Samples were mixed with 115 vol 5 x 
loading dye prior to loading. DNA was visualised under UV light using a UV 
transilluminator. 
Polyacrylamide 
10 I-ll of formamide dye was added to each amplified sample which was then heated to 95°C 
on a hot plate for 3 minutes and 3.0 I-ll loaded onto a denaturating acrylamide gel. DNA was 
electroporesed in 6% acrylamide (containing 0.3 % bis-acrylamide), 8 M urea buffered in 
1x TBE and run at 1400 V (30 mA, 30 W) for an appropriate time period for band 
separation. On completion the gels were dried onto whatmann 3MM paper by incubation 
with vacumn at 80°C for 20 minutes. MS bands were visualised by exposure to X-OMAT 
TM AR-S film for 1-7 nights depending on signal intensity. In the case of microsatellite 
analysis genotypes were scored independently by two observers and data entered into the 
appropriate databases for analysis 
2.4.3 Isolation of DNA from Agarose 
Spin Method 
Bands were excised from agarose and cut into small pieces using a sterile razor blade. A 
hole was pricked in the base of a shortened 1.5 ml eppendorf and a triangle of Whatmann 
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filter paper opened in it. This structure was placed in a full sized 1.5ml eppendorf and the 
gel fragments compressed inside the Whatmann paper. It was spun at increasing 
revolutions for 40 second intervals to elute the DNA. The filtrate was then ethanol 
precipitated (Section 2.4.4). 
The QIAEXII gel extraction kit 
Bands were excised from agarose and DNA isolated using the QIAEX gel extraction kit 
according to the manufacturers instructions (Qiagen). 
High pure purification kit 
In the case of single products being generated in the reaction they were purified using the 
High Pure Purification kit following the manufacturers instructions (Boehringer). 
2.4.4 Ethanol Precipitation of Nucleic Acids 
DNA was precipitated with 10% 3M sodium acetate and two volumes of 95% ethanol. The 
mixture was incubated at -80°C for 2 hours and centrifuged at 13,000 rpm for 30 minutes. 
The supematant was decanted and the pellet washed in 70% ethanol, dried and resuspended 
in distilled water or appropriate solution. 
2.4.5 Cloning of DNA Fragments 
Preparation of plasmid vectors 
All cloning used pBluescriptii, lac19 lacz(a-fragment)ApR (Short et al., 1988). After 
digestion with EcoRV the DNA was resuspended in phosphatase buffer and 
dephosphorylated using 24 units of calf intestinal alkaline phosphatase at 37°C for 45 
minutes. The vector DNA was then phenol/chloroform-extracted three times and ethanol-
precipitated. The plasmid pellet was resuspended in distilled water and stored at -20°C. 
22 
Preparation of insert DNA 
200 ng of DNA, l U/~-tl Klenow, 1x dNTPs, 1 U T4 DNA polymerase and 0.5x T4 DNA 
polymerase buffer, add water to 20 ~-tl. Incubate at room temperature 30 minutes then at 
65°C for 5 minutes. Add 1x PNK buffer and IOU PNK and incubate at 37°C for 15 
minutes followed by an incubation at 65°C for 10 minutes. Ethanol precipitate and 
resuspend the DNA in distilled water. 
Ligation of insert DNA into vector 
ligation reactions contained the following: 
30 ng vector DNA 
100 ng insert DNA 
1x T4 DNA ligase buffer 
800 units of T4 DNA ligase 
dH20 to 10 ~-tl. 
Reactions were incubated at 14 °C overnight. 
Preparation of competent cells 
10 ml of '¥B was innoculated with a single DH5a colony and grown at 37°C until 
A550=0.30 was reached (approximately 3 hours). A 5 ml portion of culture was then 
transferred to 100 ml of prewarmed '¥B and grown until A550=0.55 (approximately 2 
hours). The cells were then chilled on wet ice, transferred into 50 ml falcon tubes and 
centrifuged (speed 5) for 8 minutes. The broth was decanted and the pellet resuspended in 
15 ml of ice-cold Tfbl (per 50 ml culture). This was spun for a further 8 minutes, 
supernatant removed and pellet resuspended in 2 ml of ice-cold Tfbll (per 15 ml culture). 
Cells were snap frozen in 100 ~-tl aliquots using a dry ice/ethanol bath and stored at -80°C. 
Transformation 
DH5a: (supE44 hsdR17 recAJ endAJ gyrA96 thi-1 relAJ) was used as the host strain for 
all transformations. 100 ~-tl of competent cells were thawed at room temperature, placed on 
ice for 10 minutes and half the ligation mix added. After incubation for a further 30 minutes 
they were heat treated at 42°C for 2 minutes and immediately placed on ice for 3 minutes. 
Luria broth was added (300 ~-tl) and the cells left shaking for 60 minutes at 37°C. The 
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cultured cells were plated onto BB agar containing 100 mg/ml ampicillin, 40 mg/ml BCIG, 
40 mg/ml IPTG and incubated overnight at 37°C. 
2.4.6 Plasmid DNA Isolation 
Wizard minipreps 
Plasmids were isolated using the Wizard™ miniprep system following the manufacturers 
instructions (Promega). 
Polyethylene glycol preparations 
The PEG method was used to isolate plasmid DNA for the purpose of sequencing. 
TB (5 ml with 5 mg/ml of ampicillin) was innoculated with a loopful of cells and incubated 
at 37°C with shaking overnight. DNA was extracted as described by Applied Biosystems 
Incorporated. 
2.4.7 DNA Sequencing 
DNA sequencing was carried out by the Centre for Gene Research (Department of 
Biochemistry, University of Otago, Dunedin) on an Applied Biosystems 373 DNA 
Sequencer. 
2.4.8 Oligonucleotide Synthesis 
Oligonucleotides were synthesised on an Applied Biosystems Inc. 380A DNA synthesizer 
operated by Michelle French (University of Otago, Dunedin). 
2.4.9 Southern Hybridisation 
DNA Transfer 
Transfer of DNA was essentially as in (Sambrook et al., 1989) with the following 
modifications. Gels were depurinated by washing in 0.25 M HCl for 15 minutes, rinsed in 
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distilled water and washed twice in an alkaline wash (1.5 M NaCl, 0.5 M NaOH) with 
gentle shaking. Gels were blotted directly from the alkaline wash solution by capillary 
action for twelve hours. Filters were removed and treated in the following solutions at 61 °C 
with shaking: 
1x 15 minutes 
1x 15 minutes 
1x 15 minutes 
2xSSC, 0.1 % SDS, 0.1M Tris pH7.2 
2xSSC, 0.1% SDS 
2xSSC, 0.1 % SDS 
For colony hybridisation Hybond N+ membranes were placed in contact with the colonies 
for 1 minute, peeled off and placed on 0.5 M NaOH/ NaCl soaked 3MM Whatmann for 30 
minutes. 
Prehybridisation and Hybridisation 
Membranes were placed into hybaid ·hybridisation bottles separated by layers of mesh 
soaked in 10 ml of 65°C hybridisation solution (Section 2.2). The membranes were 
incubated at 65°C, with rotation, for 2 hours. After prehybridisation all solution was 
emptied from the bottle and the prepared probe added with 15 mls of fresh preheated 
solution. The bottle was returned to the oven and incubated a further 12 hours at 65°C with 
rotation. Membranes were then removed from the bottle and washed in the following 
solutions at 63°C with shaking: 
1x 1 minute 
1x 15 minutes 
1x 30 minutes 
2x SSC, 0.1% SDS 
2x SSC, 0.1% SDS 
1x SSC, 0.1% SDS 
Each membrane was blotted dry and sealed in plastic prior to being exposed to X-OMAT 
TM AR-S film for an appropriate period of time depending on the signal intensity. 
2.4.10 Preparation of Radioactively Labeled DNA 
Oligonucleotides (8 pmoll)-11) were end-labeled using 1 ~Ci.J..Ll [y-33P]dATP and 0.05 U/~1 
T4 polynucleotide kinase, as described by (Sambrook et al., 1989). 
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Probe DNA (50 ng) was labeled with 1 !lCi.!-.tl [a-
32
P]dCTP using a Random prime DNA 
Labeling Kit (Boehringer Mannheim). 
2.5 RNA PREPARATION 
2.5.1 Cesium Chloride Method 
50 mg of tissue or 5 ml of blood was Homogenised in 2.5 ml guanidinium cocktail and 16 
Ill of Beta-mecaptoethanol. RNA was extracted as described by Chomczynski 
(Chomczynski and Sacchi, 1987). 
2.5.2 TRizol reagent preparation 
Used as per manufacturers instructions (Life Technologies) to isolate total RNA. 
2.5.3 Rneasy Mini Kit 
Used to isolate RNA as per manufacturers instructions (Qiagen). 
2.6 REVERSE TRANSCRIPTION 
0.25-0.5 ng of RNA was added to a mix containing 1 pmoll!ll of an oligo T 17 primer and 
heated to 70°C for 10 minutes and then quickly chilled on ice and the following components 
added: 
5x Superscript Buffer (Boehringer) 
1mMDTT 
0.5 mMdNTP 
10 U/!ll Superscript II reverse transcriptase 
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This mix was further incubated at 42°C for 50 minutes and the reaction terminated by 
heating at 70°C for 15 minutes. 
2.7 PCR VARIATIONS 
2.7.1 Standard PCR 
cDNA was added to a PCR mix of: 
1x Buffer (Life Technologies or Boehringer) 
0.2rnMdNTP 
Variable Mg2+ 
1 pmoll).ll Primer left 
1 pmoll).ll Primer right 
Taq or HIFI Polymerase 
All PCR reactions were carried out on a Stratagene Robocycler. 
2. 7.2 Microsatellite PCR 
50 ng of genomic DNA was added to the PCR cocktail below. Primers were labeled as in 
Section 2.4.10. Reaction conditions are mentioned in each chapter with the corresponding 
primer information. 
50 ng genomic DNA 
1x PCR buffer (Life Technologies) 
0.2 mM dNTPs 
variable Mg2+ 
2 ).lg/).ll BSA 
0.48 pmoll).ll unlabeled primer 
0.03 pmoll).lllabeled primer 
0.04 U/).ll Taq Polymerase 
Products were electrophoresed as described in Section 2.4.2. 
2.7.3 Competitive RT-PCR 
Synthesis of Mdr 1 and Actin Internal Control RNA 
RNA was syntheised from each linearised plasmid DNA by combining: 
1x T7 RNA Buffer (Life Technologies) 
lOmMDDT 
1 U/J..tl RNasin ®Ribonuclease inhibitor 
2.5 mM each of ATP, GTP, CTP and UTP. 
1.0-2.5 J..lg/J,.lllinearised template DNA 
1 U/J..tl T7 RNA polymerase 
27 
This mix was incubated for two hours at 40°C. 2 J..tl of RQ1 RNase free Dnase (Promega) 
was then added and the mix incubated at 37°C for 15 minutes. RNA was phenol-
chloroform extracted, ethanol precipitated (Section 2.4.4) and the pellet resuspended in 70 
% ethanol for storage at -80°C. Prior to use the solution was spun for 30 minutes and the 
pellet resuspended in DEPC treated RzO. 
RT-PCR 
1J,.lg/J,.ll of RNA was added to a mixture containing: 
1.0 pmol/J..tl primer con 7 or primer L 
1 J..tl Competitive DNA (MDR1: 1 pg/J,.ll and Actin: 0.8 pg/J..tl) 
1 U/J..tl Rnasin inhibitor 
8mMDDT 
1x First Strand buffer (Boehringer) 
0.1 mMdNTP 
5 U/J..tl Superscript II 
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This mixture was incubated at 50°C for 1 hour on a Stratagene Robocycler. 1.0 pmolfl,tl con 
7 or primer L was labeled with y3P ATP (Section 2.4.10) and added to the following mix: 
1x Gibco Buffer (Life Technologies) 
0.26mMdNTP 
2 1-lg/!-ll BSA 
0.04 U/1-ll Taq polymerase 
0.2 pmoll!-ll unlabeled primer (MDR1: con 8, actin: primer U) 
0.1 pmoll!-lllabeled primer (MDR1: con 7, actin: primer L) 
10 I-ll of this cocktail was added to the cDNA mix. The PCR consisted of 28 cycles of 
93°C, 30 seconds; 63°C or 58°C (actin, MDR1 respectively), 45 seconds; 72°C, 1 minute 
with an initial denaturation time of 2 minutes and a final extension time of 5 minutes. 
Controls included wells with no cDNA, no PCR mix, internal control only RNA and target 
only RNA. MDR1 and actin products were separated on denaturating acrylamide gels 
(Section 2.4.2) and run for 3 and 5.5 hours respectively. Dried down gels were exposed to 
a Fujifilm Bioimaging Plate for 2-8 hours depending on signal intensity and band density 
read off the screen using the Bioimaging Analyser BAS-1500 (Fuji). 
Software and Analysis 
Band density is measured by drawing a rectangular box down a lane spanning bands of 
interest (Figure 2.1A). A profile of this region is constructed on which reading limits can 
be assigned (Figure 2.1B) and band densities of selected peaks recorded. Band density 
values are used to calculate ratios first between the MDR1 internal control and target bands 
(and similarly with actin) and secondly, the ratio of the respective MDR1/actin ratios. The 
final ratio obtained from each animal to compare MDR1 mRNA levels is shown in Figure 
2.1C. Data was statistically analysed using two tailed student t-tests, two independent 
samples or paired samples. All F-values are given at a significance level of 0.05. 
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Figure 2.1 Competitive PCR methodology. (A) Typical polyacrylamide gel showing the 
internal control and target amplified products. (B) profile drawn of the bands selected from 
(A). Boxes are drawn around the two peaks (representing the two products) to establish the 
boundaries of quantitation. (C) quantitation values are used to obtain the MDRl 
expression ratio relative to the actin gene. 
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2.7.4 Single Cell RT-PCR 
Cell Separation and Fluorescent Labeling 
Blood was collected by jugular venipuncture into acid citrate dextose and maintained at 
room temperature prior to cell separation. Single cell RT-PCR used the method described 
by (Mirsky et al., 1996). Monoclonal antibodies Plg45A (anti-bovine IgM; 5!-lg/ml) used to 
label proliferal blood monocytes (PBMCs) were purchased from VMRD (Pullman, W A). B 
cells were labeled directly with fluorescein isothiocyanate (FITC)-conjugated goat F(ab')2 
anti-mouse IgG2b (Southern Biotechnology, Birmingham, AL). Mouse IgG2b was used 
as an irrelevant isotype control for indirect immunofluorescence. 
Cell Sorting 
A laser based flow cytometer equipped with a single cell deposition device (Epics™ 751 
with autoclone; Coulter Electronics. Miami. USA) and a Cicero™ data acquisition and 
sorting system (Cytomation, Fort Collins, USA) were used to sort leukocytes on the basis 
of forward and 90° light scatter. B-cells were sorted on log FITC fluorescence. The desired 
number of cells (500 or 1000) were sorted into wells of 96-well microtitre plates containing 
10 J.ll of lysis solution (150 mM KCl, 100 mM Tris-HCl, 0.25 mM NaC12, 0.05 % N-
onide® P-40 pH 8.3 and 8U RNasin). Two wells received 1000 cells (Positive controls), 
six wells received no cells (negative controls) and the remainder had 500 cells sorted into 
them. 
RT-PCR 
10 J.ll of the following mix was added to each well containing the sorted, lysed B- or 
leukocyte cells: 
2.5 mM dNTPs 
2mMDDT 
1 U/J.ll Reverse Transcriptase (M-ML V) 
8 pmol/J.ll primer MDR 1629 
8 pmol/J.ll GAPDH-R 
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This mix was incubated at 42°C for 60 minutes and a further 10 minutes at 94°C on a PTC-
100 thermal cyder. 
First Round PCR 
Both the target and the external control first round amplifications were carried out in the 
same wells of a microtitre plate. 
Cold start mix 
2.5 mMMgC12 
1 pmol/J.Ll MDR 1629 
1 pmol/)ll MDR con 22 
1 pmol/J.Ll GAPDH-L 
1 pmol/J.Ll GAPDH-R 
Hot Start 
2.5 mMMgC12 
0.5 mM dNTPs 
0.04 U/J.Ll Taq Polymerase 
10 J.Ll of the cold start mix was added to each well cDNA and incubated at 94°C for 4 
minutes before adding 5 J.Ll of the hot start mix. The cycling parameters used were: 39 
cycles of 94 °C, 1 minute; 60°C, 1 minute; 72°C 1 minute with a final extension time of 5 
minutes. 
Second Round PCR 
Aliquots (5 J.Ll) of the first round amplification mixes were transferred into two trays 
representing separated MDR1 and GAPDH amplifications. 25 )ll of cold mix containing 
heminested primers was added to each well and the trays incubated at 94°C for 4 minutes. 
20 J.Ll of the hot start was then added and the cycling parameters for the second round of 
PCR were: 29 cycles 94°C 1 minute; 63°C, 1 minute; 72°C 30 seconds with a final 
extension time of 5 minutes. 
Cold Start 
1x Buffer (Life Technologies) 
0.8 pmol/J.Ll MDR 1629 or GAPDH-L 
0.8 pmol/J.Ll MDR 1380 or GAPDH-Int 
Hot Start 
1x Buffer (Life Technologies) 
0.5 mM dNTPs 
0.02 U/J.Ll Taq Polymerase 
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Products of the MDR1 and GAPDH second round amplifications from each initial well 
were visualised with UV light after electrophoresis in 6 % polyacrylamide gels and staining 
with ethidium bromide. 
2. 7.5 Bandstab PCR 
There was no one standard PCR cocktail or set of amplification conditions that were used 
in all reactions therefore the respective conditions are described in each relevant chapter. 
One variant on the PCR methodology that was used routinely to purify and reamplify a 
number of products was a technique referred to as bandstab PCR. The band of interest is 
stabbed with a sterile pipette tip and DNA transferred directly into the PCR cocktail by 
dipping and swirling the end of the tip in the mix. 
2.8 S'RACE AND 3'RACE 
The 5'/3' RACE kit was used to isolate sheep MDR1 5' sequence as per manufacturers 
instructions (Boehringer). 3' RACE was used to isolate the 3' end of the sheep MDR1 and 
MDR2 genes (Frohman, 1990). 
2.9 PEDIGREES 
2.9.1 International Mapping Flock (IMF) 
The AgResearch IMF was developed for genetic mapping in sheep and consists of 9 three 
generation pedigrees comprising 127 individuals (Crawford et al., 1995). Five breeds 
contributed to the pedigrees, Texel, Coopworth, Perendale, Romney and Merino. The 
different breed crosses were used to try and maximise the heterozyosity of the F 1 
generation. 
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2.9.2 Woolflock Pedigrees 
The AgResearch Woolflock families were developed to investigate fleece traits and consist 
of 4 three generation half sib families (Wuliji et al., 1995). Ultra fine Merino rams were 
mated with high fleece weight selected Romney ewes to produce four F 1 rams. These were 
then backcrossed to either Merino or Romney ewes creating approximately 100 progeny 
per sire for each backcross. In total the flock contains 411 3/4 Merino, 1/4 Romney 
offspring and 381 3/4 Romney, 1/4 Merino progeny. 
2.9.3 Facial Eczema Selection Lines 
The FE selection lines are maintained at Ruakura, Hamilton and the DNA prepared in our 
laboratory. The FE selection lines were set up in 1975 as described by Morris et al., 
(1989). Briefly 160 rams were progeny tested and the sires with offspring recording low 
liver injury scores were used as resistance (R) flock rams and those with the highest used 
as susceptible (S) flock rams. They were mated to randomly assigned ewes. Progeny tested 
rams were used for matings in 1975-1982. In 1982 the experiments was expanded with the 
addition of a control flock and reorganised with the introduction of performance testing 
(Section 2.9.5) to select the breeding rams. In later years to maintain fertility in the 
susceptible line S-sired females from unrelated dams were introduced into the breeding 
population. Figure 2.2 depicts the divergence of the selection line flocks since 1982. 
2.9.4 Facial Eczema Half-Sib Pedigrees 
DNA from the FE resource family animals was prepared in our laboratory. The FE 
resource families were set up in 1992 as described by (Crawford et al., 1997). Briefly four 
rams derived from reciprocal crosses of the selection lines (Section 2.9.3) were mated with 
130 to 170 ewes, from a FE-free area, to generate four half-sib families (Figure 2.3). 
These four half-sib pedigrees were performance tested (Section 2.9.5) and the tails 
representing the 22 most resistant and 22 most susceptible animals used to examine linkage 
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Figure 2.2 BV(LogeGGT) levels showing the divergence of the Resistant and Susceptible 
lines from the Control flock. The performance tested line represents a separate flock that 
was set up in 1982 (Morris et al., 1989) and was merged with the resistant flock in 1988. 
Adapted from Morris et al., 1995. 
2.9.5 Performance Testing 
Gamma-glutamyltransferase (GGT) is a liver enzyme released into the blood stream when 
the liver is damaged. Since FE disease is a result of liver damage caused by sporidesmin 
the quantitation of serum GGT levels of a sporidesmin dosed animal measure its degree of 
resistance to the disease (Towers and Stratton, 1978). Blood samples are collected before 
sporidesmin dosing and 21 days after dosing and GGT levels recorded. An elevation of 
more than 30 % above the pre-dose (base) GGT concentration is taken as indicative of liver 
injury and of susceptibility of an animal to that dose rate of sporidesmin. A sequential 
double dosing procedure was used to minimise the risk of lambs suffering severe clinical 
disease. Those animals showing no appreciable elevation of GGT were subjected to a 
second round of sporidesmin dosing (R flock males only) using a higher level of challenge. 
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Analysis of enzyme (GGT) data indicated that variability among animals increased with 
enzyme activity, and hence data were analysed after transformation to natural logarithms 
(Towers and Stratton, 1978). Breeding values (BV) were assigned based on the deviation 
of the animals logGGT recording from that of the mean logGGT after adjusting for fixed 
effects and the incorporation of both heritability data and data from related individuals 
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Figure 2.3 Structure of the FE half-sib pedigrees. Four sires were selected (two from 
each reciprocal mating) from the F1 and mated to approximately 200 unselected ewes to 
produce the half sib pedigrees. Each offspring was challenged with sporidesmin to get an 
estimate of resistance to the toxin by measuring GGT levels. The distribution of this 
sampling is shown by the normal curve. The two shaded tails represent the 22 most 
susceptible and 22 most resistant offspring which form the initial sample. 
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2.10 DATABASES 
2.10.1 International Mapping Flock Database 
All genotype data was entered into a custom built relational database (RDB) containing data 
on the sheep map. Custom built software (Dodds, pers comm) was used for preliminary 
two point linkage analysis to all other markers in the database and to check that genotypes 
scored in the pedigrees followed Mendelian inheritance. 
2.10.2 Woolflock Database 
The woolflock half-sib database was essentially the same as the IMF data base with custom 
built software to carry out preliminary linkage analysis. 
2.10.3 CRI-MAP 
The IMF and half sib Wool flock data sets were merged in CRI-MAP (Lander and Green, 
1987) to construct a map using the BUILD option with a tolerance for rejecting orders set at 
a lod difference of 3 and genetic distances estimated by use of the Kosambi mapping 
function. Maximum likelihood estimates of recombination fractions were calculated with 
the TWOPOINT option, with significance threshold of a lod greater than 3. Genotypes 
resulting in recombinants (CHROMPIC option) were rechecked. 
2.11 CULTURING LYMPHOCYTES 
Cells were spun at 1500 rpm 15 minutes at 10°C. 1 rnl of the middle buffy layer of white 
blood cells was pipetted off into 25 cm2 culture flasks and 17.6 mls RPMI media, 4 rnls 1 
mg/rnl conA and 1 f-I,IIrnl gentomycin added. Flasks were incubated in a C02 incubator at 
37°C for 60 hours at which time each flask was divided into three individual flasks and 
challenged with one of three doses (0, 5, and 50 ng/rnl) of sporidesmin toxin. The cells 
were incubated for a further 24 and RNA prepared using the CsCl preparation method 
(Section 2.5.1). 
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2.12 FLUORESCENT IN SITU HYBRIDISATION 
YACs containing the sheep MDR1 gene (or a portion of) were isolated using standard PCR 
(Section 2.7.1). YAC DNA was then used as a probe for fluoresence in situ hybridisation 
(FISH) of sheep chromosomes. Fluorescent in situ hybridisations were performed by Ms 
Tracey Van Stijn as described by Broom (Broom et al., 1998). 
The map position of the signal is expressed as the fractional length (FL) of the total 
chromosome, from pter (top of the short arm) to qter (bottom of the long arm), and is 
designated FLpter as in Toldo (Toldo et al., 1993). In addition NOR (nucleolus organizer 
region) staining can be used to distinguish some of the more similar sheep chromosomes 
(Ansari et al., 1993). 
2.13 YEAST ARTIFICAL CHROMOSOMES 
Yeast clones containing Y ACs were grown in 100 ml YPD for 24-48 hours at 26°C without 
shaking. Cells were harvested and YAC plugs made as described by (Broom et al., 1998) 
2.14 SEQUENCE SOFTWARE AND ANALYSIS 
DNA sequence was edited using SSEDIT. This programme was utilised in editing raw 
sequence data. 
DNA sequences were entered and assembled using VTUTIN (Stockwell, 1985). 
Analysis on compiled sequence used GCG software (Genetics Computer Group, 1994) a 
suite of programs run on a digital DEC station 5000/200. 
Homology searches were performed using BLAST (Altschul et al., 1990) on the National 
Center for Biotechnology Information (NCIB) BLAST E-mail server. 
CHAPTER THREE 





The elucidation of the structural organisation of a gene including coding length, protein 
motifs and microsatellite markers are useful for analysing the role and function of the gene 
at the molecular level. Members of the multiple drug resistance (1\IDR) family have been 
characterised in humans and a variety of rodents (Chen et al., 1986; Hsu et al, 1990; 
Devine et al., 1991; Silverman et al., 1991). Until now no report on the organisation of any 
ruminant MDR gene has been available. 
MDR1 belongs to a small multigene family with two members in humans (l\1DR1 and 
MDR2) and three in rodents (mdrl, mdr2, mdr3). Structural and sequence similarity with a 
number of other prokaryotic and eukaryotic transport proteins defines MDR1 as a member 
of the superfamily of ATP-binding cassette (ABC) transport proteins. 
Overexpression of MDR1 confers drug resistance to a wide range of cytotoxic compounds, 
through an energy driven process, that lowers the intracellular concentration of these toxic 
compounds (Gatmaitan and Arias, 1993). The MDR1 prototype is composed of 12 putative 
transmembrane domains (TMDs) and two nucleotide binding domains (NBDs). 
The MDR proteins undergo extensive post-translational modification in the form of both 
glycosylation and phosphorylation. N-linked glycosylation sites are predicted throughout 
the primary structure of mammalian MDR proteins. The number and positioning differs but 
the only externally placed sites are located in the first extracellular loop. MDR1 was first 
shown to be phosphorylated 20 years ago (Carlsen et al., 1977). Subsequent experiments 
have suggested the protein is phosphorylated by protein kinase C (PKC) at several discrete 
sites in the highly divergent linker region (Chambers et al., 1993). 
3.1.1 Aims of Chapter Three 
This chapter describes the isolation and characterisation of sheep MDR1 cDNA clones. It 
has allowed the inference that this gene functions, as do other MDR genes, as a membrane 
bound transporter. 
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3.2 MATERIALS AND METHODS 
3.2.1 RNA Extraction from Tissue 
Total cellular RNA was isolated from freshly excised sheep liver using the guanidinium 
CsCl method (Section 2.5.1). 
3.2.2 RT-PCR 
3.2.2.1 Generation of 1st strand cDNA 
RNA was reverse transcribed to produce cDNA as described in Section 2.6. The generated 
cDNA was used to amplify four overlapping fragments that spanned the sheep MDR1 
gene. These fragments, named MDR1 112, MDR1 1117, MDR1 1728 and MDR1 2528, 
were amplified using the polymerase chain reaction (PCR) and primer pairs designed from 
published consensus MDR1 sequences. 
3.2.2.2 Oligonucleotide Design 
Primers were designed to areas of MDR1 sequence which were conserved between species 
but specific to the gene. In using these parameters it was hoped the sheep MDR1 and not 
other MDR members would be amplified. All primers used in amplification and sequencing 
of the four MDR1 cDNA fragments are listed in Table 3.1. 
41 
Primer Forward/ Primer Sequence (5'-3') 5' Start Site 
Reverse of cDNA 
MDR1 1A12 
con 10 R GCATTGGCTTCCTTGACAGC 1522 
con 31 F GTCGGGATGGATCTTGAAGG 0006(-) 
con 12 R GTCATAGAGCCTCTGCATCAGC 1329 
con 37 F ATGGATCTTGAAGGGGACCGCAATGG 0001 
con42 R TTTTCGAGACGTCATCTGTGAGGCG 0535 
con 38 F ATTTTGGTGCCTGGCAGCTGG 0417 
con 41 F ATGCAAAAGCTGGAGCAGTAGC 0755 
MDR1 1117 
con 11 F GTATTGACAGCTATTCGAAGAGTGGGC 1151 
con 14 R AATATTATTGCAAATGCTGG 2191 
con 18 R GCAGGCCTCCATTTATAATGGC 2167 
con22 F GTTCACTTCCATTACCCATCTCG 1204 
con26 R GTTCATTTCCTTTTGTCTGC 1899 
con 3 F CTGAAAACATTCGCTATGGCCG 1469 
con 35 F CGCAATGCTGACATCATTGCTGG 1792 
MDR1 1728 
con 3 F CTGAAAACATTCGCTATGGCCG 1469 
con6 R TCACTGGCGCTTTGTTCCAGC 3838 
con2 R AATCACCAGGATCAAGTCTGCG 3732 
con 17 F CCTTTTGGAGGATTATGAAGC 2101 
con 39 F AAAGCAGGCGAGATCCTCACCAGGC 2350 
con27 R GCTGTAGCTGTCAATCAAAGGG 3060 
con28 F TTCCGATCCATGCTCAGACAGG 2390 
con 29 F CCTTCATCTATGGTTGGC 2564 
con4 R CTGCAGTCAAACAGGATGGGCTC 3370 
con 7 R TGAGCGATCACAATGCAGGTGC 3689 
con 34 F TCCTATGCTGGCTGTTTCCG 2869 
con40 R TTTCAGGGCTTGTCCAGACAGC 2650 
MDRl 2528 
con 1 F GGGAAGAGCACAGTGGTCCAG 3238 
con6 R TCACTGGCGCTTTGTTCCAGC 3838 
con 8 F CTCCTGGAGCGGTTCTACGACC 3259 
con 7 R TGAGCGATCACAATGCAGGTGC 3689 
con 36 F ACAGCCTCACATCTTGCTTCTGG 3591 
Table 3.1 Primer sequences used in PCR and sequencing of the sheep :MDRl cDNA 
fragments. Orientation is indicated by F (forward) or R (reverse). 
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3.2.2.3 Amplification of Fragments 
All amplifications used High Fidelity (HIFI) polymerase (Boehringer Mannheim). The 
inherent 3'-5' exonuclease proof reading activity of this enzyme mix results in a 3-fold 
increase in fidelity of DNA synthesis compared to Taq DNA polymerase. A standard PCR 
mix (Section 2.7.1) with 50 ng cDNA, 2 mM Mg2+ and 0.03 U/~-tl HIFI polymerase was 
used to amplify first round products. An aliquot C2~-tl) of these first round reactions was 
used in a second nested PCR. All PCR reactions were pe1formed in thin walled tubes with 
PCR conditions presented in Table 3.2. 
Primer Pairs Mg"+ PCR Cycles 
MDR1 1A12 
con 31 & con 10 2.0mM 94°C 3': 1 cycle ; 94°C 1', 56°C 1', 72°C 1'30" : 28 cycles; 72°C 
5': 1 cycle 
con 37 & con 12 2.0mM 94°C 2': 1 cycle; 94°C 2', 56 oc 40", 72°C 30": 28 cycles; 72°C 
5': 1 cycle 
MDR1 1117 
con 11 & con 14 2.0mM 94°C 3': 1 cycle; 94°C 1', 56°C 1', 72°C 1': 28 cycles; 72°C 5': 
1 cycle 
con 22 & con 18 3.0 mM 94°C 3': 1 cycle; 94°C 1', 56°C 1', 72°C 1': 28 cycles ; 72°C 5' : 
1 cycle 
MDR1 1728 
con 3 & con 6 3.0 mM 95°C 3': 1 cycle; 94°C 1', 54°C 1', 72°C 2' : 28 cycles; 72°C 5' : 
1 cycle 
con 17 & con 2 2.0mM 95°C 3': 1 cycle; 94°C 1', 55°C 1', 72°C 2' : 28 cycles; 72°C 5' : 
1 cycle 
MDR1 2528 
con 1 & con 6 1.0 mM 94°C 3': 1 cycle; 94°C 1', 57°C 1', 72°C 45": 28 cycles; 72°C 5': 
1 cycle 
con 8 & con 6 2.0mM 94°C 3': 1 cycle; 94°C 1', 58°C 1', 72°C 45": 28 cycles; 72°C 5': 
1 cycle 
Table 3.2 Primer pairs and corresponding PCR conditions used in amplifying MDRI 
cDNA fragments. The second pairing in each box represents the nested primers. 
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3.2.3 Cloning and Sequencing of Sheep cDNA Fragments 
Each duplicate PCR (eight in total) representing the four fragments were gel purified using 
the QIAEXII kit (Qiagen) and partially sequenced to confirm their homology to :MDR1 
prior to cloning. Purified DNA was then ligated into pBluescript II and transformed into 
E.coli DHSa prior to plating onto selective media (Section 2.4.5). 
Colony hybridisation probing with 50 ng of purified PCR product was used to identify 
positive transformants and plasmid DNA isolated using the wizard plasmid purification kit 
(Promega). DNA was digested with 1 U/!-t1 Xbal and 1 U/).!1 Sali in a mix containing 1x 
Buffer H (Boehringer) to screen for recombinants carrying the correct insert size. Two 
clones were selected for sequence characterisation. 
DNA for sequencing was prepared from overnight cultures using the polyethylene glycol 
(PEG) preparation (Section 2.4.6). As the maximum reading ability was 400 bp the larger 
clones required additional :MDR1 specific primers to be designed to obtain the complete 
sheep :MDR1 cDNA sequence (Table 3.1). Sequence at any point was derived from at least 
two clones obtained from independent amplifications. Both strands were sequenced and 
any ambiguities were checked by direct sequencing of the PCR product. 
3.2.4 Rapid Amplification of 5' and 3' Ends 
3.2.4.1 5' RACE 
As the conservation of 5' UTRs between :MDR genes is low, primers designed to human 
:MDR1 sequence did not amplify sheep DNA. The 5'/3' RACE kit (Boehringer) was used 
to isolate sheep :MDR1 5' sequence. 
First strand cDNA was synthesised using con 42. The resulting product was purified 
through the High Pure PCR Product Purification Kit (Boehringer) and a homopolymeric 
tail added using terminal transferase and dATP. First round PCR used the oligo dT-anchor 
primer and an :MDR1 specific primer, con 71. Amplification conditions were: 10 cycles of 
94°C, 15 seconds; 55°C, 30 seconds; 72°C, 40 seconds; followed by 25 cycles of 94°C, 15 
seconds; 55°C, 30 seconds; 72°C, 40 seconds (plus 20 seconds each cycle) with an initial 
denaturation time of 2 minutes and a final extension time of 7 minutes. Resulting products 
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were further amplified in a nested PCR using the anchor primer and a nested MDR1 
specific primer, con 59. Amplification conditions were as in the first round PCR with the 
annealing temperature raised to 60°C. All primers are listed in Table 3.3. The final product 
was gel purified using the QIAEXII kit and directly sequenced using con 59 prior to 
cloning into pBluescriptll. 




oligo d(T)-anchor primer* GACCACGCGTATCGATGTCGACTTTTTTTTTTTTTTTTV 
anchor primer* GACCACGCGTATCGATGTCGAC 
Table 3.3 Primers used in 5' RACE. The first box lists the MDR1 gene specific primers. 
Those labeled with an * are supplied with the 5'/3' RACE kit (Boehringer). The "V" in 
oligo d(T)-anchor primer represents either an A, G or C base. 
3.2.4.2 3' RACE 
Isolating the 3' UTR of MDR1 involved amplification using an oligo d(T) 17 primer; 5 '-
GACTCGAGTCGACATCGA(T)17-3' and a gene specific primer con 36; 5'-
ACAGCCTCACATCTTGCTTCTGG-3', located 5' to the TAG termination codon. 50 ng 
of either cDNA or sheep genomic DNA was added to a standard PCR mix (Section 2. 7.1) 
containing 2 mM Mg2+ and 0.04 U/J..Ll HIFI polymerase. The PCR was in thin walled 0.5 
ml tubes with: 28 cycles of 92°C, 30 seconds; 54°C, 45 seconds; 72°C 1 minute with an 
initial denaturation time of 2 minutes and a final extension time of 5 minutes. 
Nested 3' RACE 
10 J..Ll of the above PCR was run out on a 1% agarose gel and the appropriate sized bands 
further amplified by bandstabbing (Section 2. 7 .5) into a hemi-nested PCR using a second 
gene specific primer, con 32, of sequence: 5'-CAGAACGCAGACTTGATAGTGG-3'. 
The resulting product was purified using the spin method (Section 2.4.3) and sequenced 
directly using con 32. 
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3.3 RESULTS 
3.3.1 Amplification of MDRl cDNA 
Figure 3.1 represents a schematic diagram of the four PCR products amplified to obtain the 
full length sheep MDR1 cDNA. Sizes were originally estimated from the human MDR1 
cDNA as 1.5 kb, 0.98 kb, 1.6 kb and 0.60 kb. 
1 2 3 4 5 6 A B 7 8 9 10 11 12 2A 2B 






599bp I MDRl 2528 
Figure 3.1 Sheep MDR1 cDNA clone positions. The proposed transmembrane regions 
are marked by numbered boxes. The two consensus sequences that form the potential 
nucleotide binding folds are marked by solid boxes lettered A, B and 2A, 2B. The 
positions of the four cloned PCR products, MDR1 1A12, MDR1 1117, MDR1 1728 and 
MDR1 2528 are shown. Their lengths in nucleotides are shown. 
In the case of the three larger PCR products (MDR1: 1A12, 1117, 1728) a contaminant eo-
amplified with the estimated sized product. Purity involved re-amplification using bandstab 
PCR. All products were gel isolated and direct sequencing gave recognisable but not 
optimal sequence. The cloning of these products allowed not only the generation of better 
quality sequence but a sustainable and easily accessible resource of each respective cDNA 
fragment for further manipulation and sequence analysis. 
3.3.2 Nucleotide and Predicted Amino Acid Sequence 
The complete nucleotide and amino acid sequence of the sheep MDR1 gene is depicted in 
Figure 3.2. The sheep MDR1 cDNA ORF is capable of encoding a polypeptide of 1286 
amino acids in length (Genbank accession number U78609). 
GAGAAGTCGGGGCGCGTTCGAGCAGCGGCTCTTCAAGACTCTCAGGAGCCGAGACCGCTGTTCGCATTCGCCGCGTTTTTCCGCTGGAGT -63 
CTGAATCTCTTCTTCAAAGGTTCACGCCTTAGTGAACGTTCCGAGGGAAAGCCCGAGGTCGCGATGGATCTTGAAGGGGACCGCAATGGA 27 
M D L E G D R N G 
A 
AGAGCAGCGGGGGGAAATTTCTTGAAAAGGGACAAAAAAAGGTTTTTCAGTAAAAAAGATGAGAAGAAAGAAAAGAGACCAACTGTCAGT 117 
R A A G G N F L K R D K K R F F S K K D E K K E K R P T V S 
ACTTTTACAATGTTTCGCTATTCAAATTGGCTCGATAGGTTGTGTATGGTGCTGGGGACTTTGGCTGCCATCATCCACGGAGCTGGACTC 207 
T F T M F R Y S N W L D R L C M V L G T L A A I I H G A G L 
A A 
CCCCTCATGATGCTAGTGTTTGGAGACATGACGGATAGCTTTGCAGGTGCTGGAAATTTCGGGAACATAACTCTTTCAAACATAAGTAAT 297 
P L M M L v F G D M T D s F A G A G N F G IN I T I L sIN I sl[1!] 
ACAAGTACTATAGACAGAACAGAGTATGGCAAGAAGCTGGAGAAGGAAATGACCACGTATGCCTACTATTACTCTGGAATTGGTGCTGGC 387 
~ T I D R T E Y G K K L E K E M T T Y A Y Y Y S G I G A G 
GTGCTTATTGCCGCTTACATCCAGGTCTCATTTTGGTGTCTGGCCGCTGGAAGACAAGTACACAGAATCAGAAAACAGTTTTTTCATGCC 477 
V L I A A Y I Q V S F W C L A A G R Q V H R I R K Q F F H A 
ATCATGCAACAGGAAATAGGCTGGTTTGACGTGCATGACGTTGGAAAACTTAACACCCGCCTCACAAATGACGTCTCCAAAATTAATGAA 567 
I M Q Q E I G W F D V H D V G K L N T R L T N D V S K I N E 
GGAATTGGTGACAAAATCGGAATGTTCTTTCAGGCAATGGCGACATTCTTCACCGGTTTTATAATAGGATTTACAACAGGTTGGAACCTC 657 
G I G D K I G M F F Q A M A T F F T G F I I G F T T G W ~ 
ACCCTTGTGATTCTGGCCATCATTCCTGTTCTTGGCCTGTCAGCTGCTATCTGGGCAAAGATACTGTCTTCATTTACTGATAAAAAACTT 747 
~L V I L A I I P V L G L S A A I W A K I L S S F T D K K L 
TTGGCATATGCAAAAGCTGGAGCAGTAGCTGAAGAGGTCTTAGCGGCTATTAAAACTGTGATTGCATTTGGAGGACAAAAAAAAGAACTT 837 
L A Y A K A G A V A E E V L A A I K T V I A F G G Q K K E L 
GAAAGGTACAACAAAAACTTGGAAGAAGCCAAGAGAATTGGAATAAAGAAGGCTATCACGGCCAACATCTCTATGGGAGCTGCTTTTCTG 927 
E R Y N K N L E E A K R I G I K K A I T A IN I si M G A A F L 
TTGATCTATGCATCCTATGCCCTGGCGTTCTGGTACGGGACCTCCTTGGTCCTCTCAAGAGAATATTCCATTGGACAAGTGCTCACAGTC 1017 
L I Y A S Y A L A F W Y G T S L V L S R E Y S I G Q V L T V 
TTCTTTTCTGTATTAATTGGAGCTTTTAGTATTGGACAGGCATCTCCAAACATTGAGGCATTTGCAAACGCAAGAGGAGCAGCTTATGAA 1107 
F F S V L I G A F S I G Q A S P N I E A F A N A R G A A Y E 
GTCTTCAAGATCATTGATAACAAACCAAGCATCGACAGCTATTCAAACACTGGGCACAAACCCGACAATATTAAAGGAAATCTGGAATTC 1197 
V F K I I D N K P S I D S Y S N T G H K P D N I K G N L E F 
AGAAATGTTCACTTCCATTACCCATCTCGAAACGAAGTTAAGATCTTGAAGGGCCTCAACCTGAAGGTAGGGAGTGGGCAGACGGTGGCC 1287 
R N V H F H Y P S R N E V K I L K G L N L K V G S G Q T V A 
CTGGTTGGGAACAGTGGCTGTGGGAAGAGCACCACCGTCCAGCTGATGCAGAGGCTCTATGACCCCACGGAGGGCATGGTCAGTATCGAC 1377 
L V G N S G C G K S T T V Q L M Q R L Y D P T E G M V S I D 
GGACAGGATATCAGGACCATCAACGTAAGGTATCTGCGGGAGATTATCGGGGTGGTGAGTCAGGAGCCTGTGCTGTTTGCCACCACGATA 1467 
G Q D I R T I N V R Y L R E I I G V V S Q E P V L F A T T I 
GCTGAGAACATTCGCTACGGCCGTGAAGATGTCACCATGGATGAGATTCAGAAAGCTGTGAAGGAAGCCAACGCCTATGACTTTATCATG 1557 




K L P N K F D T L V G E R G A Q L S G G Q K Q R I A I A R A 
CTGGTTCGCAACCCCAAGATCCTCCTGTTGGATGAGGCCACCTCAGCGCTGGGCACCGAGAGTGAAGCGGTGGTTCAGGCGGCCCTGGAT 1737 
L V R N P K I L L L D E A T S A L G T E S E A V V Q A A L D 
AAGGCCAGAGAAGGCCGGACCACCATTGTGATAGCGCATCGTCTGTCCACGGTTCGCAATGCTGACATCATTGCTGGTCTTGATGATGGA 1827 
K A R E G R T T I V I A H R L S T V R N A D I I A G L D D G 
GTCATCGTGGAGGAAGGCAGTCATGATGAGCTCATGGGGAAAAAAGGCATTTACTTCAAACTTGTCACAATGCAGACAAAAGGAAATGAA 1917 
V I V E E G S H D E L M G K K G I Y F K L V T M Q T K G N E 
CTTGAATTGGAAAATACCCCTGGTGAATCCCTAAGTAAAACTGATGACTTGTACATGTCCTCCCAAGATTCAAGATCCAGTCTAATCAGA 2007 
L E L E N T P G E S L S K T D D L Y M S S Q D S R S ~ L I R 
AGAAAATCAACTCGCAGGAGTATCCGTGGATCCCAAAGCCAGGACAGAAAGCTCAGTACAGAAGAAACTTTGGATGAAAGTGTACCTCCC 2097 
R K ~ T R R ~ I R G [[] Q S Q D R K L [[] T E E T L D E S V P P 
GTTTCCTTTTGGAGGATTATGAAGCTGAATATAACTGAATGGCCTTATTTTGTGGTTGGTGTATTTTGTGCCATTATAAATGGAGGCCTG 2187 
V s F w R I M K L IN I Tl E w p y F V V G V F c A I I N G G L 
CAACCAGCATTCTCAGTCATATTTTCAAGGATTATAGGAATCTTCACCAGAAATGACAATGACGAAACCAAACGACAGAACAGTAACTTG 2277 
Q P A F S V I F S R I I G I F T R N D N D E T K R Q N S N L 
TTTTCACTGTTGTTTCTAATCCTTGGAATTATTTCTTTTATTACATTTTTCCTTCAGGGCTTCACGTTCGGCAAAGCAGGCGAGATCCTC 2367 
F S L L F L I L G I I S F I T F F L Q G F T F G K A G E I L 
ACCAGGCGGCTGCGGTACCTGGTTTTCAGGTCGATGCTGAGACAGGATGTGAGCTGGTTCGATGACCCTAAAAACACCACGGGAGCATTG 2457 
T R R L R y L V F R s M L R Q D V s w F D D p K IN T Tl G A L 
ACGACCAGGCTTGCCAATGACGCCGCTCAAGTTAAAGGGGCTGTAGGTTCCAGGCTTGCTGTAATTACCCAGAATATTGCAAATCTTGGC 2547 
T T R L A N D A A Q V K G A V G S R L A V I T Q N I A N L G 
ACAGGCATTATCATATCCCTCATCTATGGCTGGCAGTTAACACTTCTCCTGTTAGCAATTGTACCCATCATTGCAGTAGCAGGAGTTATT 2637 
T G I I I S L I Y G W Q L T L L L L A I V P I I A V A G V I 
GAAATGAAAATGCTGTCTGGACAAGCCCTGAAAGATAAGAAAGAACTGGAAGGTGCTGGGAAGATTGCCACTGAAGCAATAGAAAACTTC 2727 
E M K M L S G Q A L K D K K E L E G A G K I A T E A I E N F 
CGGACGGTTGTTTCTTTGACTCGGGAGGAGAGGTTTGAATATATGTATGCCCAGAGTTTGCAGGTACCATACAGAAACTCCTTGAGGAGA 2817 
R T V V S L T R E E R F E Y M Y A Q S L Q V P Y R N S L R R 
GCGCATGTCTTTGGAATTACATTTTCCATCACTCAGGCAATGATGTATTTCTCCTATGCTGGCTGTTTCCGGTTTGGTGCCTACTTGGTG 2907 
A H V F G I T F S I T Q A M M Y F S Y A G C F R F G A Y L V 
GCCCAAGGCATCATGGAGTTTCAGGATGTTCTCTTAGTGTTCTCAGCTGTTGTCTTTGGTGCCATGGCTGTGGGACAGGTCAGTACATTT 2997 
A Q G I M E F Q D V L L V F S A V V F G A M A V G Q V S T F 
GCTCCTGACTATGCCAAGGCCAAAGTGTCAGCAGCCCACGTCATCAATATCATTGAAAAAATTCCTCTGATTGACAGCTACAGCACGGAA 3087 
A P D Y A K A K V S A A H V I N I I E K I P L I D S Y S T E 
GGCCTAAAGCCGAGTACAGTGGAAGGAAGTGTGGCATTTAATGACGTCGTGTTCAACTACCCCACTCGACCAGACGTCCCAGTGCTTCGG 3177 
G L K P S T V E G S V A F N D V V F N Y P T R P D V P V L R 
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GGGCTGAGCCTGGAGGTGAAGAAGGGCCAGACGCTGGCGCTGGTGGGCAGTAGTGGCTGTGGGAAGAGCACGGTCGTCCAGCTCCTGGAG 3267 
G L S L E V K K G Q T L A L V G S S G C G K S T V V Q L L E 
CGGTTCTACGACCCCTTGGCTGGCACAGTGTTTATTGACGGCAAGGAAGTAAAGCAGCTGAATGTCCAGTGGCTGCGGGCACACATGGGC 3357 
R F Y D P L A G T V F I D G K E V K Q L N V Q W L R A H M G 
ATCGTGTCCCAGGAGCCCATTCTGTTTGACTGCAGCATCGGCGAGAATATCGCCTACGGAGACAACAGCCGGGTCGTGTCCCAGGAGGAG 3447 
I V S Q E P I L F D C S I G E N I A Y G D N S R V V S Q E E 
ATTGAGCACGCGGCCAAGGAGGCCAACATCCACTCCTTCATCGAGATGCTGCCGGACAAATACAACACCAGAGTAGGGGACAAAGGAACT 3537 
I E H A A K E A N I H S F I E M L P D K Y N T R V G D K G T 
CAGCTCTCTGGTGGCCAGAAACAGCGCATTGCCATAGCTCGCGCCCTTGTTAGACAGCCTCACATCTTGCTTCTGGATGAAGCTACCTCG 3627 
Q L S G G Q K Q R I A I A R A L V R Q P H I L L L D E A T S 
GCTCTGGACACGGAAAGTGAAAAGGTGGTCCAAGAAGCCCTGGACAAAGCCCGAGAGGGACGCACCTGCATCGTGATCGCTCACCGGCTG 3717 
A L D T E S E K V V Q E A L D K A R E G R T C I V I A H R L 
TCCACCATCCAGAACGCAGACTTGATAGTGGTGTTTCAGAATGGCAGAGTCAAGGAGCATGGCACACACCAGCAGCTGCTGGCACAGAAA 3807 
S T I Q N A D L I V V F Q N G R V K E H G T H Q Q L L A Q K 
GGCATCTATTTCTCCATGGTCAGTGTCCAGGCTGGAACAAAGCGCTAGTGAACGGTGACCATATAAGCTGTCAAATATTGTCTTATAGTA 3897 






Figure 3.2 Nucleotide sequence and deduced amino acid sequence of the sheep MDRl gene. 
Nucleotides are numbered positively in the 5' to 3' orientation beginning with residue 1 of the 
first putative ATG initiation codon and ending with the last residue including 13 adenine 
residues of the poly( A) tail. Nucleotides in the 5' UTR are numbered negatively beginning at 
the first putative initiator methionine. The deduced amino acid sequence is shown below the 
nucleotide sequence. Stars identify inframe termination codons, Arrows indicate the first three 
puative methionine initiator codons. Potential N-linked glycosylation sites are identified by 
boxed groups of residues corresponding to the sequence Asn-X-Ser or Asn-X-Thr. The highly 
hydrophobic segments possibly representing membrane spanning domains are underlined. 
Amino acid sequences compatible with the nucleotide binding fold consensus sequence and the 
Walker A motif are underlined by a thick line. The ABC family motif is underlined by a double 
line. The putative polyadenylation signal in the 3'UTR is underlined by a thin line. Conserved 
serine residues in the linker region are boxed. 
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The first possible initiator ATG codon is followed by 3858 nucleotides forming a single 
open reading frame (ORF). The presence of stop codons in all other reading frames within 
the first 60 nucleotides of the cDNA indicates that these are unlikely to be transcribed. 
Within the first 165 nucleotides two additional inframe initiator ATG codons are found at 
positions 279 bp and 315 bp. Of these three putative ATG initiator codons the first two are 
located 3 bp downstream from a purine residue and the first and third are followed at 
position +4 by a G residue. Both of these features are characteristic of genuine eukaryotic 
initiation sites (Kozak, 1984; 1986). 
Although the first inframe initiator codon is usually favoured as the initiator we cannot rule 
out the possibility that another downstream ATG is used. However the ATG codon at 
position + 1 was assigned as the probable initiator methione since: (i) it initiates a predicted 
polypeptide of size and sequence highly homologous to the products of human, mouse and 
hamster mdrl proteins and (ii) it aligns precisely with the position of initiator methionine 
predicted for these three species. The region upstream of the initiator methionine has a high 
G+C content, a characteristic of 5' untranslated regions (UTRs) of other eukaryotic 
mRNAs (Hariharan and Adams, 1987). 
The sheep MDR1 coding sequence ends with a tandem TAG/TGA termination signal and is 
followed by a segment of 516 nucleotides of 3'UTR ending with a poly(A) tail. Within the 
3 'UTR immediately upstream from the poly( A) tail is a putative AATAAA polyadenylation 
signal. Motifs similar in sequence and positioning are seen in the human (Chen et al., 1986), dog 
(Puel et al., 1998), mouse (Gros et al., 1986c) and hamster (Devine et al., 1991) 3'UTRs 
(Figure 3.3). 
3' UTR Sequence (5'-3') MDR 
1 
Sh AGATTATAGAAGTAGCAAAAAGTACTG.AATGTTTGCATATAGTGC ... CTAr AATAAAA TAAACTTTTATATGAGTCA 516 
Ca AGATTATAGAAGTGGTAAAAAGTACTG. AATGTTTGAATAAAGTGCTAGCTN AATAAAA TAAACTTTTATATGA 395 
Hu AGATTATAGAAGTAGCAAAAAGTATTGAAATGTTTGCATAAAGTG ... TCTAr AATAAAA rTAAACTTTCATGTGA 361 
Mb TGATTATAAAGATTGTAAAAAGCACT ...... ATTTCTTAAATTGCCTATAJV iAATTAAA !rTTTCATATA 355 
Ha AAATCATGTGTGTATC~AAATGTTTGTATAAAGT ... ATATATAGTGAAACTA 366 
Figure 3.3 Polyadenylation signals in the 3'UTR of sheep MDR1 (Sh), dog MDR1 (Ca), 
human MDR1 (Hu), hamster mdr1a (Ha) and mouse mdr1a (Mo) mdr1 protein sequences. The 
numbers at the end of the respective rows indicate the length of the 3' UTR in the corresponding 









The isolated sheep 3'UTR has high homology to the MDR1 (class I) genes. The length of 
MDR1 3'UTRs range from 355 bp to 395 bp. In contrast MDR2 (class Ill) has 3'UTRs of 
approximately 50 bp. The isolated sheep MDR1 3'UTR is 516 bp. An alignment of this 
sequence with other MDR1 3 'UTRs indicates apart from a short 6 bp GT repeat there are 
no apparent insertions to account for the increased 3 'UTR length. 
3.3.3 Sequence Homology 
Analysis of the primary structure of the sheep MDR1 gene product revealed that this protein 
consisted of two approximately equal halves sharing considerable amino acid sequence 
homology. An alignment of theN-terminal (residues 1-634) and C-terminal (residues 635-
1302) halves of this protein is shown in Figure 3.4. For an optimal alignment 3 large 
insertions (12, 11 and 18 residues) and 2 small gaps (2 residues) were introduced. Of the 
amino acids aligned 40.5% are identical. A further 23.5% represent pairs of functionally 
similar residues. Two pairs of segments show a particular high homology level. These 
include residues 520-596 and 1166-1242 (82.9%) as well as residues 424-451 and 1068-
1095 (77.8%). These segments contained the potential NBDs. 
One of the strongest pieces of evidence that the isolated sheep sequence is that of MDR1 
came from sequence comparison to other mammalian MDR genes (Table 3.4). Within each 
species the isolated sheep sequence was most similar to the MDR1 (class I) members and 
most divergent from the MDR2 (class Ill) members. In particular the sheep protein had 
high homology to the human MDR1 gene. 
Alignment of the sheep, human, mouse, hamster and dog MDR1 amino acid sequences 
presented in Figure 3.5 illustrates certain key features of the proteins. It depicts the 
infrequency of amino acid substitutions throughout most of the protein. Few gaps are 
needed for alignment of the MDR genes and these are mainly in segments with pronounced 
divergence: theN- terminus; the linker region; and the extracellular segment between TM 1 
and TM 2 in theN- terminal half. Almost complete identity is found within the cytoplasmic 
domain surrounding the nucleotide binding folds (98.3% ). This homology decreases in the 
proposed transmembrane associated domains (68.6%) and is the lowest in the linker region 
that joins the two halves of the protein ( 44.3% ). Apart from a 4 amino acid insertion in the 
N-terminal end of the protein the sheep MDR1 gene has no regions that differ vastly in 
length or homology with MDR1 sequences of other animal species. 
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· · 11 · · ···I I ·I · I I 11 · · · · I · · ··I· I · Ill· I· I ···I· 0.. • ... " .. " ........ 0.. • .. .. .. ...... 0 .. .. .. .. .. .. .. .. ...... " .. 0 .. 0 0 0 • .. 
Ov-C LELENTPGESLSKTDDLYMSSQDSRSSLIRRKSTRRSIRGSQSQDRKLSTEETLDESVPPVSFWRIMKL.NITEWPYFVVGVFCAIINGGLQPAFSVIFS 
Ov-N DMTDSFAGAGNFGNITLSNISNTSTIDRTEYGKKLEKEMTTYAYYYSGIGAGVLIAAYIQVSFWCLAAGRQVHRIRKQFFHAIMQQEIGWFD .. VHDVGK 
I ·I · I· · · · · · ·I ·I ··I · I·· ·I· I I· · · I··· Ill · I .. • .. .. .. .. 0 .. .. .. .. .. • 0 .... 0.. • ...... 0 • .. .. .. .. .. .. .. .. 0 ....... .... " .... .. 
Ov-C RIIGIFTRNDN .................. DETKRQNSNL .. FSLLFLILGIISFITFFLQGFTFGKAGEILTRRLRYLVFRSMLRQDVSWFDDPKNTTGA 
Ov-N LNTRLTNDVSKINEGIGDKIGMFFQAMATFFTGFIIGFTTGWNLTLVILAIIPVLGLSAAIWAKILSSFTDKKLLAYAKAGAVAEEVLAAIKTVIAFGGQ 
I. Ill. 11 ... :.::: I.::::: I.: I.: 11: 11:: · 11 ·Ill:: Ill: I::::·:· I I: 11: ·I· · · · 11 :I· I·:··:: 11: ·: · : 
Ov-C LTTRLANDAAQVKGAVGSRLAVITQNIANLGTGIIISLIYGWQLTLLLLAIVPIIAVAGVIEMKMLSGQALKDKKELEGAGKIATEAIENFRTVVSLTRE 
Ov-N KKELERYNKNLEEAKRIGIKKAITANISMGAAFLLIYASYALAFWYGTSLVLSREYSIGQVLTVFFSVLIGAFSIGQASPNIEAFANARGAAYEVFKIID 
. I ... I: : I ::::I .. I.:: . ::I Ill . I:: I. 11 . :. : 11 11 . I:: 11:.: 11. I. . . :I. I: .. I . I:. 11: 
Ov-C ERFEYMYAQSLQVPYRNSLRRAHVFGITFSITQAMMYFSYAGCFRFGAYLVAQGIMEFQDVLLVFSAVVFGAMAVGQVSTFAPDYAKAKVSAAHVINIIE 
Ov-N NKPSIDSYSNTGHKPDNIKGNLEFRNVHFHYPSRNEVKILKGLNLKVGSGQTVAL NSGCGKST VQLMQRLYDPTEGMVSIDGQDIRTINVRYLREII 
I Ill I I .. I I I .. : . I . : . I . : I I : I I . I : I . : I : 11 . I . I . Ill : 11 11 . 11 Ill I I · I I I : : I : I 11 · I I I 11 · : : : : 11 · : I I · : 
Ov-C KIPLIDSYSTEGLKPSTVEGSVAFNDVVFNYPTRPDVPVLRGLSLEVKKGQTLAL SSGCGKST QLLERFYDPLAGTVFIDGKEVKQLNVQWLRAHM 
Ov-N GVVSQEPVLFATTIAENIRYGRED .. VTMDEIQKAVKEANAYDFIMKLPNKFDTLVGERGAQLSGGQKQRIAIARALVRNP ILLLD TSALGTESEAV 
I: 11111: 11 ... I: Ill 11 :. I. : 11:. I. Ill I · · 11 · 11: I:: I 11:: I· 111111111111111111 ·I· 11111111111: Ill I I 
Ov-C GIVSQEPILFDCSIGENIAYGDNSRVVSQEEIEHAAKEANIHSFIEMLPDKYNTRVGDKGTQLSGGQKQRIAIARALVRQP ILLLD TSALDTESEKV 
Ov-N VQAALDKAREGRTTIVIAHRLSTVRNADIIAGLDDGVIVEEGSHDELMGKKGIYFKLVTMQTKGN 
11. 1111111111. 111111111:. Ill: I .. ::: I : I -1-1:: I:: -11111.: I.: I ... 
Ov-C VQEALDKAREGRTCIVIAHRLSTIQNADLIVVFQNGRVKEHGTHQQLLAQKGIYFSMVSVQAGTK 
Figure 3.4 Alignment of theN- and C- terminal halves of the sheep MDRI protein to show the similarity between the two halves. The top line 
represents the amino terminus sequence and the bottom line the C-terminal end. A bar indicates complete identity between the two amino acids. 
Two dots indicate amino acids with greater than 50% similarity and one dot greater than 10% similarity. The ABC family motif is underlined. 




Percent Nucleotide Similarity 
human human mouse mouse mouse hamster hamster hamster dog 
Genes MDR1 MDR2 mdr1a mdrlb mdr2 mdr1a mdrlb mdr2 MDR1 
(mdr3) (mdr1) (pgp1) (pgp2) (pgp3) 
87.0 73.0 83.0 79.0 72.0 84.0 80.0 72.0 86.0 
sheep (94) (85) (92) (89) (85) (93) (90) (85) (93) 
dog 0.90 0.74 0.85 0.81 0.73 0.85 0.82 0.72 
MDR1 (95) (86) (93) (90) (86) (93) (91) (86) ---
hamster 73.0 87.0 72.0 71.0 91.0 74.0 72.0 
mdr2 (86) (95) (84) (83) (98) (85) (85) --- ---
(p,q;p3) 
hamster 83.0 71.0 84.0 89.0 71.0 88.0 
mdr1b (91) (85) (92) (95) (84) (92) --- --- ---
(pgp2) 
hamster 86.0 73.0 91.0 85.0 73.0 
mdr1a (93) (85) (96) (92) (86) --- --- --- ---
(pgp1) 
mouse 73.0 87.0 73.0 72.0 
mdr2 (87) (95) (86) (84) --- --- --- --- ---
mouse 82.0 71.0 87.0 
mdr1b (90) (84) (92) --- --- --- --- --- ---
(mdr1) 
mouse 85.0 72.0 
mdr1a (93) (85) --- --- --- --- --- --- ---
(mdr3) 
human 75.0 
MDR2 (87) --- --- -- --- --- --- --- ---
Table 3.4 Nucleotide similarity between J\1DR genes. The bracketed figure corresponds 
to amino acid similarity between the two respective genes. Alternative nomenclature for 
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oa LDEATSALDTESEAVVQi:jALPKA!!~GRTTIVIABRLSTVRNADVIAGFDDGVIVE GNHDELMKEKGIYFKLVTMQT!!GN 
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ea RSMLRQDVSWFDDPKNTTGALTTRLANDAAQVKGA.tGS AVITQNIANLG'l'GIIISLilt' 
'h RSMLRQDVSWFDDPK!ITTGALTTRLANDAAQVKGAVGS AVITQNIANL<lTGIIISLI 
ha XSMLRQDV.SWFDWI?KNT.TGALTTRLA!IDA.GQVKGA~ .. (il LAVITQNIANLGTGIIISLilt' 
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MKMI.SGQALKDKKELEGAGKIATEAIENl"RTVVSLT~EQKF AQSLQVPYRNSLRKAH FGITFSFTQAMMYl"SY 
MKMLSGQALKDKKELEGAGKIATEAIENF!!TVVSLTREQKF AQSLQVPYRNSLRKAE FG'!/8FS~TQAMMlt'FSY 
MKMLSGQALKDKKELEGAGKIATEAIENFRTVVSLTRE!ilffF AQSLQVPYRNSLRI{AE FGIT1/S~TQAMMYFSY 
MKMLSGQALKDKKELEG~KIATZAIENFRTVVSL'l'RSQKF YAQSLQIPYRN~L.~KAE FGI'l'FSFTQAMMYFSlt' 





MLVFSAVVFGAMA · N SSF PDYAKAKVSA~EIIIlJI:IEK.~.PiliiDSYSTEGL:EPWLEG 
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'" GIVSQEPILFDCSIAENIAYGDNSHVVS~EEI~• AKEAN 
'h GIVSQEPILFDCSIGENIAYGDNSRVVSQEEI AKEAN 
ha GIVSQEPILFDCSIAEN:tAYGDNSRVVSQ,j)EI RAAKEAN 
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Figure 3.5 Alignment of the human (M14758), dog (AF045016), sheep (U78609), 
hamster (M60040) and mouse (M14757) MDR1 amino acid sequences. This alignment 
shows the conserved nature of this protein across evolutionary divergent animal species. In 
positions where not all sequences agree the amino acid(s) in the minority are white faced 
with a black background. Therefore the black areas represent regions of divergence 
between the proteins. Similar amino acids are shaded with a gray background. Regions of 
high sequence conservation are white in background with black type. The TMDs are boxed 
and NBDs underlined. 
3.3.4 Structural Analysis of the Sheep MDRl Protein 
The sequence most highly conserved between the sheep MDR1 gene and other MDR genes 
is the 200 bp region surrounding the NBDs. These regions are highly hydrophilic and 
include no potential TM spanning segments. Included in the sheep NBDs are two short 
motifs associated with many active membrane transport proteins (Figure 3.2) (Walker et 
al., 1982) (Higgins et al., 1985). In addition a motif specific to the ABC transport family, 
LSGGQ, is found at residues 586 and 1231. 
Hydropathy analysis detected a series of highly hydrophobic domains. These domains 
could be grouped into 6 distinct pairs (Figure 3.6: numbered 1-12.). The alignment of the 
sheep plot with the human MDR1 and MDR2 hydropathy plots (Figure 3.6) shows the 
high degree of conservation between these proteins and the subtle differences between the 
MDR1 and MDR2 proteins, particularly in TMDs 1& 2 and TMDs 7 & 8. 
The sheep TMDs were further analysed using the TMED application (Eisenberg et al., 
1984). A tentative model predicted TM segments that were generally at similar positions in 
the human (Chen et al., 1986) and mouse (Gros et al., 1986c) MDR1 sequences. There 
were however two exceptions: (i) a single transmembrane segment was predicted to 
straddle TMD 3 and 4 of the N-term:inal half; (ii) a single transmembrane segment was 

















Figure 3.6 Comparison of the hydrophobicity plots of the predicted sheep MDR1 protein 
to those of the human MDR1 and MDR2 proteins. The hydrophobicity plots were obtained 
using the algorithm of Kyte and Doolittle (Kyte and Doolittle, 1982) for a window of 21 
and a density of 4000 per 100 platen units. Hydrophobic regions are above the line and 
hydrophilic regions below. Dark boxes numbered 1 to 12 indicate the approximate 
positions of the putative membrane spanning regions of the sheep MDR1 protein. The 
numbers along the bottom represent amino acid positions. The numbers up the side 
represent average hydropathy. 
There are a number of reasons why this model is unlikely to depict fully the true topology 
of the sheep MDR1 gene: (i) previous studies support a 12 TM spanning structure; (ii) there 
is agreement that theN- and C- termini, the ATP binding sites and the linker region are 
located within the cell; (iii) Loops ii and iv are both cytoplasmic therefore the sequence 
between them must be either exposed to the cytoplasm or span the membrane twice. Given 
the hydrophobic nature of this region and the similarities with the human and mouse 
MDR1, for which the data show loop iii, (between TMDs 3 and 4) is periplasmic, the later 
interpretation is more probable. The final 12 TM spanning model is summarised in Table 
3.5. 
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TMD Position (a a) Orientation Loops Loop Length Location 
1 56-76 C-E 45 E 
2 121-138 E-C i 67 c 
3 205-221 C-E ii 0 E 
4 222-235 E-C iii 65 c 
5 300-321 C-E lV 14 E 
6 335-351 E-C V Linker Region c 
7 717-737 C-E vi 25 E 
8 762-778 E-C vii 78 c 
9 856-867 C-E viii 0 E 
10 868-879 E-C iv 62 c 
11 941-962 C-E V 19 E 
12 981-997 E-C C-terminus c 
Table 3. 5 Predicted transmembrane spanning domains. The location, orientation and 
length (bp) of each Tl\ID and loop structure is listed. C-E, cytoplasmic to external 
orientation; E-C, external to cytoplasniic orientation; E, external; C, cytoplasmic. 
3.3.5 Post Translational Modification 
Seven putative N-linked glycosylation sites (NXT, NXS) are predicted from the sheep 
11DR1 amino acid sequence. If our predicted membrane topology is correct, only the first 
three sites are located outside the cell in divergent sequence between TM 1 and TM 2 in 
loop i. An additional four glycosylation sites are predicted on the cytoplasmic side of the 
membrane. 
One of the most divergent regions, the 60 amino acid segment joining the two homologous 
halves of the protein, contains a number of serine (s) residues whose positioning is 
conserved across 11DR1 genes. The five serine residues boxed in Figure 3.2 represent 
those known to be accessible to phosphorylation by PKC or PKA (Germann et al., 1996). 
Four of these five sites are well conserved across the sheep, human, dog, hamster and 
mouse sequences. The fifth serine is only found in human and sheep. 
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3.4 DISCUSSION 
In this chapter we report the characterisation of the full length sheep MDR1 cDNA. The 
predicted amino acid sequence indicates that this gene is most likely a membrane 
glycoprotein that participates in an energy dependent process. 
The high sequence homology between the two halves would indicate that the MDR1 protein 
has been formed by the duplication of an ancestral gene or the fusion of two similar but 
independent proteins. Past work on the conservation of intron positioning in the human 
MDR1 gene has suggested the latter to be more plausible (Pauly et al., 1995). 
The homology of the sheep MDR1 sequence to other MDR genes, in particular the human 
MDR1 protein, is extensive. Very little amino acid substitution was seen between species. 
Complete identity in the putative NBDs was not surprising considering the importance of 
ATP binding and hydrolysis for drug transport. This basic structural unit is conserved in a 
larger multigene family of ABC membrane transporters. This high degree of evolutionary 
conservation may indicate an important role in normal cellular physiology and possibly 
indicates a common ancestral origin. 
Conserved across species 3'UTRs are indicative of individual isoforms (Ng et al., 1989). 
The isolated sheep 3'UTR shows strongest homology to the MDR1 class of proteins which 
is supportive of its placement in this gene class. 
Analysis on the topology of the protein found 12 hydrophobic regions ranging in length 
from 16 to 21 residues. These could be grouped into six distinct pairs representing 
membrane spanning regions similar to those previously described for integral membrane 
proteins (Wickner and Lodish, 1985). The problem encountered in separating TM 3 and 4 
was not an isolated case. The human and mouse TM 3 and 4 were found to be separated by 
only 4 and 6 residues respectively. Similar reports have been documented with bacterial 
membrane proteins where the close proximity of TMDs 3 and 4 has not allowed the 
separate helices to be easily distinguished (Pearce et al., 1992). The hamster mdr1 gene 
deviates from this model where TMD 3 and 4 are fused and assigned TMD 3 and a unique 
TMD 4 assigned between residues 283 and 340 (Devine et al., 1991). Such a model is 
unlikely in the sheep MDR1 gene as there are no hydrophobic residues in this region to 
suggest an alternate transmembrane spanning segment. Although it could be argued from 
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initial TMD placements that the sheep MDR1 gene product has only 10 transmembrane 
regions, a 30 bp, highly hydrophobic, sequence between TMD 2 and TMD 5 suggested the 
presence of membrane spanning regions. It is probable the power of the analysis does not 
provide exact separation of such closely associated domains and that the assignment of the 
TMDs using such a programme should be viewed only as a guide. The proposed 12 TMD 
model fits well with the topology of other characterised MDR proteins. The N- and C-
terminal regions, the NBDs and linker region are located within the cell. TMDs 5, 6, 11 
and 12 show the highest sequence conservation between species. Previous work has 
assigned these TMDs as major drug binding sites and suggests a structure is formed 
through which the substrate must pass through to allow extrusion from the cell (Ruetz and 
Gros, 1994). The sheep MDR1 protein is predicted to have 6 periplasmic and 6 
cytoplasmic loops. A number of the loops are relatively short (loops iii and viii) and 
probably serve simply to provide a "turn" in the protein directing it back through the 
bilayer. Other loops are longer and may provide specific functions. The largest loop, (i), is 
exposed to the periplasm and contains three N-linked glycosylation consensus sites. 
The presence of these clustered glycosylation sites suggest that the amino terminus of 
MDR1 is multiply glycosylated. All mammalian MDR genes analysed to date contain 
between 2 to 4 glycosylation sites in this loop although the precise positioning differs. This 
conservation suggests that there is some kind of evolutionary constraint to maintain these 
sites. Since the position of the sequence is not conserved it is most likely that a requirement 
for N-linked glycosylation per se is responsible for this constraint. 
The five serine residues previously studied as potential phosphorylation sites were located 
in the sheep MDR1 gene. It would seem four of the five serine residues are highly 
conserved through a number of different species. The fifth serine is conserved only in the 
human and sheep sequence. Of the five putative phosphorylation sites the fifth is the only 
one not shown to be phosphorylated in vitro (Chambers et al, 1993; 1994). 
Consistent with the sheep MDR1 gene being an active membrane transporter a number of 
motifs common to such proteins including the Walker A motif, the A TP binding motifs and 
the ABC family specific motif are evident. 
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3.4.1 Summary of Chapter Three 
This study characterised, for the first time, a member of the ruminant MDR family. This 
family of membrane transport proteins has been proven to be important in the drug resistant 
properties displayed by certain cells. The isolated sheep MDR gene shows high sequence 
and structural homology to the characterised human and rodent MDRl family and has been 
denoted as their equivalent in sheep. This is strongly supported by the organisation of the 
3'UTR. 
Although the function of the sheep MDRl protein is unknown, features discussed suggest 
it participates in an energy dependent membrane associated process. Functional studies on 
this gene will allow the interpretation of its involvement in resistance to the cytotoxic drug, 
sporidesmin. Characterisation of the sheep MDRl sequence allows design of appropriate 
sheep specific probes and primer pairs for functional analyses. 
CHAPTER FOUR 




The discovery of highly polymorphic markers, in particular microsatellites (MS)(Weber 
and May, 1989; Tautz, 1989; Litt and Luty, 1989), has provided the tools for the 
development of dense genetic linkage maps. Linkage maps have allowed the discovery of 
the location of many genetic disorders in humans. Microsatellites are also very prevalent in 
other mammals including livestock and the impetus now is to use these detailed maps to 
locate chromosomal regions and eventually genes that are involved in productive traits of 
livestock (Goerges, 1993a; 1993b). 
4.1.1 Linkage Mapping 
4.1.1.1 Genetic linkage maps 
Genetic linkage maps describe the location of markers and genes on each chromosome 
including marker order and estimates of the distance that separates them. Genetic linkage 
was first observed as exceptions to Mendels laws of independent assortment. When genes 
or genetic markers are near each other on the same chromosome they are not inherited 
independently in families but eo-segregate at meiosis. This phenomenon is called genetic 
linkage. With a high density of genetic markers spread over each chromosome, the markers 
can be assembled into a linkage map of the genome (Botstein et al., 1980). eo-segregating 
markers are placed into linkage groups with the proportion of recombinants (crossovers) 
detected between linked markers being used as a measure of distance between them. 
Therefore the requirements for linkage mapping include large numbers of informative 
polymorphic genetic markers and large families in which to study the eo-segregation at 
meiosis. Until recently polymorphisms could only be detected if they were expressed by 
differences in behaviour of a protein such as enzyme activity or electrophoretic mobility. 
This situation changed dramatically with the discovery of restriction fragment length 
polymorphisms (RFLPs) and microsatellites (MS). 
Development of linkage maps relies on the phenomenon of recombination and applied 
linkage analysis. 
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4.1.1.2 Linkage Analysis and Recombination 
Two loci are genetically linked if the alleles present at these loci on a particular chromosome 
tend to be transmitted together through meiosis. When pairs of homologous chromosomes 
come together during meiosis they exchange genetic material in a process called 
recombination. The result of this is the formation of hybrid chromosomes. Unless a 
recombination event occurs between two genetic markers they will be inherited together. 
The chance of crossover is proportional to the distance separating them. 
The recombination fraction, 8, is the proportion of recombination events occurring between 
two loci. Recombination fractions range from 8=0, for loci very close to each other, to 
8=0.5 for loci on different chromosomes (unlinked). Two loci are said to be linked when 
8<0.5. The objectives of linkage analysis are to test if the observed deviation from 8=0.5 is 
statistically significant. The unit of recombination is the centimorgan (cM) which 
corresponds to an approximate recombination frequency of 1% and a physical distance of 
106 bp. Because of the occurrence of multiple crossovers 8 is not an additive measure of 
distance and is therefore transformed by a map function into a map distance. The method 
used to do this in the present analysis is Kosambi map units. This function translates 
8=0.27 into 30 cM (Ott, 1991). 
In a linkage analysis the eo-inheritance of marker and gene are followed within a family. 
The lod score is the most common way of presenting the results of a linkage analysis 
(Morton, 1955). The probability that the observed inheritance pattern could occur by 
chance alone (i.e. that they are unlinked) is calculated. The calculation is then repeated 
assuming a particular degree of linkage and the ratio of the two probabilities (no linkage 
versus a specified degree of linkage) is determined. 
Z(8) = log10 L(8)/L(0.5) 
This ratio expresses the odds for (and against) that degree of linkage and because the 
logarithm of the ratio is used it is known as the logarithm of the odds or lod score. A 
maximum lod score of three is taken as evidence of linkage. This represents 1000: 1 odds 
that the two loci are linked. 
63 
4.1.1.3 Sheep Linkage Map 
Over the last 50 years the application of quantitative genetics and selective breeding has 
seen an improvement in the productive characteristics of sheep. Many of the economically 
important traits in sheep such as growth rate, wool characteristics and disease resistance are 
multigenic in nature. To understand these complex traits a genetic linkage map of highly 
informative markers covering a majority of the sheep genome is an essential first step. 
Significant progress has been made recently in the development of the sheep genetic linkage 
map (Crawford et al., 1995) constructed from segregation analysis in the AgResearch 
International Mapping Flock (IMF) (section 4.2.3.1). This map contains 246 polymorphic 
markers assigning linkage groups to all 26 sheep autosomes. Except for seven restriction 
fragment length polymorphism (RFLP) markers and seven protein polymorphisms all the 
markers are microsatellites (MS). Recently, a second generation linkage map was 
completed with over 500 markers (de Gortari et al., 1998). A genetic linkage map of the 
sheep X chromosome has also been published with fourteen MS and seven genes 
(Galloway et al., 1996). 
4.1.1.4 Microsatellite and RFLP Markers 
In higher eukaryotes naturally occurring polymorphisms are used to construct these linkage 
maps. All polymorphisms occur at the level of DNA but unfortunately few of them are 
associated with readily scorable phenotypes. The advent of recombinant DNA technology 
gave a new approach to defining potentially large numbers of marker loci. These 
technologies use DNA probes and PCR to identify polymorphic DNA sequences (Botstein 
et al., 1980). 
Two classes of loci are generally recognised for the construction of genetic linkage maps. 
The first class (type I) are associated with gene sequences and the second class (type II) are 
highly polymorphic usually anonymous DNA segments. The type I markers, RFLPs, are 
based on variation in banding patterns due to the loss or gain of a restriction site. They tend 
to be less informative than the highly polymorphic type II (MS) markers; however the 
existence of a MS framework allows type I markers to be mapped, with respect to the more 
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informative markers, enabling the placement of genes using RFLPs onto the sheep genetic 
linkage map. 
Type II MS markers include an array of simple sequences (1-4 bp) repeated in tandem 
which are interspersed throughout the mammalian genome. Primers are designed to flank 
the repeat region and are used to study variation in microsatellite repeat length. Each 
individual will amplify two bands, one representing the allele inherited from the sire and 
one from the dam. MS are currently the marker of choice for map construction. However 
MS primer sites are poorly conserved between species and only 50% of the MS loci 
derived from cattle will amplify sheep DNA. The sheep linkage map is comprised of 402 
bovine, 101 sheep and 1 cervine MS marker. Loci other than MS include 7 RFLP, 2 
bovine proteins, 2 sheep proteins and 4 erythrocyte antigens. 
4.1.2 Comparative Mapping 
Despite progress in the sheep genetic map described above the resolution of maps in 
livestock species is a long way behind that of mouse and human. More recently it has been 
realised that comparison of maps from related species that are 'information rich', for 
example humans and mouse, can be used to help 'map poor' species such as sheep, cows 
and pigs. This type of analysis has provided the basis for a small field of comparative 
mapping. 
The genetic maps of species show extensive conservation of synteny ("on the same 
chromosome") and gene order (Echard et al., 1994). This idea can even be extended 
beyond comparison of closely related species and can give important information about 
evolutionary relationships (O'Brien et al., 1993). The size of conserved syntenic blocks 
between species vary in accordance with the evolutionary distance between the species 
being compared. 
In comparison to linkage mapping highly polymorphic loci are not so useful for 
comparative mapping as they are seldom conserved except between closely related species. 
Loci associated with known genes tend to be more highly conserved between distantly 
related species and so are more useful for making comparisons. 
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As well as providing evolutionary information, comparative mappmg can also be a 
powerful and cost effective tool for the localisation of disease or trait genes in poorly 
mapped species. In order to estimate, with accuracy, the position of a gene of interest that 
is mapped in another species, but not the species being studied, it is not necessary to have 
detailed maps of both species, just enough anchoring gene markers so that syntenic regions 
can be identified. Ultimately comparative mapping allows the efforts required for mapping 
complex traits and developing linkage maps to be shared between species. 
4.1.3 Physical Mapping 
In situ hybridisation allows the visual placement of loci onto a cytogenetic map using 
fluorescently labeled probes (Trask, 1991). Conventional Fluorescent in situ hybridisation 
(FISH), as applied to metaphase spreads, has a resolving power of 1 Mb. For higher 
resolution, FISH has been applied to interphase cell nuclei where the DNA is less 
condensed than in metaphase. This permits resolution in the 50-100 Kb range. 
4.1.4 Aims of Chapter Four 
The sheep cDNA sequence characterised in Chapter One provides a source for designing 
sheep specific primers and probes with which to isolate polymorphic genetic markers. Such 
markers are essential tools to map single genes (Botstein, 1980) and to identify gene 
association to complex genetic traits. In this chapter the mapping of the sheep MDR gene is 
described. A number of strategies were employed: (i) RFLP analysis: screening sheep 
genomic DNA to detect restriction polymorphisms; (ii) MS analysis: identification of highly 
polymorphic repeat sequences linked to MDR1; (iii) Fluorescent in situ hybridisation 
(FISH) to physically map the gene and (iv) comparative mapping with the human and 
rodent placements ofMDR1. 
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4.2 MATERIALS AND METHODS 
4.2.1 RFLP Analysis 
Genomic sheep DNA from 5-6 unrelated individuals was digested with a range of 
restriction enzymes (5 ug DNA with 25U restriction enzyme). The 16 restriction enzymes 
were: Mspl, Taql, Pstl, EcoRI, Puvii, Hindl.II, EcoRV, Seal, BstXI, Bglii, Rsal, 
BamHI, BstEII, Xbal, Apal and Hinjl. Genomic restriction fragments were separated by 
gel electrophoresis in 1.0% agarose run at 30V for 16 hours and transferred to Hybond N+ 
filters (Section 2.4.9). 
Probe DNA (100 ng) was labeled with a 32PdCTP (Section 2.4.10). The filters were 
initially screened with the 1350 bp region of clone MDR1 1A12 (Figure 3.1) sequence 
spanning one of the highly conserved NBDs. A shortened version, 1200 bp in length, 
lacking the NBD, was made for subsequent screening. Filter hybridisation was carried out 
as described in Section 2.4.9. Autoradiographs were inspected for polymorphic bands and 
scored independently by two observers prior to being recorded in their respective 
data bases. 
4.2.2 Microsatellite Analysis 
4.2.2.1 Primer Design 
The isolation of two MS loci, OarMEM2 and OarMEM3, are described in Chapter Five. 
Table 4.1 summarises primer pairs and sequences used in OarMEM2 and OarMEM3 
amplification. 
MS Primer Sequence (5'-3') 
OarMEM2 con46 AGAGTCGGACACGACTGAAGTGAC 
con 47 CCCAAATCTAACAGGCAGTATGCTC 
OarMEM3 con 51 CTCTGAGGAACTGATGTTTGAAGC 
con 52 CCTTACAACTGGCCAACATGC 
Table 4.1 Primers used m the amplification of OarMEM2 and OarMEM3. 
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4.2.2.2 PCR Amplification 
Amplification of OarMEM2 and OarMEM3 used the standard MS PCR cocktail (Section 
2.7.2) with Mg2+ concentrations and PCR conditions as described in Table 4.2 
MS Primer Pairs Mg2+ Cycles 
OarMEM2 con 46 & con 47 2.0mM 93°C 3': 1 cycle; 93°C 1', 56°C 1', 72°C 30": 28 
cycles; 72°C 5': 1 cycle 
OarMEM3 con 51 & con 52 1.5 mM 93°C 3': 1 cycle; 93°C 1', 56°C 1', 72°C 15": 28 
cycles; 72°C 5': 1 cycle 
Table 4.2 Primer pairs and conditions used for amplifying OarMEM2 and OarMEM3. 
4.2.3 Fluorescent In Situ Hybridisation 
l\1DR1-YACs were isolated using PCR (Section 2.7.1). YAC DNA was then used as a 
probe for fluorescent in situ hybridisation (FISH) of sheep chromosomes. Fluorescent in 
situ hybridisations were performed by Ms Tracey Van Stijn at our laboratory and by 
methods described in Section 2.12. 
68 
4.3 RESULTS 
4.3.1 Linkage Mapping 
4.3.1.1 RFLP Data 
The initial 1350 bp probe containing the N-terminal NBD hybridised to a 
uncharacteristically large number of bands suggesting a degree of cross hybridisation to 
other regions of the genome. The shortened probe, lacking the highly conserved NBD 
sequence hybridised to fewer bands. 
Ofthe initial 16 enzymes screened EcoRI identified polymorphic bands at 7.2 kb and 4.1 
kb (Figure 4.1). 
1 2 3 4 5 6 
Figure 4.1 Genotyping of the selection lines with the EcoRI RFLP. The two arrows 
indicate the alleles associated with this polymorphism. Animals 1 and 4 are heterozygous at 
this loci. Animals 2, 3, 5 and 6 are homozygous for the A allele. 
This polymorphism was used to analyse MDR1linkage in both the IMF and the Woolflock 
pedigrees. Most of the IMF animals (80%) were able to be genotyped for the 
polymorphism. Of the four Woolflock families two sires were heterozygous, and thus 
informative for the polymorphism, and 84% of their offspring were able to be assigned a 
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genotype. eo-segregation of alleles at this locus with those of other markers screened in the 
pedigrees were analysed to identify the map location of l\IDR1. This preliminary analysis 
placed l\IDR1 on sheep chromosome 4 where it was significantly linked to at least five 
other markers by two point linkage analysis (Table 4.3). 
Locus 1 Locus 2 Recombination (8) LOD Score 
MDRl MAF70 0.19 10.00 
BMS1172 0.08 9.94 
McM144 0.12 8.95 
RM67 0.23 3.90 
BMS1237 0.04 3.63 
Table 4.3 Two point linkage analysis of 1\IDRl. Linked markers are listed in order of 
decreasing LOD score. Kosambi (8) values are given. 
4.3.1.2 Microsatellite Data 
An alternative approach was taken for further confirmation on map placement of l\IDR1 
when two MS markers (OarMEM2 and OarMEM3) were isolated during a separate analysis 
(Chapter Five). 
Using the same methodology as with the RFLP polymorphism, the IMF animals were 
genotyped for OarMEM2 and OarMEM3. Unlike RFLPs in which there are only two allele 
variants in any pedigree MS markers can amplify several different sized polymorphic 
bands. OarMEM2 and OarMEM3 amplified 16 and 15 different alleles respectively. Over 
80 % of the IMF animals were able to be assigned genotypes for both of the MS markers. 
Table 4.4 displays the results of the multipoint linkage analysis. OarMEM2 and OarMEM3 
showed strong linkage to the same group of markers as the l\IDR1 RFLP marker. No 
recombinants were found between OarMEM2 or OarMEM3 and the l\IDR1 gene in the 78 
and 86 eo-informative meioses respectively. 
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Locus 1 Locus 2 Recombination (8) Lod Score 
OarMEM2 OarMEM3 0.00 48.77 
MAF70 0.11 24.23 
MDR1 0.00 21.69 
McM144 0.10 21.74 
BMS1172 0.08 15.44 
McM218 0.19 12.95 
BMS1237 0.02 10.56 
MAF50 0.17 6.47 
RM67 0.18 7.07 
OarMEM3 OarMEM2 0.00 48.77 
MAF70 0.12 24.94 
MDR1 0.00 23.48 
McM144 0.11 22.46 
BMS1172 0.08 15.48 
McM218 0.18 14.95 
BMS1237 0.02 11.44 
MAF50 0.16 7.25 
RM67 0.20 6.22 
Table 4.4 Two point linkage analysis of rnicrosatellites OarMEM2 and OarMEM3. 
Markers with associated LOD scores and 8 values are tabulated. 
The inheritance of a maximum of two allelic bands per animal is usually seen in MS 
analysis. One allele inherited from the sire and one from the dam. OarMEM2 and 
OarMEM3 were unusual in that MS amplification produced up to six alleles in each 
individual (Figure 4.2A). Examination of inheritance identified alleles segregating as 





Animal Haplotypes Alleles 
1 * BDF 1,* 
2 CF * 2' * 
3 AA * 3' * 
4 BDF EE 1,4 
5 AA CF 1,2 
6 AA EE 3,4 
7 AA EE 3,4 
8 AA BDF 1,3 
9 AA EE 3,4 
10 BDF CF 1,2 
11 BDF CF 1,2 
12 AA BDF 1,3 
13 AA BDF 1,3 
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Figure 4.2 (A) Oar:MEM3 amplification in IMF pedigree B. The schematic diagram 
above represents the family tree of this pedigree. Squares = males and circles = females. 
Animals 1, 2 and 3 are grandparents (GP). Animals 4 and 5 are the parents of animals 6 to 
13. A-F represent the variant allele bands of which some animals amplify up to 5. (B) 
Segregating haplotypes for each animal (A-F) and the associated assigned alleles (1-5). For 
example the B and D allele bands can be seen segregating with the F allele as one unit in 
animals 1, 8, 10, 11, 12 and 13. This haplotype has been assigned allele 4. The * for 
animals 1, 2 and 3 indicates a haplotype unable to be assigned. 
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4.3.1.3 Map Construction 
The IMF and half-sib Woolflock data were combined to construct a genetic linkage map of 
sheep chromosome 4 that included the placement of MDRl, OarMEM2 and OarMEM3 
(Figure 4.3). MDRl was mapped to chromosome 4 flanked by markers BM1237 and 
McM144 at an estimated 4.0 cM and 12.0 cM respectively. None of the markers 















Figure 4. 3 Sex-averaged map of sheep chromosome 4 using the BUILD option of CRI-
MAP. MDRl is flanked by markers BM1237 and McM144. The two microsatellite 
markers, OarMEM2 and OarMEM3, are positioned close to MDRl with no recombination 
and are drawn in a box opposite the MDRl map position. The black oval represents the 
centromere. Interval lengths are shown in Kosambi cM. 
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4.3.2 Physical Mapping 
Fluorescent in situ hybridisation probing with MDR1-YAC DNA resulted in a specific 
fluorescent signal on a large acrocentric chromosome (Figure 4.4). This site labeled, in all 
of the metaphases examined, as two fluorescent spots at the same site on sister chromatids. 
Figure 4. 4 Localisation of the sheep MDR1 gene locus by FISH. Y AC 58 hybridised to 
sheep chromosome 4 (arrows). 
The target chromosome was identified as chromosome 4 by positive NOR staining (Ansari 
et al., 1993). The fluorescent signals were concentrated at FLpter 0.31-0.45 and were 
assigned to the interval4q15 to 4q21 (Figure 4.5). 
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Chromosome 4 
Figure 4.5 Idiograms of sheep chromosome 4. The left hand chromosome is G-banded 
(Kaftanovskaya and Serov, 1992) and the right hand chromosome is R-banded (Ansari et 
al., 1993). The proposed location of the MDR1 gene is marked by a thick black line. 
4.3.3 Comparative Mapping 
Comparison of the genetic maps of sheep with other mammalian species has shown 
extensive conservation of synteny. 
Loci previously mapped around the site of the MDR family in human, sheep, mouse and 
cattle are tabulated (Table 4.5). From this data the sheep equivalent to human chromosome 
7 is sheep 4 and 24 and that in mice sheep 4 is predominately homologous to mouse 6 and 
13 and sheep 24 to portions of mouse 5, 7 and 11. 
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Loci Human Sheep Mouse Cattle 
INHBA 7p15-13 4q27 13 4q26 
Elastin (ELN) 7q11.23 24q16 5 29q16-18 
Erythroprotein (EPO) 7q21.3 24 5 -
Malate dehydrogenase 2, 7cent-q22 24 5 29 
NAD(MDH2) 
MDR Genes 7q20-30 4 5 -
CFTR 7q32.1 4 6 4 
Leptin 7q32.1 4 6 4q32 
TCRB 7q35.0 4 6 4 
Table 4.5 Orthologous loci on human chromosome 7 in mice, sheep and cattle. 
The location of the human MDR genes on chromosome 7q21-31 suggests the placement of 
the sheep MDR family to chromosome 4 or 24. Region 7q21-31 in humans is in a region of 
ambiguity where loci on either side map to different sheep chromosomes. In mice the MDR 
family maps to chromosome 5 equivalent to sheep 24. This reasoning has not been 
supported by the strong linkage mapping which would favour the alternate, chromosome 4. 
Table 4.6 displays the orthologous human, mouse and cattle chromosomes to sheep 24. 
loci sheep human mouse cattle 
HBA2 24 16p13 11 29 
IL4R 24 16p12 7 29 
PRKCB1 24 16p12.37 7 29 
SPN 24 16p11.2 7 -
Table 4.6 Placement of sheep chromosome 24 loci on the human, mouse and cattle maps. 
It is accepted that the mouse genome is the more fragmented of the analysed species. In 
contrast there is a high level of conserved synteny between sheep and cattle. All sheep 4 
tabulated loci have mapped to cattle 4 and all those on sheep 24 to cattle 29. Although the 
MDR family has not been characterised in cattle it could be inferred from this data that it 
would map to chromosome 4. 
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4.1 DISCUSSION 
The placement of MDR1 on the sheep genetic map resulted from a combination of 
genetical, physical and comparative mapping techniques. Three genetic markers were 
analysed using linkage analysis. An RFLP polymorphism mapped MDR1 to sheep 
chromosome 4 and two MS markers confirmed this placement. No recombination between 
the three markers was recorded. 
4.4.1 Linkage Mapping 
During our studies we observed a degree of cross hybridisation to the sheep MDR1 probe. 
These hybridising fragments may represent other MDR class members or MDR-like genes. 
A large body of evidence does indicate that this family is multigenic (Ling et al., 1992). 
The lack of hybridisation of some of these original bands with the shorter probe which 
excluded the NBD may indicate they represented other A TP-binding genes. However to 
conclude that the bands remaining belonged solely to other MDR family members is 
probably unreasonable and further experiments would be required to identify the number of 
MDR genes in sheep. 
Amplification of OarMEM2 and OarMEM3 generated multiple allelic bands that appeared to 
segregate as single haplotypes. This suggests multiple binding of primers and possibly that 
this area of the genome is present in more than one copy. It has been hypothesized by 
previous work that the members of the MDR family have arisen from a number of 
duplication events (Ng et al., 1989; Gros et al., 1988). The priming and amplification of 
multiple alleles could thus reflect areas of high homology between duplicated class 
members. Length polymorphisms in corresponding repeat sequences may represent 
divergence since duplication. 
These observations tend to suggest that the sheep MDR family has at least two gene 
members. Southern analysis on cow genomic DNA (Ling et al., 1992) suggests that the 
bovidiae family, to which sheep belong, has three gene members. Such an analysis has 
been attempted on sheep genomic DNA (pers. comm.) however no conclusive results were 
obtained. 
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The functional reason for multiple genes is unknown nor is it understood what the 
consequences, in terms of function and expression, are when there are many MDR 
isoforms present. Duplication of a gene will cause an immediate increase in the expression 
levels of the gene message and perhaps protein product. In pigs five members are predicted 
(Childs and Ling, 1996) however evidence of expression of all these classes has not been 
found. Those lacking expression have a SINE element inserted in their 3' UTR and it is 
possible this down-regulates detrimental high expression levels. A minimum of two MDR 
genes are seen in vertebrates which is suggestive that these two classes were present in a 
common mammalian ancestor. Perhaps representing two basic functional classes, with one 
class associated with multiple drug resistance. 
4.4.2 Physical Mapping 
The physical placement of MDR1 to band 4q15-4q21 locates it close to the sheep CFfR 
gene in region 4q23-q25. This is consistent with the gene locus structure previously 
described in humans (Riordan et al., 1989) and is interesting as the MDR1 and CFfR 
genes have been reported as being co-ordinately regulated in cystic fibrosis knockout mice 
(Trezise et al., 1997). It is postulated that in the absence of CFTR expression or function 
the cellular response may be to activate other chloride channels by increasing expression of 
genes encoding chloride channel regulators such as MDR1. 
4.4.3 Comparative Mapping 
Comparative mapping techniques add valuable information to mapping studies allowing the 
transfer of information between species about genes, disease and QTUtrait loci location 
(Echard et al., 1994, Montgomery et al., 1995, O'Brien et al., 1993). This study 
contributed three new markers to the sheep linkage map. The assignment of the MDR1 
gene amongst these has allowed the comparison of this region in sheep with orthologous 
regions in humans and mouse. Although comparative mapping of sheep with more distant 
species such as primates and rodents has shown a greater degree of divergence than with 
more closely related species there are 42 segments that have been identified as being 
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conserved between the sheep and human genomes. The observations on the map positions 
of the MDR family suggest that during mammalian evolution the segment containing the 
MDR genes which is part of human chromosome 7, has during ruminant evolution been 
conserved on sheep chromosome 4 (which has a part equivalent to human 16). During 
mouse evolution it has been fused to a segment equivalent to human 4 to generate mouse 5. 
The number of chromosomal breakages appears to increase as a function of evolutionary 
distance between species. Of those examples considered sheep show fewer rearrangements 
of the genome with respect to humans than do mice and this may reflect their closer 
evolutionary relationship. Caution is necessary when inferring marker positions especially 
between distantly related species as often gene order and distance are changed. Genetic or 
physical mapping is required to confirm preliminary positionings. 
4.4.4 Summary of Chapter Four 
This chapter localised the MDRl gene to sheep chromosome 4. In addition it has raised the 
question of whether there are other class members in this family. Two microsatellite 
markers have been identified for the MDRl gene and mapped to the same linkage group on 
sheep chromosome 4. The value of these MS markers is further displayed in Chapter Five 
to study the segregation of MDRl in facial eczema (FE) selection lines. 
CHAPTER FIVE 





The identification of genetic markers linked to important agricultural traits allows the 
identification of animals with desired characteristics. This process is known as marker 
assisted selection (Whittaker et al., 1995). In the case of disease resistance, animals can be 
selected for breeding without exposure to the toxic agent. 
Most agricultural traits are polygenic and the genes or loci that determine such quantitative 
variation are known as quantitative trait loci (QTL)(Lander and Schork, 1994). Our ability 
to study such quantitative variation has been enhanced by both the rapid development of 
linkage maps based on MS and RFLP markers (Section 4.1.1.4) and the development of 
statistical methods to analyse available data. 
There are two main approaches to identification of genes involved in such traits. The first is 
the candidate gene approach where loci are chosen based on prior knowledge of potential 
involvement of the gene in the phenotype of interest. Genes mapped in other species are 
positioned on a chromosome, in the species of interest, based on syntenic information. The 
second approach is to use QTL analysis. This methodology involves looking for linkage 
disequilibrium between a region on the chromosome and the trait in the population being 
studied (Knott et al., 1996). Ultimately the goal is to find the gene involved in the QTL and 
find the DNA variation that is responsible for the difference in phenotype. 
There are two main ways of identifying QTL and testing the involvement of candidate 
genes in phenotype variation. The first is looking for consistent inheritance of alleles of 
your gene (or marker) with the phenotype in pedigrees that are segregating the trait. The 
second looks for association: that is the presence of consistent differences at your loci 
between extreme groups of animals. 
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5.1.1 Determining Gene Involvement 
5.1.1.1 Candidate Genes 
To date the candidate gene approach has been the main method for analysing the genetics of 
FE. The toxicity of sporidesmin is due to the generation of free radicals (Section 1.1.6). A 
number of antioxidant enzymes involved in free radical detoxification have been analysed 
as candidate genes. To date only the catalase gene has shown any association with the 
disease phenotype (Phua et al., 1998). 
5.1.1.2 QTL Studies 
A QTL scan of the entire sheep genome has recently been undertaken (Phua et al., 1998). 
Twelve sheep chromosomes have been analysed, with four regions showing possible QTL. 
Cmrently the identification of possible candidate loci in these regions are being 
investigated. Unfortunately no known sheep genes have been mapped in these areas and 
extrapolation from the evolutionary distant human genome map is hindered by lack of 
conserved synteny between the two species. 
5.1.2 Development of Genetic Markers near Candidate Genes 
5.1.2.1 YACs 
Y ACs have become powerful tools for mapping of higher organisms. They permit the 
cloning of megabases of foreign DNA, enhancing our ability to dissect the higher genomes. 
One of the major operational problems with the use of Y ACs has been the percentage of 
clones carrying chimeric DNA sequences, that is sequences from different regions of the 
genome cloned into a single YAC (Monaco and Larin, 1994; Kouprina et al., 1994). 
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Currently, isolated Y ACs are used as probes for in situ hybridisation and for isolating 
polymorphic MS markers both as a source to analyse the segregation of linked genes with 
traits and to extend the sheep linkage map. 
Subcloning of individual YAC segments 1s required for further characterisation and 
isolation of such polymorphic markers. One of the more recent approaches has taken 
advantage of the presence of short interspersed nuclear elements (SINEs). 
5.1.2.2 SINE Elements 
Short interspersed nuclear elements (SINEs) are typically of the order 100-500 bp in length 
with up to 100,000 copies distributed throughout vertebrate genomes (Rogers, 1985) and 
are often found associated with MS sequences (Buchanan et al., 1993). Oligonucleotides 
have been designed for use as single primers in PCR amplification of inter-SINE regions 
(Kaukinen and Varvio, 1992). SINEs have been estimated to occur every 10 kb in the 
sheep genome (Rogers, 1985). 
5.1.3 Aims of Chapter Five 
This chapter investigates the linkage and association of :MDR1 with FE resistance. In 
segregation studies we first isolated informative MS markers which were heterozygous for 
at least one of the four FE half-sib pedigree sires. Allele associations were determined from 
the FE selection lines. The isolation of polymorphic microsatellite markers linked to the 
MDR1 gene and their use in this kind of analysis will be described. 
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5.2 MATERIAL AND METHODS 
5.2.1 Yeast Artificial chromosomes 
5.2.1.1 Screening the sheep genomic YAC library 
A sheep genomic YAC library has been constructed (Broom and Hill, 1994) and was 
available at the Biochemistry Department, University of Otago, Dunedin. A recent estimate 
of the chimerism of the sheep genomic YAC library was as high as 60 % (Broom, pers. 
comm.). In addition many clones are unstable and delete internal regions from their inserts. 
The library was screened using MDR1 specific primers and DNA prepared from YAC 
clones pooled according to the methods described by Bentley (Bentley et al., 1992). 
Positive (genomic sheep DNA) and negative (no DNA) controls were included with every 
amplification. 
PCR primers and conditions for screening the YAC library 
Two primers con 22: (5'-GTTCACTTCCATTACCCATCTCG-3') and con 10: (5'-
GCATTGGCTTCCTTGACAGC-3') were used to amplify a product containing 330 bp of 
exon sequence (1204 bp to 1541 bp) and approximately 285 bp ofintron sequence. 
50 ng of Y AC DNA was added to a standard PCR mix (Section 2. 7.1) containing 2 rrM 
Mg2+ and 0.04 U/J.,tl HIFI polymerase. The conditions used for amplification of products 
were: 28 cycles of 93°C, 1 minute; 57°C, 1 minute; 72°C, 45 seconds, with an initial 
denaturation time of 3 minutes and a final extension time of 5 minutes. The 27 1 o Y AC pool 
amplifications were carried out in 0.5 ml thin walled tubes and the 2° and 3° pools in 96 
well microtitre plates on Techne Thermal Cyders. 
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5.2.1.2 Isolation of YAC DNA 
Yeast clones containing YACs were grown in 100 ml YPD for 24-48 hours at 26°C. Cells 
were harvested and YAC plugs were made as described in Section 2.13. DNA was 
extracted from agarose plugs for use in PCR. 
5.2.2 SINE PCR 
5.2.2.1 Primers 
Previous investigators designed consensus primers to a number of short interspersed 
nuclear elements (SINEs). The primer sequences and their original reference are in Table 
5.1. 
Primer Primer Sequence Reference 
Bov-A CAGAGTCGGACACGACTGAA Lenstra et al, 1993 
Bov-AF GATTTTCCAGGCAAGAGTACTGGAGTGGG Seyfert et al, 1993 
Bov-AR CCCACTCCAGTACTCTTGCCTGGAAAATC Seyfert et al, 1993 
AMS1 CAAGAATCTTCTCCAACACCACAGTTCA Lenstra et al, 1993 
Table 5.1 SINE primers and their corresponding references. 
5.2.2.2 PCR conditions 
50 ng of YAC DNA was added to a standard PCR cocktail (Section 2.7.1) with 3 mM 
Mg2+ and 0.04 U/~-tl Taq Polymerase. All SINE PCR reactions were in thin walled 0.5 ml 
tubes with: 28 cycles of 94 °C, 1 minute; 58°C, 1 minute; 72°C 4 minutes with an initial 
denaturation time of 3 minutes and a final extension time of 7 minutes. Resulting products 
were electrophoresed in 1 % agarose gels. 
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5.2.3 (AC)n Repeat Hybridisation 
The PCR products in section 5.2.2.2 were transferred onto Hybond N+ membranes 
and hybridised as described in Section 2.4.9. 50 ng of (AC)n repeat DNA was labeled with 
[a32P]dCTP using the random primer DNA labeling kit (Boehringer). 
5.2.4 Microsatellite Isolation and Characterisation 
PCR products identified as containing (AC\ repeat DNA from the hybridisation experiment 
were amplified further using bandstab PCR (Section 2.7.5) under identical conditions to 
section 5.2.2.2. These products were gel purified and cloned into pBluescriptii for 
sequencing and further MS characterisation. 
5.2.4.1 Primer Design 
Primer pairs designed to the region flanking each of the three MS sequences are given in 
Table 5.2. 
Microsatellite Primer Sequence (5'-3') 
Oar:MEMl con44 AAACATGACTGAGCACATGCGC 
con45 TTTTGGTTTCCATGTATTCATGGC 
Oar:MEM2 con46 AGAGTCGGACACGACTGAAGTGAC 
con47 CCCAAATCTAACAGGCAGTATGCTC 
con 55 TGGTGAGTTCTATGGACAGAGG 
Oar:MEM3 con 51 CTCTGAGGAACTGATGTTTGAAGC 
con 52 CCTTACAACTGGCCAACATGC 
con 53 GACAAAATCTAACCCAGAAGAATAGG 
con 58 TTTGCTCCTTCATGATCCAGGC 
Table 5.2 Microsatellite pnmers designed to amplify Oadv1EM1, Oar:MEM2, and 
Oar:MEM3. 
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5.2.4.2 Microsatellite Amplification 
50 ng of genomic DNA was added to a standard MS amplification cocktail (Section 2. 7 .2). 
One of the primer pairs (0.8 pmol/J.Ll) was radioactively labeled with ['(3P]ATP using 
standard conditions (Section 2.4.10) and added to the PCR cocktail. Reactions were carried 
out in a 96- welled microtitre tray with PCR conditions as laid out in Table 5.3. At the 
completion of the reaction the products were electrophoresed on acrylamide gels and 
analysed as described in Section 2.4.2. 
Mg2+ 
Microsatellite Primer Pair Conditions (mM) 
OarMEMl con44 93°c 3': 1 cycle; 93°c 1', 57°c 1', 72°c 15": 28 cycles; 1.5 
con 45 * 72°C 3': 1 cycle 
OarMEM2' con46 93°C 3': 1 cycle; 93°C 1', 57°C 1', 72°C 15": 28 cycles; 1.5 
con 47* 72°C 3': 1 cycle 
con 55* 93°C 3': 1 cycle; 93°C 1', 56°C 1', 72°C 15": 28 cycles; 1.5 
con47 72°C 5': 1 cycle 
OarMEM3 con 51* 93°C 3': 1 cycle; 93°C 1', 56°C 1', 72°C 15": 28 cycles; 1.5 
con 52 72°C 5': 1 cycle 
con 53* 93°C 3': 1 cycle; 93°C 1', 56°C 1', 72°C 30": 28 cycles; 2.0 
con 58 72°C 5': 1 cycle 
Table 5.3 PCR conditions for amplification of OarMEM1, OarMEM2 and OarMEM3. 
The radioactively labeled primer in each pair is denoted by an asterisk. 
5.2.5 Pedigrees and Databases 
5.2.5.1 Facial Eczema Selection Lines 
The FE selection lines were set up in 1975 to examine the effects of selective breeding for 
resistance or susceptibility to FE. Foundation and maintenance of these flocks is described 
further by Morris et al., (1989) and in Section 2.9.3. 
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5.2.5.2 Facial Eczema Half-Sib Pedigrees 
The FE half-sib families were developed as a resource for studying the genetic basis of FE 
resistance. As both resistant and susceptible selection lines involved only a small number of 
animals it was decided to outcross rather than backcross pedigrees to search for regions of 
the genome segregating with FE traits The development of these pedigrees is described in 
Section 2.9.4. 
5.2.6 QTL Analysis 
QTL analyses were carried out by Dr John McEwan (pers. comm.). The FE selection line 
animals were challenged with sporidesrnin and serum gamma glutamyltransferase (GGT), 
glutamate dehydrogenase (GDH) levels and weight at time of weaning were recorded. Both 
GTT and GDH are intracellular enzymes whose levels are raised after liver damage. DNA 
was collected from all progeny and sires. Eleven markers on chromosome four were 
included in the analysis. Marker information and phenotype data was analysed as described 
by Knott (Knott et al., 1996) with suggestive and significant linkage probabilities (Lander 
and Krugylak, 1995). Briefly it considers the conditional probability (McEwan et al., 
1998) that an animal has inherited a particular phase for a given point on a chromosome 
against the phenotype data, which is simultaneously adjusted for fixed affects. The process 
is repeated at 2 cM intervals along the chromosome. Conditional probabilities are inferred 
from flanking markers scored in the parent and progeny. 
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5.3 RESULTS 
5.3.1 Microsatellite Isolation 
5.3.1.1 YAC Screening 
The first step in the isolation of MDR1-linked MS markers was the screening of a sheep 
genomic Y AC library for MDR1 positive clones. 
Optimisation of YAC PCR 
The MDR1 specific primers amplified a product of 530 bp from both sheep genomic and 
YAC clone DNA. This indicated sheep MDR1 introns 12 and 13 were of a combined size 
85 bp smaller than the corresponding human introns. The Mg2+ concentration was found to 
be critical in obtaining a single high quality PCR product. A concentration <2 mM showed 
a reduction in product yield (Figure 5.1). In addition, Mg2+ concentrations >2.5 mM 
produced a second non-specific product. Digestion of the 530 bp amplified product with 
EcoRV, of which there is a known site 155 bp from the con 10 primer site, was used to 
confirm the correct product (data not shown). 
M 1.5 2.0 2.5 3.0 3.5 4.0 
Figure 5.1 Mg2+ optimisation for arobust YAC PCR. Mg concentrations between 1.5 
and 4.0 mM were tested. Lanes are headed by their final Mg2+ concentration. Lane M, 
marker A. EcoRI!Hindiii digest. The arrow indicates the band of interest. 
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Isolating Positive MDRI YAC clones 
The results from screening the sheep genomic YAC library are summarised in Table 5.4. 
Five positive MDR1 Y ACs were isolated. 
l 0 Screen 2°Screen 3°Screen 
pool Co-ordinate YAC 
25 B9 393 
26 c2 407 
26 c4 402 
4 cl 61 
4 Bl2 58 
Table 5.4 Summary of Y AC screening results. The 1° and 2° pools from which each Y AC 
was derived are listed. 
5.3.1.2 SINE PCR on MDRl Positive YACs 
Further manipulation of these five YACs was necessary to produce sheep DNA fragments 
of an optimal size for characterisation of MS sequence. 
SINE Product Amplification 
DNA from each of the five positive YACs (58, 61, 393, 402 and 407) was used as a 
template for amplification with four SINE primers (Bov-A, Bov-AR, Bov-AF and AMSI). 
The amplified products shown in Figure 5.2 ranged in size from 250 bp to 3500 bp. 
Identical bands were amplified from Y AC 58 and YAC 61 using single SINE primers. Two 
Y ACs that share overlapping regions of sequence, would be expected to have some primer 
sites in common. 
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M1 58 61 393 402 407 M2 M1 58 61 393 402 407 M2 
M1 58 61 393 402 407 M2 M1 58 61 393 402 407 M2 
Figure 5.2 SINE PCR on YAC DNA using primers (A) BovAR; (B) AMSI; (C) BovA; 
(D) BovAF. Lane M1, marker 'A EcoRI!Hindlll digested; M2 marker DNA pUC 18/19 
Haeiii digested. Y AC number is above each respective lane. 
Southern Hybridisation of SINE Products 
A Southern Blot on the Bov-AR and Bov-A gel products (Figure 5.3 A and C) was used to 
identify which of the amplified fragments carried (AC)n MS repeat sequence. Of the five 
original Y ACs isolated there was no hybridisation to any of Y AC 393 PCR products 
(Figure 5.3B and D). YACs 58 and 61 hybridised to similar sized bands amplified from 
both the Bov-AR and Bov-A SINE primers. YAC 402 hybridised to a band of the same 
size as YACs 58 and 61 with SINE primer Bov-AR and to a product of a different size with 
primer Bov-A. This may be indicative of Y AC 402lacking the Bov-A primer sites of Y ACs 
58 and 61 but sharing the sequence harbouring the Bov-AR primer sequences. 
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YACs YACs 







Figure 5.3 Hybridisation of repeat DNA to SINE PCR products. (A) Bov-AR SINE 
PCR gel; (B) Southern hybridisation of Bov-AR gel; (C) Bov-A SINE PCR gel; (D) 
Southern hybridisation of Bov-A gel. Each Southern blot was hybridised with [a32P]dCTP 
labeled (AC)n DNA. Lane M1, marker 'A EcoRIJHindiii digested; M2, marker DNA pUC 
18/19 Haeiii digested. Lanes are headed with YAC number and the Southern blots aligned 
under the PCR gels to the respective lanes. 
Assignment of Microsatellite Carrying SINE PCR Products 
The presence of multiple bands in the original SINE PCRs (Figure 5.3 A&C) made it 
difficult to assign the above hybridising fragments to specific products. Putative bands 
were assigned a number and isolated away from each other using bandstab PCR (Figure 
5.4A). Hybridisation of these separated bands with (AC)n DNA allowed assignment of 
positive MS carrying SINE PCR fragments (Figure 5.4B). 
Three of the seven isolated SINE PCR products showed a strong hybridisation signal after 
a 30 minute exposure to autoradiograph film. Longer exposures revealed signals for all 
seven PCR products indicating possible (AC)n repeat sequences. 
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BANDS 
M1 1 2 3 4 5 M2 6 7 
Figure 5.4 Identification of (AC)n carrying PCR fragments. (A) bandstab PCR gel; (B) 
Southern hybridisation of bandstab PCR gel probing with (AC)n DNA. Lanes are labeled 
with the assigned band number. Lane Ml, marker 'A EcoRI!Hindiii digested; M2, marker 
DNA pUC 18119 Haeiii digested. 
5.3.1.3 Summary of Microsatellite Isolation 
A summary of this work involving the isolation of MS carrying fragments from screening a 
sheep genomic YAC library is presented in Table 5.5. Five positive MDRl YAC clones 
were isolated. From two SINE primers seven MS carrying fragments were amplified using 
PCR. The cloning and sequencing of a subset of these seven fragments was used to 
characterise a number of MS markers linked to the MDRl gene. 
Assigned SINE Estimated Band 
Product YAC Primer Size (kb) 
1 58 Bov-AR 1.2 
2 61 Bov-AR 1.2 
3 58 Bov-AR 1.0 
4 402 Bov-AR 0.9 
5 407 Bov-AR 0.8 
6 58 Bov-A 0.35 
7 402 Bov-A 0.5 
Table 5.5 Summary on the characteristics of the seven positive MS PCR products. 
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5.3.2 Cloning and Characterisation of Microsatellite Containing 
Fragments 
5.3.2.1 Cloning of Microsatellite Fragments 
Four of the seven (AC)n containing products (1, 2, 5 and 6) were selected for cloning and 
sequence characterisation. Below is a brief summary of results from these cloning 
experiments (Table 5.6). 
Colony Restriction 
Amplified Hybridisation Digest Total number 
Product Positives Positives of Positives 
1 0160 - -
11/30 3/4 3 
2 3/30 3/3 3 
5 7/60 717 7 
6 8/60 8/8 8 
Table 5.6 Cloning of four MS carrying PCR products. The proportion of transformants 
identified in the colony hybridisation and the subsequent restriction analysis are shown. 
The transformation efficiencies of all MS containing bands was low. In the case of band 1 
the ligation was repeated before any positives were isolated. Close to 100 % of the positive 
clones selected from colony hybridisation contained the correct sized insert displaying the 
effectiveness of colony hybridisation for isolating rare cloning events. 
From these analyses two positive transformants from each of the four products were picked 
for sequencing. 
5.3.2.2 Sequencing of Microsatellite Fragments 
The two transformants from each of bands 1, 2, 5 and 6 had both complementary strands 
sequenced and the internal MS sequence characterised. The corresponding MS markers 
were named OarMEM3, OarMEM4, OarMEM1 and OarMEM2 respectively (Table 5.7). 
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Microsatellite Microsatellite Sequence Band number Size (kb) 
OarMEMl (GC)5(AC) 17 5 0.8 
OarMEM2 (AC)zo 6 0.35 
OarMEM3 (AC)4AT(AC) 14 1 1.2 
OarMEM4 (AC)4AT(AC) 14 2 1.2 
Table 5. 7 Characterisation of Microsatellites OarMEM1, OarMEM2, OarMEM3 and 
OarMEM4. Their associated band number and size from which they were isolated is given. 
Full clone sequence from which OarMEM2 and OarMEM3 primers were designed is 
presented in Appendix A 
A database search of the sequence carrying OarMEM2 resulted in matches with the sheep 
MDR1 and other MDR gene sequences. The 0.35 kb fragment included regions of sheep 
MDR1 exon 13 and intron 14. 
Initial sequence from the ends of the 1.2 kb product harbouring OarMEM3 revealed no MS 
sequence. To isolate OarMEM3 a further two primers were designed; con 49: 5 '-
TTTACCGTGTICACTATCC-3' and con 50: 5'TCCGTIGCTCTCAGGTICAATTCC-3' 
to sequence into the middle of the 1.2 kb product. 
OarMEM4 sequence was identical to OarMEM3. Moreover these MS markers were 
originally isolated from identical sized products (bands) in YACs 58 and 61 respectively. 
5.3.2.3 Mapping of Microsatellite Markers 
Mapping of OarMEM1, OarMEM2 and OarMEM3 involved genotyping animals in the IMF 
pedigrees and establishing linkage to groups of loci. 
OarMEMI 
There were not enough informative meioses to map OarMEM1 using the IMF. One sire 
was identified from the FE half-sib families (family 4) that was heterozygous for 
OarMEM1 and also MAF70. This family was genotyped for both OarMEM1 and MAF70 
and no evidence was found for linkage between these two markers (lod=-2 at theta=0.23). 
Fluorescent in situ hybridisation (FISH) with Y AC 407 DNA, from which OarMEM1 was 
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isolated, showed YAC 407 was chimeric (Figure 5.5). It is likely that OarMEM1 was from 
sheep chromosome 10. No further analysis of this MS was undertaken. 
Figure 5.5 FISH probing with YAC 407. Sheep chromosome 10 (arrow A) and 
chromosome 4 (arrow B) have hybridised to this YAC. 
OarMEM2 and OarMEM3 
The mapping of both OarMEM2 and OarMEM3 is presented in Chapter Four Section 
4.3.1. Both MS markers mapped to a linkage group on sheep chromosome 4 with no 
recombinants found between each other or with the MDR1 RFLP marker. 
5.3.2.4 Summary of Microsatellite Isolation and Characterisation 
Of the four potential MS markers characterised two were of identical sequence (OarMEM3 
and OarMEM4) and one failed to show linkage to MDR1 (OarMEM1). OarMEM2 and 
OarMEM3 showed linkage to MDR1. 
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5.3.3 MDRl Segregation with the Facial Eczema Resistance 
5.3.3.1 MDRl Linkage to FE Resistance in Half-Sib Pedigrees 
OarMEMJ 
Family 4 was genotyped to ascertain linkage to MAF70. Although the A allele frequency 
appeared higher in the susceptible animals (suggesting linkage) the majority of offspring 
were heterozygous making it impossible to differentiate whether the A allele had been 
inherited from the sire (Figure 5.6). Analysis of OarMEM1 using eo-segregation with 





Figure 5.6 Genotyping of OarMEM1 in FE family 4. (A) Susceptible animals; (B) 
Resistant animals. The A and B alleles are indicated by arrows. 
OarMEM2 
OarMEM2 was heterozygous in three of the four FE sires (families 2, 3 and 4). MS 
amplification yielded a clearly distinguishable A allele but the assignment of a second B 
allele was ambiguous. Of the 132 animals genotyped 17 amplified a single bright product 
that was not clearly one of the sire alleles (Figure 5.7 asterisk). Therefore OarMEM2 was 




Figure 5.7 Amplification of OarMEM2 in FE family 3. Only resistant animals are shown. 
The same pattern was seen for susceptible animals. The sire is labeled. The sires A allele is 
indicated by an arrow. The second ambiguous allele is indicated by the B arrow. Lanes 
containing only the B allele are marked by an asterisk. 
OarMEM3 
The genotyping of FE family 3 has been depicted as a representative of the four pedigrees 
(Figure 5.8) in which the sire was heterozygous for OarMEM3. The characterisation of this 
MS was unusual in that more than two allelic bands were amplified per animal. The sire 
was assigned four alleles, three of which were segregating as a single haplotype (B, C and 
D). A summary of OarMEM3 segregation in the FE pedigrees is shown in Table 5.8. 
~ 
"""'" 1J1 
AB AB AC BC BC AC AB BC AC BC BC AC AB BC AC AC BC BC BC AC AC BC BC BC BC AC AB AC 
Figure 5.8 Genotyping of OarMEM3 in FE family 3. Allele A and alleles B, C and D can 
be seen segregating in the offspring. The respective genotypes are above each lane. The 
sires alleles have been designated A (A) and B (BCD haplotype). C refers to the second 
allele inherited from the ungenotyped dam. 
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Family 
1 2 3 4 
Phenotype A B A B A B A B 
Resistant 0 7 9 11 11 0 7 8 
Susceptible 0 7 12 5 5 3 4 8 
Table 5.8 OarMEM3 segregation in the four FE families summarising the frequency of A 
and B allele linkages to the resistant and susceptible phenotypes. * Sire 1 had haplotypes 
AB and BB segregating in the offspring. Heritance of the sires haplotype was unable to be 
assigned in animals with both the A and B alleles as the inheritance of AB and BB were 
indistinguishable. 
Analysis of the segregation data presented above showed no significant linkage of :MDR1 
allele inheritance to FE resistance. The major drawback with the FE resource families is 
their low power to detect the segregation of genes that have recessive or minor effects. 
5.3.3.2 MDRl Association in the FE Selection Lines 
The second method for identifying :MDR1 involvement in FE is to examine association of 
:MDR1 with FE using the selection line animals and looking for a consistent bias of alleles 
in the R or S flocks. Approximately 65 animals from each of the R and S flocks and 40 
animals from the control (C) flock were genotyped using OarMEM3. The recorded allele 
frequencies from within each flock are presented in Figure 5.9. None of the alleles, A to H, 
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Figure 5. 9 :MDRl allele association in R, S and C flock animals. The top graph is the 
allele frequencies within the resistant animals, the middle the control and the bottom the 
susceptible. Alleles A to H are labeled along the X axis and percent frequency within each 
flock, of these respective alleles, shown up the Y axis. Above each bar is the number of 
animals recorded with the respective allele. 
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To confirm this data the EcoRI RFLP polymorphism used to map MDR1, Section 4 .3 .1.1, 
was genotyped in 30 R, 30 S and 30 C flock animals . A representative gel is depicted in 
Figure 5 .lOA and the results are summarised in Figure 5 .lOB . 
2 3 4 5 6 7 8 9 10 
A B 
A~ 
R 22 8 
s 1 2 8 
B 
A 
AA AB AB AB AB AA AB AA AB BB 
Figure 5.10 (A) EcoRI RFLP data from susceptible selection line animals. The EcoRI 
RFLP bands are indicated by the arrows. Animals 1, 6 and 8 are homozygous for the A 
allele; animal 10 for the B allele and 2, 3, 4, 5, 7 and 9 heterozygous at this loci. The 
respective genotypes are given below each lane. (B) Contingency table of the RFLP allele 
segregation data. A and B alleles are along the top and the R and S phenotypes down the 
side. 
Collective data from the FE selection line animals indicates no significant association 
between MDR1 alleles and the FE disease resistant phenotype. 
5.3.3.3 QTL Analysis on Chromosome Four 
In confirmation with the above analysis a QTL scan of chromosome 4 showed no 
indication of association of MDR1 to GGT/GDH levels or animal body weight. The 
genome scan was undertaken by Dr Sin Phua (pers. comrn.) with data generated for MDR1 
included (Figure 5.11 arrow). There appeared to be no region of chromosome 4 with 
significant linkage to FE. 
























Figure 5.11 QTL Analysis on sheep chromosome 4. Significant and suggested linkage 
levels are indicated. The markers were tested for linkage to logGGT (pink), logGDH (blue) 
(both liver enzymes indicative of liver injury) and liveweight (red). 11 markers in total were 
tested, BMS1788, McM218, MDR1, MAF70, RM67, MAFSO, TGLA116, OarCP26, 
OarHH35, BM3212 and OarHH64. MDR1 is indicated by the arrow. 
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5.4 DISCUSSION 
5.4.1 Isolating Microsatellites from YACs 
The work described in this chapter emphasises the caution required when usmg MS 
markers derived from YAC clones. The presence of chimerism can lead to misleading 
positive results and it is vital for the integrity of the data that each MS is proven to be linked 
to the gene of interest. The fact that OarMEM2 and OarMEM3 were isolated from bands of 
the same size amplifying in different Y ACs supports the proposal that the isolation of MS 
markers from bands that amplify in more than one YAC is a robust mechanism for reducing 
the risk of isolating a marker from a chimeric Y AC. 
The additional allelic bands amplifying with OarMEM3 primers indicates their binding to 
other regions of high homology and adds weight to already accumulating evidence that 
:MD RI is a member of a multigene family in sheep. The fact that one of the MS haplotypes 
contained three alleles suggests that the :MD RI region has been duplicated at least two times 
in sheep. 
5.4.2 MDRl Linkage and Association to Facial Eczema 
OarMEM3 analysis indicated no significant linkage of the :MDRl locus with FE resistance 
or susceptibility. The mating scheme of the four FE resource families, which consist of 
sires outcrossed to unrelated ewes to generate half-sib progeny, is a standard pedigree 
structure used to detect polygenic traits in livestock. Since a recessive allele is only 
expressed in an individual when both its homologous chromosomes carry the same allele 
type, the ability to detect linkage of a sire's recessive allele to its progeny's trait is 
dependent on the frequency of the recessive allele in the dam population. In 1997 a 
backcross was set up mating one of the FE sires to 80 susceptible FE selection line ewes in 
an attempt to overcome this limitation. This pedigree is still small and another year of 
backcross matings is required before it contains a useful number of animals. 
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Similarly gene alleles with minor effects can be missed in linkage studies of markers to 
traits in outcross pedigrees, particularly when the trait is polygenic as for FE disease. The 
fact that the FE selection lines after two decades of selection still show continued 
divergence from the control flock would suggest that there are many genes affecting FE 
resistance that have yet to reach homozygosity. The addition of unselected females into the 
S line (Morris et al., 1991) to improve fertility will have slowed down the rate of genetic 
progress in this line. Thus it would be harder to identify genes responsible for conferring 
susceptibility to the toxin than those responsible for inherited resistance. 
Association studies of allele distribution in divergent genetic lines can provide a means to 
test for gene involvement in a trait. Genotyping of the selection line animals for OarMEM3 
and the EcoRI RFLP indicated no significant association of any J\.1DR1 allele with FE 
resistance or susceptibility. 
A QTL scan of chromosome 4 detected no significant association of any markers (including 
J\.1DR1) to the measured FE traits. 
5.4.3 Summary of Chapter Five 
From this combined data it would appear that the J\.1DR1 gene per se is not involved in the 
inheritance of resistance or susceptibility to FE. It does not exclude however that a protein 
acting in trans is differentially expressed in drug resistant cells and directly affects the level 
of J\.1DR1 transcription, the post translational stability of the protein, or indirectly affects 
resistance of the cell to the FE toxin. 
CHAPTER SIX 
MDRl GENE EXPRESSION AND 




The use of PCR for detection and analysis of gene transcription has provided a sensitive 
tool for the study of gene regulation and gene expression. However, the central features of 
PCR that provide sensitivity for detection also present a challenge in the application of 
quantitative methodologies. Due to its exponential nature, PCR yield is affected by small 
experimental variation and thus becomes prone to significant standard error arising from 
inherent well to well variations in amplification efficiency. Various strategies have been 
developed to compensate for this variability, most utilising the principle of competitive 
PCR (Wang et al., 1989). 
6.1.1 Competitive and Semi-Quantitative PCR 
In competitive PCR a known concentration of a synthetic template (internal control) is eo-
amplified with a constant unknown amount of target DNA. The target and control templates 
have the same primer binding sequences but the amplified products can be discriminated 
and differentially quantified (Wang et al., 1989). Assuming both target and control 
templates are matched in amplification efficiencies the relative amounts of product derived 
from the target and control templates following amplification can be assumed to reflect the 
relative amounts of input template present prior to amplification. As the amount of internal 
control template spiked into the reaction prior to amplification is known the unknown 
quantity of input target template can be calculated (Zachar et al., 1993). 
In some situations it is not necessary to measure absolute levels of mRNA (Buck et al., 
1991). In these cases useful information can be obtained from the comparison of relative 
expression levels. In these reactions the expression level of the gene of interest is compared 
to that of an exogenous gene (external control). Levels of mRNA can be semi-quantified by 
using the ratio of the gene of interest to that of the external control normalising the data. A 
constituatively expressed gene is usually chosen as the external control (Raeymaekers, 
1995) which acts as a control for variations in RNA quality. Generally RNA purity is 
assessed using the ratio of absorbance at 260 nm to that at 280 nm. Recently this measure 
has been reported to be inaccurate (Glasel, 1995). Concomitant amplification of actin, 
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GAPDH or other housekeeping genes can be used to ensure uniformity in the collected 
data. 
6.1.2 Target Tissues 
Animals grazing in P. chanarnm infected pasture ingest the sporidesmin toxin which is 
absorbed through the gastrointestinal tract into the bloodstream and removed by the liver. 
The major site of sporidesmin damage is the biliary epithelium in which necrosis and 
inflammatory changes are observed within 2 hours of dosing (Ferguson et al., 1992). 
Bissinger and Kuchler (1994) looked at Saccharomyces cerevisiae as a model organism to 
search for genes that can mediate resistance to sporidesmin. A gene was isolated, STS 1, 
and found to be an ABC transporter with strong similarity to the MDR family. Mutant 
STS1 cells exhibited supersensitivity to sporidesmin. Conversely overexpression of STS1 
lead to increased resistance to the mycotoxin. 
6.1.3 MDR1 Expression 
MDR1 is found expressed in the liver, primarily in the canalicular membranes of the biliary 
tract (Thiebaut et al., 1989), where its normal physiological function remains to be 
determined (Lum et al., 1995). Indirect evidence for the role of MDR1 in biliary drug 
excretion comes from in vitro experiments which show transport across canalicular 
membranes is unidirectional and can be inhibited by classical MDR modulators (Gatmaitan 
and Arias, 1993). 
In leukocytes, MDR1 expression has been studied using flow cytometry (Drach et al., 
1992). Human monocytes and granulocytes express MDR1 mRNA at very low levels in 
normal tissue. MDR1 expression in sheep leukocytes has not been investigated, however 
previously work has indicated no differential sensitivity to the toxin between R and S 
leukocytes (Collins, pers. comm.). 
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6.1.3.3 Regulation of MDRl Expression 
Overexpression of MDR1 is due to. (i) gene duplication (Gros et al., 1986b); or (ii) 
transcriptional or post-transcriptional regulation (Scotto et al., 1986). Functional studies of 
the MDR1 promoter have identified a number of promoter elements and transcription 
factors necessary for its basal activity (Chin et al., 1993; Goldsmith et al., 1993; Borellini 
et al, 1990; Buschman et al., 1992; Yu et al., 1993; Comwell and Smith 1993; Madden et 
al., 1993; Combates et al., 1994). None of these studies have identified functional 
differences between drug resistant and drug susceptible cells. Recently it was discovered 
that stable integration of transfected genes is required for differential expression (Ince and 
Scotto, 1996). From this report the first differentially expressed MDR1 promoter element, 
J\.1ED1, initiated efficient expression from multiple start sites in drug resistant cells but had 
no effect in drug sensitive cells. 
6.1.4 Flow Cytometry 
In conjungation with RT-PCR, flow cytometry is used to detect and analyse expression of 
specific genes at the cellular level (Li et al., 1991). Flow cytometry allows the separation of 
individual cells from a heterogenous population or a population in which the cell of interest 
is in the minority (Gaynor et al., 1996). The advancement of incorporating reverse 
transcription into the sorting and PCR amplification procedure allowed experimental design 
that could determine gene expression patterns. 
6.1.5 Aims of Chapter Six 
Results from the previous chapter indicated no genetic evidence that an alteration in the 
MDR1 gene per se contributed resistance or susceptibility to FE. This chapter examines the 
possibility of interacting factors indirectly conferring resistance or susceptibility by directly 
controlling MDR1 expression levels. It reports on differences in MDR1 expression in 
flocks selected for either resistance or susceptibility to sporidesmin and we examine the 
effect of sporidesmin dosing on MDR1 expression. We have chosen analysis of liver tissue 
because of the potential for this organ to modify sporidesmin toxicity and because of the 
role of sporidesmin-induced liver and biliary tract damage in producing many of the 
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symptoms and consequences of FE. In addition MDRl expressiOn m leukocytes was 
examined using the competitive PCR and flow cytometry techniques. Leukocytes offer an 
easily accessible and cultured source of cells. If MDRl is differentially expressed in 
leukocytes of resistant and susceptible animals a simple blood test could be devised for use 
in selecting resistant animals for breeding. It would not, as the current GOT test does, 
require exposure of livestock to the toxin. 
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6.2 MATERIALS AND METHODS 
6.2.1 Competitive PCR 
The flow chart in Figure 6.1 gives an overview of the expression studies carried out in this 
chapter. Each step is covered in more detail in sections 6.2.1.1 to 6.2.2.2 
target cDNA 'hoop ~DNA 




transcribe MDRl RNA 
t 
quantitate quantitate 
(known total target RNA concentration; (known concentration 
unknown MDRl RNA concentration) of MDRl RNA) 
~RTilltocDNA I 
t 
amplifying using MDRl 
primers 
run on a polyacrylamide gel 
expose to phosphoimage cassette 
t 
quantitate band intensities 
Figure 6.1 The overall scheme for quantitation of MDR1 gene expression. The same 
methodology is used in actin competitor PCR. The internal control refers to the actin or 
MDR1 sequence that has had a loop of AT rich sequence inserted prior to cloning into 
pBluescriptii. RNA is synthetically produced using the T7 RNA promoter. The target 
sequence is the non-mutated version of the internal control and is transcribed from animal 
tissue or cells rather than synthetically produced. 
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6.2.1.1 Synthesis of MDR1 Internal Control 
The MDR1 internal control was synthesised using PCR generated mutagenesis to insert a 
27 bp loop into one end of the target sequence. 
Primers Used for Amplification 
MDR1 cDNA sequence was amplified using a pair of primers (Table 6.1) designed to exon 
26 and 28 of the MDR1 gene. These exons were separated by three introns of estimated 
sizes 5400, 3300, and 1400 bp to prevent amplification of genomic DNA. The MDR1 
specific primers were selected so that they would not amplify any closely related MDR 
genes. 
MDRl Primers Sequence (5'-3') 
con 7 TGAGCGATCACAATGCAGGTGC 
con 8 CTCCTGGAGCGGTTCTACGACC 
con43 CTCCTGGAGCGGTTCTACGACCCCTTGGCTG(AAATATTTA 
TATTAAAATTATTTTAAA)GCACAGTGTTTATTGACGG 
Table 6.1 Primers used in expression analysis of MDRl. The nucleotides within the 
brackets of con 43 represent the AT insert sequence. 
Amplification of Internal Control and Target 
The production of the internal control construct is outlined in Figure 6.2A. The production 
of the internal control used the "looped oligo" method (Sarkar and Bolander, 1994). The 
competitor was made "size-distinguishable" from the standard or wildtype products by 
insertion of a loop using PCR generated mutagenesis. 
For internal control production sheep cDNA was amplified in a standard mix (Section 
2.7.1) using primers con 7 and con 43 followed by a hemi-nested reaction using con 7 and 
con 8, 1.5 mM Mg2+ and 0.3 U/1-ll Taq Polymerase. Both amplification conditions were: 28 
cycles of 94°C, 1 minute; 58.5°C, 1 minute; 72°C, 1 minute with an initial denaturation time 
of 2 minutes and a final extension time of 5 minutes. The MDR1 internal control construct 
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Figure 6.2 Generation of MDR1 internal control. Con 7, con S and con 43 are 
oligonucleotides for PCR; the direction of synthesis is indicated by arrow heads. The loop 
in oligonucleotide con 43 represents non-MDR sequence. For the generation of the internal 
control molecule a PCR with con 7 and con 43 is carried out, the amplified product is then 
diluted and used as template for a second PCR with oligonucleotides con 7 and con S. 
6.2.1.2 Synthesis of Actin Internal Control 
At the outset of this experiment the actin internal control was kindly supplied by Genevieve 
Matthews, cloned into pBluescriptii and stored as a frozen glycerol stock. The actin 
primers used in this analysis were supplied by Dr Glen Buchan, Deer Research Laboratory, 
University of Otago, Dunedin (Table 6.2). The U primer begins at base 155S of the human 
cytoplasmic beta-actin gene (M10277). Six bases after the primer is an intron/exon 
boundary in the human actin gene. 
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Table 6.2 Actin primers. Primer X includes the 20 bp insertion sequence. 
Actin cDNA was amplified in a standard reaction mix (Section 2.7.1) containing primer U 
and L, 1.5 mM Mg2+ and 0.3 U/f.!l Taq Polymerase. Amplifications were: 28 cycles of 
92°C, 1 minute; 63°C, 1 minute; 72°C, 20 seconds with an initial denaturation time of 3 
minutes and a final extension time of 5 minutes. 
6.2.1.3 Clone Orientation and Linearisation 
Ligation of each construct into pBluescriptii was bidirectional. However, only one 
direction (Figure 6.3) was viable for the synthesis of RNA using the T7 promoter. A 
number of MDR1 internal control transformants were examined by PCR and sequenced to 
select a suitable clone. 
















Figure 6,3 Correct clone orientation for RNA synthesis. 
The selected MDR1 and actin internal control clones were linearised prior to RNA synthesis 
using Sall. Digests were carried out with 100 ng of DNA, 1 U/f.!l Sall in 1x Buffer H 
(Boehringer). The mix was incubated at 37°C for 2 hours and a sample of each was 
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electrophoresed on an agarose gel to check that complete digestion had occurred. Linearised 
plasmids were phenol/chloroform extracted and ethanol precipitated (Section 2.4.4). Pellets 
were resuspended in DEPC treated RzO and stored at -20°C. Linearised cDNA was used in 
the production of RNA transcript (Section 2.7.3). 
6.2.2 Analysing MDRl Expression in Hepatocytes 
6.2.2.1 Animal Tissue Samples 
A total of 20 FE selection line animals, 10 resistant (R) and 10 susceptible (S) were 
selected in 1996 and a further 20 in 1998. FiveR and five S animals received a dose of 
sporidesmin (Table 6.3) two days prior to culling. In addition the 1998 dosed R and S 
animals had biopsy samples taken prior to dosage. The toxin was delivered by oral 
intubation in a single dose as described by Morris (Morris et al., 1989). Animals were 
maintained at Ruakura, Hamilton. All tissue samples were stored at -80°C. These tissue 
samples were kindly supplied by Dr C.A. Morris and Dr W. Jordan who set up the 
challenges as part of a project to examine changes in liver proteins, after challenge, using 
two-dimensional gel electrophoresis (Lu et al., 1994). 
Year Resistant Dose (mg/kg Susceptible Dose 
liveweight) (mg/kg liveweight) 
1996 0.35 0.15 
1998 0.35 0.15 
Table 6.3 Doses of sporidesmin administered to the 1996 and 1998, resistant and 
susceptible animals. 
6.2.2.2 Target RNA Extraction and Competitive PCR 
A number of methods were compared for use in RNA extraction from liver tissue. TRlzol 
®Reagent (Life Technologies) gave the highest quality and yield of RNA (Section 2.5.2). 
The concentration of each RNA sample was obtained from averaging multiple 
spectrophotometer readings. Working stocks of 1 ~-tgl~-tl were diluted in DEPC treated water 
for use in PCR. 
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All Competitive PCR reactions were performed as described in Section 2.7.3. Samples 
were analysed in duplicate wells and in duplicate microtitre trays. Both the reverse 
transcriptase (RT) and PCR amplification steps could be achieved sequentially in a single 
microtitre well. The internal control concentration, to be spiked into each amplification, 
was estimated by amplifying titrations of internal control RNA using the standard 
conditions. All software used in analysis of competitive PCR gels is described in Section 
2.7.3. 
6.2.3 Analysing MDRl Expression in Leukocyte Populations 
Leukocytes were isolated from five resistant and five susceptible animals and challenged 
with variable dosages of sporidesmin as described in Section 2.11. RNA was prepared 
from these animals using the CsCl preparation method. Competitive PCR was performed 
with 100 ~-tg/~-tl of RNA and internal control concentrations for MDR1 and actin of 0.05 
pg/~-tl or 0.08 pg/~-tl respectively. 
6.2.4 Analysing MDRl Expression in Single Leukocytes 
6.2.4.1 Cell Isolation and Sorting 
The expression level of MDR1 in B-cells and general leukocytes was examined using the 
single cell RT-PCR methodology incorporating flow cytometry to sort cells with RT-PCR 
to analyse cell expression. Blood was collected by jugular venipuncture into acid citrate 
dextose and maintained at room temperature prior to cell separation and harvesting of cells. 
A laser based flow cytometer equipped with a single cell deposition device (Epics™ 751 
with autoclone; Coulter Electronics. Miami. USA) and a Cicero™ data acquisition and 
sorting system (Cytomation, Fort Collins, USA) were used to sort leukocytes (Section 
2.7.4). 
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6.2.4.2 Primers and PCR Amplification 
The amplification of J\.1DR1 and control genes were performed with herni-nested primers in 
two stages. The three primers, designed to amplify across J\.1DR1 exons 11, 13 and 15 
(Table 6.4), amplified products of 426 bp and 250 bp. GAPDH was used as an external 
control and was amplified using primers kindly supplied by Dr Harris Lewin (Table 6.4) 
which amplified products of 284 bp and 231 bp. Primer sets used for detection of J\.1DR1 
and GAPDH cDNA were designed to cross an intron/exon boundary ensuring that the 
products of amplification did not originate from genomic DNA. 
Primer Sequence (5'-3') 
MDR11629 TCTTTGCTTCTGTCCACCGCTTA 
con22 GTTCACTTCCATTACCCATCTCG 
MDRl 1380 * ACAGGATATCAGGACCATCAACG 
GAPDH-L GAAGGTCGGAGTCAACGGAT 
GAPDH-R TGGACTCCACGACGTACTCA 
GAPDH-INT * TCTCGCTCCTGGAAGATGGT 
Table 6.4 Primers used in RT-PCR on leukocytes. * indicates the herni-nested primer. 
Con 22 and J\.1DR11380 and GAPDH-L and GAPDH-INT were used in the second round 
reactions. 
The methodology involved in RT-PCR of single cells is described in Section 2.7.4. 
The frequency of B- or leukocytes expressing J\.1DR1 was estimated using a computer 
programme (SCDCP) developed for single cell analysis (Mirsky et al., 1993). 
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6.3 RESULTS 
6.3.1 MDRl Expression in Liver Sheep Cells 
6.3.1.1 Synthesis of MDRl Internal Control 
A PCR product containing the 27 bp insertion was amplified and cloned. Four putative 
positive white transformants were analysed by (i) Xbai!Sall digestion to access insert size 
(Figure 6.4A) and (ii) re-amplification ability using primers con 7 and con 8 (Figure 6.4B). 
M1 2 3 4 -ve M2 
A 8 
Figure 6.4 MDR1 internal control clones. (A) Restriction digest of MDR1 internal 
control clones to analyse insert size; M1, marker /..EcoRI!Hindiii; M2, marker pUC 18/19 
Haeiii; Lanes 1-4 internal control clones 1-4. Clones 1, 3 and 4 have correct inserts. (B) 
Amplification of MDR1 internal control clones with con 7 and con 8. M1 and M2, marker 
DNA; Lanes 1-4 internal control clones 1-4. Clones 1 and 4 have amplified clear products, 
Clone 3 amplified two products. 
Of the four isolated, clones 1 and 4 had inserts of the correct size and amplified products of 
the correct size. Clone 3 had an insert of the correct size and amplified a PCR product of 
the correct size but a contaminant was also present. Clones 1 and 4 were analysed for 
orientation in the vector (Figure 6.5). Both amplified products with primers con 7 and 17 
and failed to amplify products with con 8 and T7. One clone was selected for RNA 
synthesis. In parallel with this work the clone selected for transcription was sequenced to 
confirm orientation and MDR1 specificity. 
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M 2 3 4 5 6 
Figure 6.5 Orientation analysis of two MDR1 internal control clones, 1 and 4 Lane M, 
marker 'AEcoRI/Hindlli; Lanes 1 and 2 are products amplified with con 7 and con 8; Lanes 
3 and 4 with primers con 8 and con T7 and Lanes 5 and 6 con 7 and T7. Lanes 1, 3 and 5 
represent clone 1 and lanes 2, 4, and 6 clone 4. Both represent transformants with inserts 
in the desired orientation. The amplifications using primers con 7 and con 8 are positive 
controls. 
6.3.1.2 Synthesis of Actin Internal Control 
Suitable colonies selected from streaked plates had plasmid DNA prepared, were checked 
by restriction digest and PCR amplification, and were used for synthesis of actin RNA. 
6.3.1.3 RNA Extraction From Samples 
Initial experiments involved RNA prepared using the RN easy mini kit (Qiagen). Resulting 
yields were low and the competitor PCR assays gave highly variable results. In a previous 
report (Saric and Shain, 1997) increasing the amount of cDNA template was found to 
improve both the accuracy and reproducibility of semi-quantitative RT-PCR of low 
abundant transcripts. Trials using various RNA preparation methods demonstrated that the 
TRizol extraction kit (Life Technologies) produced the highest RNA yields. This method 
was used to prepare RNA from liver tissue of both the 1996 and 1998 FE selection line 
animals used in this study (Section 6.2.2.1). 
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6.3.1.4 Selection of Internal Control Concentration 
Internal control RNA titrations of 0.05 pg/J.!l to 300 pg/J.!l (Figure 6.6) were added to 
reactions containing 1 J.!g/J.!l wildtype RNA (MDR1 or actin) to select the internal control 
concentration that best reflected that of the final target concentration. MDR1 and actin 





Figure 6.6 Designation of MDR1 and actin internal control concentrations. The 
concentrations of the internal control are given above the respective lanes. (A) MDR1 
competitive PCR. 1 pg/J.!l is the concentration at which target and internal control MDR1 
RNA are at approximately equimolar concentrations. (B) Actin Competitive PCR. 0.8 
pg/J.!l is the concentration at which target and internal control actin RNA are at 
approximately equimolar concentrations. The boxed lanes represent the selected 
concentrations. 
6.3.1.5 Competitive PCR 
Although intra-assay repeats were highly consistent (compensated for using the internal 
control) a large amount of variability was recorded between repeat trays (repeatability value 
< 0.03). Although this was disturbing and was not conducive to comparing data extracted 
from different trays the variability was consistent over all samples, thus, relative 
associations between groups remained the same. 
There were two experimental sets of data analysed: (i) 1996 animals; and (ii) 1998 animals. 
Each of the experiments analysed undosed resistant (UR), undosed susceptible (US), 
dosed resistant (DR) and dosed susceptible (DS) animals. In addition, the 1998 
experiments included biopsy samples · extracted from the dosed resistant (BR) and dosed 
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susceptible (BS) animals prior to receiving the toxin. All analysed data is in the form of 
ratios expressing the level of MDR1 mRNA relative to that of the constituatively expressed 







MDRl Expression in Hepatic Cells 
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1996 Animals 
UR US DR DS 
1998 Animals 
BR BS 
Figure 6. 7 MDR1 expression levels in liver tissue. Animals are labeled as follows: UR, 
Undosed Resistant; US, Undosed Susceptible; DR, Dosed Resistant; DS, Dosed 
Susceptible; BR, Biopsy Resistant; BS, Biopsy Susceptible. The first four bars relate to 
animals culled in 1996 and the last six to those culled in 1998. The value on the Y -axis 
represents the MDR1 versus actin ratio. Error bars are shown as standard error of the 
mean. 
There was no significant difference in MDR1 expression levels between the two undosed 
groups in either the 1996 (P>O.SO) or 1998 (P> 0.20) animals. The two dosed groups (DR 
and DS) from the 1996 and 1998 animals showed significant differences in their expression 
levels (P<0.002; P<0.0001). 
Looking at the data from the 1996 animals, the DR group had significantly higher MDR1 
expression levels than the UR animals while the DS animals showed no significant 
difference from their US counterparts (P>0.13). This was in contrast to the 1998 animals 
in which the susceptible group showed a significantly lower MDR1 expression than the US 
animals (P<O.OOl). 
The biopsy samples taken from resistant animals prior to dosage and compared to post 
dosage tissue samples showed a significant increase in MDR1 mRNA levels from pre- to 
post- dosage (P<0.0001) (Figure 6.8). This is comparable to the previous data on the 
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.MDR1 response of resistant animals to sporidesmin. Pre- and post- tissue samples from 
susceptible animals showed no significant change in .MDR1levels from pre- to post-dosage 
(P>0.25). This is inconsistent with previous comparisons of US and DS animals which 
showed lower .MDR1 levels in the DS samples. The two pairs of undosed samples (US, 
BS & UR, BR) showed significant differences in .MDR1 expression levels (P<0.001; 
P<0.002). These results suggest a high degree of variation between animals in their .MDR1 
response to sporidesmin. 
There was no significant difference in MDR1 expression levels between comparable groups 
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Figure 6. 8 Biopsy samples and MDR1 expression levels. Each pair of bars represent a 
single animal. There are four Resistant (1-4) and four susceptible (5-8) animals. Resistant 
animals received a 0.35 mg/kg dose of sporidesmin and the susceptible animals a 0.15 
mg/kg dose. MDR1 Expression values are given as ratios of MDR1 versus actin. 
6.3.1.6 Summary of MDRl Expression in Liver Cells 
There appears to be evidence of increased MDR1 mRNA levels in resistant animals that are 
exposed to the sporidesmin toxin. Susceptible animals show no significant change in 
MDR1 expression levels after dosing. 
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6.3.2 MDRl Expression Levels in Sheep Leukocytes 
This study looked at variability in MDR1 expression levels in leukocytes challenged with 
increasing sporidesmin concentrations (0, 5 and 50 ng/ml). Figure 6.9 depicts the results. 
MDR1 expression in both the resistant and susceptible leukocytes appeared to increase 
from the basal level (0 ng/ml dose) with a dose of 5 ng/ml and subsequently decreased back 
to basal levels with a challenge of 50 ng/ml. The increased expression levels at 5 ng/ml are 
statistically significant in the resistant cells (P<0.002) and insignificant in the susceptible 
(P>0.50) cells. With a further ten-fold increase in dosage, the cells isolated from resistant 
animals did not show a significant increase in MDR1 mRNA levels compared to the basal 
(0 ng/ml) level. This is possibly due to saturated MDR1 function and accumulation of 
sporidesmin resulting in cell death and loss of protein function. 
Although at 5 ng/ml the resistant and susceptible cells showed significant differences in 
their response to MDR1 expression, the overall interaction of the two cell types was not 
significantly different (P>0.17) suggesting they both showed similar trends in response to 
the doses. This highlights the requirement for a specific dosage to be identified for use in 
expression studies that emphasizes the differential expression of the resistant and 
susceptible cells but is not so toxic to kill cells. 
MDRl Expression in Leukocyte Cells 
0 5 so 
Dosage Levels (ng/ml) 
• Susceptible 
lli Resistant 
Figure 6 . 9 MDR1 Expression in Leukocytes of Resistant and Susceptible animals. Cells 
were exposed to three concentrations of sporidesmin toxin: 0, 5 and 50 ng/ml. MDR1 
expression is given as a ratio of MDR1 expression to that of actin. Error bars are shown as 
standard error of the mean. 
122 
6.3.3 MDRl Expression in Flow Sorted Sheep Leukocytes 
6.3.3.1 Setting Parameters and Cell Sorting 
Analyses included measuring cell fluorescence and forward and 90° light scattering 
properties of each cell. Forward light scatter measures cell size and 90° light scatter cell 
granularity. Figure 6.10 displays the cell characteristics present in the leukocyte 
suspension. Large cells such as macrophages and eosinophils are represented by the dots in 
the top right corner while the black mass in the bottom left represents dead cells. The 
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Figure 6.10 Forward and side light scatter of the labeled B-cell suspension. The forward 
light scatter is given on the Y-axis and the side or 90° light scatter on the X-axis as a log 
scale. The hexagonal box represents the set limits for these two criteria. The dark mass in 
the bottom left corner is dead cells. Those dots in the top right are likely to be macrophages 
and neutrophils. 
The fluorescence readings of the three prepared cell suspensions (labeled B-cells, isotype 
and washed) are shown in Figure 6.11 and were used to sort labeled B-cells. The low 
percentage of cells emitting fluorescence in the washed and isotype cell suspensions depicts 
the low background fluorescence and fluorescence arising from non-specific binding of the 
antibody. B-cell labeling was efficient with 22% of the leukocyte population indicating 
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Figure 6.11 Cell Fluorescence. (A) Labeled B-Cells; (B) Isotype Cells; (C) Washed 
Cells. A box was drawn to establish the fluorescence level at which cells will be sorted and 
below which cells will be discarded. The number of cells is given on the Y-axis and the 
fluorescence measured by a fluorescein isothiocyanate (FITC) label on the X-axis. The 
percentage of fluorescing cells is given above the respective boxes. 
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Preliminary experiments suggested the l\1DR1 gene was expressed in very few leukocytes 
therefore single cell RT-PCR was impractical and a selected number of 500 cells per well 
was chosen for cell sorting and subsequent RT-PCR. 
6.3.3.2 RT -PCR 
All wells amplified the positive GAPDH gene product. In some cases the first round 
GAPDH product could also be visualised (Figure 6.12). In wells containing leukocytes and 
B-cell populations 30% and 5.7% of wells respectively amplified a second round l\1DR1 
product. All negative controls were devoid of any products. 
2 3 4 5 6 M 7 8 9 
MDRl____. 
GAPDH____. 
Figure 6.12 RT-PCR on sorted B-cells (500/well). Lane M, Marker DNA pBR322 Mspi 
digested. Lanes 1-9, 500 B-cells per well. Second round l\1DR1 and GAPDH products are 
indicated by the arrows. The upper faint band is the first round GAPDH product. Lanes 1 
and 3 have amplified second round l\1DR1 products. 
The data was analysed for (i) the number of B-cells expressing l\1DR1 and (ii) the number 
of leukocytes expressing the gene. l\1DR1 was estimated to be expressed in 0.012% of B-
cells (standard deviation 0.008) and in 0.069% (standard deviation 0.017) of leukocytes. 
As the efficiency of cell sorting is 95%, the small percentage of B-cells found expressing 
MDR1 may be the result of contaminating T-cells. The experiment would need to be done 
in duplicate to confirm this. The higher expression in the general leukocyte population 
suggests MDR1 is expressed in cells other than B-leukocytes at low levels. 
6.3.3.3 Summary of MDRl expression in Unchallenged B-Cells and 
Leukocytes 
125 
This study demonstrates the number of leukocytes expressing MDRI in normal sheep cells 
is very low and in B-cells is negligible. It presents a methodology that could be used to 
extend genotyping to measuring a percentage of cells expressing the gene of interest or 
expression in a specific sub-population of cells. 
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6.4 DISCUSSION 
The work presented in this chapter has examined the expression levels of the sheep l\1DR1 
gene in both liver and leukocyte populations. It has compared the l\1DR1 mRNA levels in 
cells isolated from animals selected for resistance or susceptibility to FE. A subset of these 
animals received a challenge of sporidesmin either in vivo prior to cell extraction 
(hepatocyte data) or in vitro during cell culture (leukocyte data). The use of competitive 
PCR provided an efficient tool for quantitation of l\1DR1 gene expression in these 
populations. This was in contrast to Northern analysis in which large quantities of RNA 
were required and which, in the case ofl\1DR1, was not sensitive enough to detect mRNA 
levels. 
Variability found between assays would suggest factors such as Robocycler temperature 
inconsistencies are impacting on the final product yield. Although obviously a problem in 
large scale analyses, it was encouraging that replicates within a tray were highly 
reproducible and that associations remained constant between trays. Fortunately for our 
studies all samples analysed could be accommodated on a single 96 well tray. 
6.4.1 Hepatocyte Expression 
Samples taken from the same animal pre- and post- dosage allowed analysis of the changes 
in l\1DR1 expression without animal variability influencing the results. The initial decrease 
in l\1DR1 expression recorded between the 1998 DS and US animals (but not seen in the 
DS and US animals of 1996 or the DS and BS samples of 1998) may have been due to 
differences in dose response between animals rather than a true reflection of the changes in 
l\1DR1 expression. These results highlight the need to design experiments that minimise 
such variation or include steps allowing for it in the statistical analysis. 
Data collected from dosed and undosed resistant animals suggested l\1DR1 activity was 
increased in the liver cells of resistant sheep after exposure to the sporidesmin mycotoxin. 
There was no change detected in susceptible cells. 
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No significant differences were seen in MDR1 expression levels between the 1996 and 
1998 animals. It is likely the small changes gained on a yearly basis (Morris et al., 1995) 
would not reflect significant differences over the short 2 year period of this study. 
6.4.2 Leukocyte Population Expression 
Data from cultured leukocytes indicated a dose of 5 ng/ml increased MDR1 expression in 
resistant cells but that this level of raised expression was decreased back to that of the basal 
recording (0 ng/ml) with a 50 ng/ml dose. Unpublished data (Collin, pers. comm.) 
indicated a dosage of 3-30 ng/ml administered to non-selected sheep leukocytes resulted in 
20-40% cell death. Data presented here suggests that MDR1 expression is increased at 
sporidesmin levels of 5 ng/ml in resistant cells. A ten-fold increase in this dosage (50 
ng/ml) lead to a decrease in MDR1 expression possibly due to overwhelming toxin 
concentrations, marked cell death and subsequent loss of protein function. Leukocytes 
derived from susceptible animals showed a small increase in MDR1 expression that was 
not statistically significant. More frequent dosage points over the 3-50 ng/ml range need to 
be examined to identify the dosage at which resistant and susceptible animals could be 
distinguished by analysing MDR1 expression. 
6.4.3 Leukocyte Single Cell Expression 
The technique of single cell RT-PCR was learnt at the University of Illinois in Champaign-
Urbana, USA. It offers a sensitive, although relatively labour intensive, alternative method 
for measuring MDR1 expression in leukocyte populations. It has the added benefit of being 
able to select a specific cell type from a mixed population and record the percentage of cells 
expressing the gene of interest. Although MDR1 expression was only estimated in 
unchallenged sheep leukocytes this methodology could be used to examine expression in 
leukocytes isolated from the selection line animals and also adapted to study MDR1 
expression or that of other candidate genes in liver cells. 
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The number of leukocytes from a normal population expressing MDR1 was found to be 
very low. B-cells specifically showed negligible MDR1 expression. Previous work on 
normal human leukocytes indicated minimal expression of MDR1 in monocytes and 
granulocytes (Drach et al., 1992). 
6.4.4 Summary of Chapter Six 
The data presented in this chapter suggests that animals resistant to sporidesmin have 
increased levels of MDR1 mRNA. The overexpression of MDR1 may be providing a 
degree of protection to cells exposed to the toxin. It is not clear whether a similar response 
is seen in the immunological cells of the animal but preliminary data indicates an increase in 
MDR1 mRNA, in leukocytes harvested from resistant animals, that may be exploited as a 






7.1.1 MDR2 Function 
The cloning of MDR cDNA has revealed that the human, mouse and hamster families are 
composed of a small number of closely related genes, (Endicott et al., 1987; Gros et al., 
1988; Chen et al., 1986; and Van der Bliek et al., 1987), two members in humans (MDR1 
and MDR2) and three in rodents (mdr1, mdr2 and mdr3). 
Despite sharing a high degree of sequence and structural homology the I'viDR gene products 
are divided into three classes. Classes I and II consist of drug-transporting MDR genes 
which include the human I'v1DR1 and the mouse mdr1 and mdr3 proteins. Class Ill includes 
the non-drug transporting members such as human MDR2 and mouse mdr2. Gene transfer 
experiments have clearly demonstrated that the expression of class I and II genes endows 
resistance on drug sensitive cells (Devault and Gros, 1990; Gros et al., 1986c) while 
expression of human and mouse class Ill genes has no direct effect on cellular drug 
resistance (Buschman et al., 1992). 
The MDR family is thought to have originated from a common ancestor by two successive 
gene duplication events. The discovery of three genes in hamster and mouse versus two in 
humans suggested that the second duplication occurred after the divergence of rodent and 
primate lineage's. Recently a number of other mammalian and lower vertebrate species 
have been characterised for gene number (Ling et al., 1992). Five members have been 
noted in pigs (Childs and Ling, 1996) suggesting further duplication events. It is proposed 
the evolutionary diversification of the MDR gene family created closely related membrane 
proteins which transport, by the same mechanism, distinct sets of substrates in both normal 
and multidrug resistant cells (Devault and Gros, 1990). 
Analysis of RNA and protein expression has revealed that MDR genes are distributed in a 
tissue specific manner and that MDR2 is predominately expressed in the canalicular 
membrane of epithelial cells lining the lumen of the bile canaliculi and biliary ducts (Croop 
et al., 1989; Buschman et al., 1992). 
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7.1.2 MDR2 Mutant Pathology 
Knockout mice homozygous for disruptions of the 11DR2 gene are characterised by severe 
liver pathology including hepatocyte damage, inflammatory response and destruction of the 
bile canaliculi (Smit et al., 1993). The bile of these mutants is devoid of 
phosphatidylcholine (PC), the major phospholipid of the bile produced by epithelial cells to 
emulsify bile acids secreted from hepatocytes. It has been shown that 11DR2 is required for 
PC secretion into bile (van Helvoort et al., 1996). The human 11DR2 gene is also 
implicated in a similar function (Borst and Schinket, 1996). 
These symptoms are similar to those of FE. The major site of sporidesmin damage is the 
biliary epithelium in which necrosis and inflammatory changes are observed (Munday, 
1989). Subsequent invasion of the area surrounding the bile ducts leads to necrosis of liver 
cells and inflammation of the hepatic artery and portal vein branches. 
7.1.3 Aims Of Chapter Seven 
Data collected from previous experiments has indicated the presence of other gene 
sequences, with homology to sheep 11DR1 cDNA, that may represent other multigene 
family members. Sheep 11DR2 cDNA was amplified using primers designed to published 
11DR2 sequence. Two fragments were isolated that showed high sequence homology to the 
human 11DR2 cDNA (and other class Ill genes). One of these isolated regions was used to 
map sheep 11DR2. 
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7.2 MATERIAL AND METHODS 
7.2.1 MDR2A Amplification and Cloning 
Amplification of the first fragment, MDR2A, used primers con 66 5 '-
GTGCTGGAGTTCTTGCTG-3' and con 76 5'-TAGCCGCGTATTGAGTTCAGTGG-3' 
and was amplified from sheep genomic DNA in a standard PCR mix (Section 2.7.1) with 3 
mM Mg2+ and 0.04 U/111 HIFI Polymerase (Boehringer). The PCR consisted of 28 cycles 
of 92°C, 40 seconds; 62-51 °C, 40 seconds; 72°C, 40 seconds with an initial denaturation 
time of 2 minutes and a final extension time of 5 minutes. All primers were designed from 
consensus sequence of published MDR2 cDNA. 
Purification of amplified products used bands tab PCR (Section 2. 7 .5) and products were 
isolated from agarose using the spin method and cloned into pBluescriptii used standard 
procedures (Section 2.4.5). Digestion with 1 U/jll Xbal and 1 U/111 Sari in a mix containing 
1x buffer H (Boehringer) determined insert size. Selected clones were sequenced and 
further characterised. 
7 .2.2 MDR2B Amplification and Cloning 
The second fragment, MDR2B, was isolated using 3'RACE (Section 2.8). Amplification 
ofMDR2 used primers con 32 5'-CAGAACGCAGACTTGATAGTGG-3' and primer T 17 
5'-GACTCGAGTCGACATCGA(T)17-3' and was amplified from sheep genomic DNA in 
a standard PCR mix (Section 2.7.1) containing 2 mM Mg2+ and 0.04 U/111 HIFI 
Polymerase. The PCR consisted of 28 cycles of 95°C, 40 seconds; 52°C, 2 minutes; 72°C, 
3 minutes with initial cycle denaturation and extension time of 5 minutes and 40 minutes 
respectively and a final extension time of 15 minutes. 
Bandstab PCR purified the desired product. It was cloned into pBluescriptii and positive 
transformants were selected by colony hybridisation probing with 50 ng of clone MDR1 
2528 (Section 3.3.1) which spans exons 25 to 28 of the sheep MDR1 gene. 
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7.2.3 Linkage Mapping ofMDR2 
7.2.3.1 RFLP Analysis 
Filters for probing were made as described in Section 4.2.1. Filters of genomic sheep DNA 
digested with Mspi, Taqi, EcoRI and Psti were probed with purified MDR2A product. 
Standard hybridisation methods (Section 2.4.9) were used and autoradiographs were 
scored by two observers prior to being recorded. 
7 .2.3.2 Map Construction 
Both the IMF and Woolflock pedigrees were used in this analysis and are described along 
with their corresponding databases in Sections 2.9 and 2.10. 
The IMF and Woolflock data sets were merged in CRI-MAP and map construction and 
other analyses performed as described in Section 2.10.3. 
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7.3 RESULTS 
7.3.1 MDR2 Fragment Amplification and Cloning 
7.3.1.1 MDR2A 
Amplification of :MDR2A was attempted at annealing temperatures of 61 °C, 59°C, 57°C and 
55°C. Two bands of approximately 150 bp and 100 bp amplified at all four temperatures, 
the larger fragment predominated at 61 oc and the smaller band at 55°C (Figure 7 .lA). 
Reamplification of each product, using bandstab PCR (Figure 7.1B), enabled purification 
and direct sequencing which identified the larger fragment as being homologous to the 
human :MDR2 gene and the smaller product as a non-specific product. The larger 150 bp 
product was cloned, colour screened, and two out of eight positive transformants digested 
to give the correct insert (data not shown). Both clones were sequenced. 
150bp 
lOObp 
Ml 61 59 57 55 
8 
Ml 1 2 
Figure 7.1 :MDR2A amplification and purification. (A) Amplification of MDR2A 
fragments. The annealing temperatures of each respective PCR are given above the lane, 
Lane Ml, marker DNA pUC 18119 Haelll digested. (B) Purification of the two amplified 
:MDR2 products. Lane Ml, marker DNA pUC 18/19 Haelll digested; Lane 1, 150 bp 
:MDR2A fragment purified; Lane 2, 100 bp :MDR2A fragment purified. 
7.3.1.2 MDR2B 
Three prime RACE of sheep cDNA produced a smear from the 2 kb marker down to a band 
at approximately 150 bp (Figure 7.2). Bandstab PCR purified the product and colony 
hybridisation of 70 putative white transformants identified over half as positive, six were 
selected for plasmid extraction. DNA was successfully harvested from three of the clones 
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and all digested to give correct sized inserts (data not shown). Two clones were sequenced 
off both strands. 
M1 1 M2 
Figure 7.2 MDR2 3'RACE. Lane M1, marker 'A EcoRJJHindlll digested; M2 marker 
DNA pUC 18/19 HaeiiT digested; Lane 1, MDR2 3'RACE product. 
7.3.2 MDR2 Sequence Characterisation 
7 .3.2.1 MDR2A 
Fragment MDR2A was 117 bp in length and had 92 % identity to the human MDR2 gene 
and 74 % to the sheep MDRl. The sequence corresponded to a region between TMD 2 and 
TMD 3. The alignment of the sheep MDR2A sequence in Figure 7.3 with that of the human 
MDR2 and sheep MDR1 depicts the high sequence conservation of this region between the 
three proteins. The sheep MDR1 protein has a larger number of dissimilar nucleotides 
(black filled boxes) than do the two MDR2 sequences. 
humanmdr2 CCTATATACA~GTTTCA'l'TTTGGACTTTGGCAGCTGG~GACAGAT~G.  
sheepmdr2 CC'l'ATATACAGG'l''l''l'CA'l''l''l''l'GGACT'l'TGGCAGC'l'GG CGACAGA'l' AG 
sheepmdrl C8TA8AT8CAGGT8TCATTTTGGEI3T8TGGCt:JGCTGG · · GACA[A.§T · 
humanmdr2 AA.AATTAGGCISAG ..AAGT'l''l'TTTCATGCTATTCTA. CG . .ACA_?GAAATAGGiT 
sheepmdr2 AAAA'l''l'AGGCAAGAA8TTTT'l'TCA'l'GCTAT'l'CTACGACA'~GAAA'l'AGG 'I' 





Figure 7.3 Nucleotide comparison of sheep MDR2A with human MDR2 and sheep 
MDRl. In the cases where not all sequences agree, the amino acid(s) in the minority are 
white faced with a black background. The black areas therefore represent regions of 
divergence between the proteins. Similar amino acids are shaded with a grey background. 
Regions of high sequence conservation are white in background with black type. 
7.3.2.2 MDR2B 
Three prime RACE amplified a 107 bp fragment from the 3'end of the sheep MDR2 gene 
including the 51 bp 3'UTR. MDR2B was 86% identical to human MDR2 cDNA and 83 % 







shMDR2 TTCTCAA'l'GGTCAACA ...TCCAGGCCGGCACA.CAGAA. eT . GAACTCT'I'GTTACAGTATA. T 
moMDR2 TTCTCAATGGTCAACATCCAGGCCGGCACACAGAA TT GAACTCTTGTTACAGTATA.T 




Figure 7.4 Alignment of sheep MDR2 (shMDR2), mouse mdr2 (momdr2) and human 
MDR2 (huMDR2) nucleotide sequences. The black areas represent regions of divergence 
between the proteins. Similar amino acids are shaded with a gray background. Regions of 
high sequence conservation are white in background with black type. The termination 
codon is boxed. 
The sheep MDR2 gene ends with a double TGA!TGA termination signal similar to the 
TAG!TGA in sheep MDR1 and the TTA!TGA in human MDR2. It is followed by a 
segment of 51 nucleotides of 3'UTR ending with an undefined number of adenosine 
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residues . Almost centred in the 3'UTR, 18 bp upstream of the poly(A) tail, is an intact 
AATAAA polyadenylation signal of the same sequence and positioning as seen in the 
human (van der Bliek et al., 1988), mouse (Gros et al., 1988) and hamster (Endicott et al., 
1991) MDR2 sequences (Figure 7.5). The sheep MDR2 3'UTR is 465 bp shorter than the 




TTA GAACTCTTG TTACAGTATA TTTTTAAAAT AAATTCAAAT CGTTTTTCTTTAAA 
TGA GAACTTTTG CTACAGTATA TTTTAAAAAT AAATTCAAAT TATTCTACATTTTA 
TTA GAACTCTTG TTATAGTGTA TCTTAAAAAT AAATTCCGAC AAGTTTTTGAAAAA 
Figure 7.5 Alignment of the sheep, human and mouse MDR2 3 'UTRs. The termination 
codon is boxed. The adenosine residue(s) at the end of each sequence represent the start of 
the respective poly (A) tail. The polyadenylation signal motif is underlined. 
7.3.3 MDR2 Linkage Mapping 
7.3.3.1 RFLP Analysis 
Of the initial four enzymes screened Taql and EcoRI identified polymorphisms. Taql was 
initially pursued as this enzyme had two associated polymorphisms (Figure 7 .6A) and the 
EcoRI RFLP displayed heterozygosity in only one of the five animals genotyped (Figure 
7.6B). 
Genotyping of the 127 IMF animals for the two Taql RFLPs did not identify enough 
informative meioses to map the gene. Animals were also genotyped for EcoRI and the lack 
of heterozygosity meant this RFLP was also not informative enough to ascertain map 
placement. 
As an alternative resource for mapping it was decided to genotype the Woolflock pedigrees 
for Taqi. Two of the four Woolflock sires were heterozygous for the Taql RFLP. Markers 
MAF70 and MAF50 were also heterozygous for these sires and gave 34 and 22 eo-
informative meioses respectively, with MDR2, that allowed map placement of this gene 
relative to these loci. 
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Taql EcoRI 
2 3 4 5 
L...----1~0 
A B 
Figure 7.6 RFLP analysis of l\1DR2. (A) Taql RFLP. Two sets of polymorphic bands 
are indicated by connecting arrows (AB and CD). (B) EcoRI RFLP. The single 
polymorphism is indicated by the connecting arrows (EF). 
7.3.3.2 Map Construction 
Genotype information from both the IMF and Woolflock data bases were merged in CRI-
MAP and a two-point linkage analysis placed l\1DR2 on sheep chromosome 4 where it was 
significantly linked to at least two other markers, in the same linkage group as l\1DR1, with 
a lod > 3 (Table 7.1). 
Locusl Locus2 Recombination (8) Lod Score 
l\1DR2 MAF70 0.03 7.66 
MAF50 0.09 3.11 
Table 7.1 Two-point linkage analysis of l\1DR2. Linked markers are listed in order of 
decreasing lod score. Kosambi (8 values are given). 
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MDR2 failed to register significant linkage to MDRl as only two eo-informative meioses 
were recorded in the 74 commonly genotyped animals. Combined information from the 
IMF and Woolflock data bases was used to extend the genetic linkage map constructed in 
section 4.3.1.3 to include MDR2. The BUILD option of CRI-MAP placed MDR2 between 















Figure 7. 7 Placement of MDR2 on sheep chromosome 4 using the BUILD option of 
CRI-MAP. The vertical bar represents the region of most likely placement of the MDR2 
gene. The centromere is represented by a black oval. Interval lengths are shown in 
Kosambi cM. 
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7 .3.3.3 Comparative Mapping and Analysis 
The human MDR genes have been mapped to chromosome 7q21 (Callen et al., 1987) 
linked on a 450 kb fragment (Linke et al., 1991). The three mouse mdr genes have been 
mapped to chromosome 5 (Martinsson and Levan, 1987) in a 625 kb region (Raymond and 
Gros, 1990). The placement of the sheep MDR1 and MDR2 genes on chromosome 4, in 
the same linkage group, would fit with the characteristic placement of other MDR family 
members. It appears that MDR gene linkage has been conserved through primate, rodent 
and ruminant evolution. 
In humans both MDR1 and MDR2 are transcribed in the same direction. In mice they are 
orientated 5'-3' towards each other, the mdr3 member transcribed in the same direction as 
mdr1 (Figure 7.8). This suggests some genome rearrangement after the divergence of 
rodents and primates to alter orientation of gene transcription most probably of mouse 
MDR2 as: (i) MDR1 and MDR2 are duplicates and would therefore in the common 
ancestral form have been likely to be orientated in the same direction and; (ii) the mouse 
genome is known to be more fragmented than the human. 
> > 
Human MDRl MDR2 11-----
_ chromosome 7 
chromosome 5 
Mouse 
~:::L>~ r--..::;...>_, r-<....::.._---, 
mdr3 1-l ---1 mdrl 1-1---1 mdr2 
Figure 7.8 Orientation and positioning of the human (Lincke et al., 1991) and mouse 
(Raymond et al., 1990) MDR genes. The arrows above each family member indicate the 
direction of transcription. The respective chromosomes are indicated. 
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7.4 DISCUSSION 
7.4.1 MDR2 Sequence Characterisation and Mapping 
The two PCR fragments isolated in this chapter represent sequence from the sheep MDR2 
(class Ill) gene. Three prime UTRs are distinct among MDR gene family members yet are 
conserved within the same gene class across species (Ng et al., 1989). The isolation of the 
3'UTR, MDR2B, allowed classification of this sequence into an MDR class. The length of 
the 3'UTR in MDR2 is shorter by approximately 500 bp from class I or ll genes. The 
sheep MDR2 3'UTR was 51 bp in length, 465 bp shorter than the sheep MDRl gene. Both 
MDR2A and MDR2B showed stronger homology to human MDR2 than to sheep MDRl. 
This is evidence against the isolation of MDRl pseudogene fragments as it would be 
expected such fragments would show higher homology to MDRl family members than to 
MDR2 genes. 
Linkage mapping placed MDR2 near MDRl, an arrangement conserved in human and 
mouse MDR families (Raymond et al., 1990; Lincke et al., 1991). The lack of eo-
informative meioses between MDRl and MDR2 made it difficult to confirm the mapping of 
these two genes relative to each other however significant linkage to other common, highly 
informative makers (eg. MAF70), was used to place MDR2 in the same region of 
chromosome 4. 
7.4.2 MDR Family Members 
Ng et al. (1989) demonstrated that class I and Ill represent the minimal number of 
functionally distinct classes that arose from an ancient gene duplication. Species with 
higher numbers presumably have acquired them by further gene duplication events. 
Analysis of species such as pig, with five MDR genes, may provide further clues as to how 
the MDR gene family arose and evolved. The observation in sheep that a number of 
segregating haplotypes contained three alleles suggested that the MDRl region has been 
duplicated at least twice. A study predicting gene number in cows detected three MDR 
family members (Ling et al., 1992) which suggested a similar number may be found in the 
closely related sheep. 
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7 .4.3 Summary of Chapter Seven 
At the outset MDR2 was favoured as a second candidate for FE resistance. Linkage studies 
have placed MDR2 near to MDRl on sheep chromosome 4 and as such results from the 
inheritance studies (Chapter Five), that used MDRl-linked MS markers, apply equally to 
MDR2. A structural change in the MDR2 gene per se can not explain the differences in 





8.1 Facial Eczema 
Facial eczema is a disease of ruminants caused by the mycotoxin sporidesmin. It costs the 
New Zealand (N.Z) sheep industry 75 million dollars per annum in lost revenue. Ingestion 
of the toxin by susceptible animals results in a severe liver pathology and extensive biliary 
damage. The consequential retention of metabolic products, particularly phylloerthyrin the 
breakdown product from chlorophyll, leads to the photosensitisation lesions characteristic 
of the later stages of the disease. Within liver cells the cyclic reduction-oxidation of the 
sporidesmin disulphide group produces a cascade of toxic free radical species (Munday, 
1989). It is hypothesised that free radicals generated from normal cellular processes in 
addition to the influx of free radicals from sporidesmin induced production overwhelms the 
cellular detoxification systems leading to cell death and liver dysfunction. In support of 
this, free radical scavengers have been shown to inhibit the toxic effects of sporidesmin 
(Munday, 1989). In view of the knowledge that resistance to the toxic effects of 
sporidesmin are heritable (Morris et al., 1995) enzymes involved in the detoxification of 
these free radicals have been studied as candidates for resistance (Phua et al., 1988). 
8.2 MDR Family 
Multidrug resistance in cultured cells results from overexpression of a small family of 
membrane glycoproteins coded for by the MDR genes. MDR1 has been extensively studied 
in humans and rodents for its ability to lower the intracellular concentration of a broad 
range of toxic compounds conferring a drug resistant phenotype on the cell. In addition 
overexpression of a membrane protein in yeast, with high homology to other ABC 
proteins, conferred resistance to sporidesmin (Bissinger and Kuchler, 1994). Based on 
these characteristics MDR1 was thought a good candidate for resistance to FE. 
MDR1 has been shown to bind ATP (Comwell et al., 1987) and drug analogs (Safa, 
1988) and have intrinsic ATPase activity (Hamada et al., 1988) suggesting a function in 
energy dependent drug efflux. All MDR proteins are comprised of two homologous halves 
containing consensus sequence for a nucleotide binding domain and six putative 
transmembrane spanning regions. Despite the high degree of sequence homology between 
MDR family members transfection experiments reveal major functional differences. Human 
MDR1 and mouse mdrl and mdr3 confer drug resistance to susceptible cells (Schurr et al., 
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1989; Ueda et al., 1987a). Human :MDR2 and mouse mdr2 do not (Gros et al., 1988). 
Normal human and mouse tissues display :MDR1 expression in a tissue specific fashion 
with the highest levels in liver, small intestine, colon, adrenal glands and the kidney (Fojo 
et al., 1987). In hepatocytes expression is restricted to the bile canalicular membrane 
(Kamimoto et al., 1989) possibly playing a role in protection from xenobiotics (Bradley et 
al., 1990) or in facilitating excretion of endogenous compounds (Schinkel et al., 1994). 
The investigations in this thesis were undertaken in an attempt to characterise the sheep 
:MDR1 gene and to examine the involvement of this gene in resistance to FE. 
8.3 MDRl Sequencing and Characterisation 
The complete sheep :MDR1 cDNA was isolated by amplification of four sheep cDNA 
fragments using primers designed to published :MDR1 sequence. The 5' and 3' UTRs were 
isolated using 5' and 3' RACE respectively. The sheep :MDR1 cDNA encoded a protein of 
1286 amino acids. Statistical analysis of hydrophobic sequences assigned 12 putative 
transmembrane spanning regions (Chapter Three). Although problems were encountered in 
assigning T:MDs 3 and 4 the predicted model reflects the structure of other :MDR genes with 
theN- and C- terminals of the protein assigned to the cytoplasm and the nucleotide binding 
sites assumed cytoplasmic as to react with ATP. 
The sheep :MDR1 cDNA sequence showed 94% amino acid similarity to the human :MDR1 
gene. The regions of greatest similarity included the two NBD consensus sequences. 
Experiments generating chimeric genes have shown that within a species the NBDs of 
different class members are functionally interchangeable (Buschman and Gros, 1991). The 
strong structural and sequence homology of the sheep cDNA with other :MDR proteins, and 
in particular human :MDR1 and mouse mdr1, suggested the sheep :MDR1 protein may also 
function as a membrane bound transporter that actively removes drugs from the cell. 
8.4 MDRl Mapping 
The placement of the :MDR1 gene onto chromosome 4 of the sheep linkage map used a 
RFLP marker (Chapter Four). This placement was confirmed by mapping two :MDR1-
linked MS markers to the same region and physical mapping using FISH. The placement of 
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MDR1 on sheep chromosome 4 adds a coding gene to the linkage map. As MS markers are 
not well conserved across distantly related species this represents a genetic locus that can be 
used in synteny comparisons between such distantly related species. The location of sheep 
MDR1 on chromosome 4 is orthologous to the mapping of the human MDR1 gene to 
chromosome 7 and mouse mdrl to chromosome 5 (Callen et al., 1987; Martinsson and 
Levan, 1987). 
8.5 MDRl Segregation with Facial Eczema Resistance 
The analysis of MDR1 segregation with FE resistance used MDR1-linked MS markers to 
follow MDR1 inheritance in pedigrees in which FE resistance was segregating (Chapter 
Five). The purpose of identifying an allele segregating with FE resistance or susceptibility 
was to generate an effective marker assisted selection programme. At present resistant 
animals are selected through their exposure to sporidesmin and a liver injury score, based 
on an enzyme found in blood, indicative of liver damage. This procedure is unsuitable in its 
exposure of valuable livestock to the toxin. 
Results from analysing MDR1 segregation in the FE pedigrees suggested alteration in the 
sheep MDR1 gene per se was not directly linked to the disease phenotype. The major 
problem with this analysis was the low power of the outcross pedigrees to detect recessive 
or minor effect genes. Recently a backcross was set up, mating one of the FE sires to 
susceptible bred ewes. Offspring from this mating should present a higher number of 
individuals with both homologous chromosomes carrying the recessive allele. Similarly 
gene alleles with relatively minor effects can be missed in such linkage studies particularly 
when the trait is polygenic as for FE disease. In such instances association studies of allele 
distribution in divergent genetic lines can provide a means to test for allele association in the 
trait. Analysis on association of MDR1 to FE through genotyping the FE selection line 
animals supported the conclusion that MDR1 was not linked to FE resistance. 
8.6 Sheep MDR Family Members 
MS analyses on sheep DNA suggested the presence of other highly homologous sequences 
that were amplifying with specific MS designed primers and segregating together as a 
single haplotype. Studies on the MDR family in a range of mammalian and lower vertebrate 
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species has suggested a multigene family with a minimum of two members that possibly 
represent the ancestral state (Ng et al., 1989). The high sequence homology and 
conservation of intron positioning between the family members suggested gene duplication 
gave rise to various MDR class genes. The observation that a number of segregating 
haplotypes contained three alleles suggested that in sheep the MDR1 region may have been 
duplicated a minimum of two times. A recent study detected three MDR genes in cow (Ling 
et al., 1992). Southern blot analysis probing digested sheep genomic DNA with a 
conserved fragment of the gene would be useful in clarifying family number. 
The isolation of fragments of the sheep MDR2 gene confirmed the existence of at least one 
other family member. The high homology of these fragments to human MDR2 and their 
lower homology to sheep MDR1 discounted the possibility of MDR1 pseudogene isolation. 
In addition one of the fragments contained the entire sheep MDR2 3'UTR. 3'UTRs are 
commonly used to identify MDR gene class as these regions are distinct among MDR gene 
classes yet are conserved within the same gene class across species (Ng et al., 1989). The 
sheep MDR2 gene has a 3'UTR that is approximately 500 bp shorter than that of the sheep 
MDR1, and other MDR1, genes. 
8.7 Sheep MDR2 Gene 
MDR2 is known to function in the transport of phosphatidylcholine (PC) from hepatocytes 
into bile (van Helvoort et al., 1996). In homozygous mutant MDR2 knockout mice a severe 
liver and biliary pathology including hepatocyte damage, inflammation and destruction of 
the bile canalicular developed. These symptoms are similar to those generated in animals 
susceptible to sporidesmin (Smit et al., 1993). PC is the major phospholipid of the bile and 
is produced by epithelial cells of the canaliculi to emulsify bile acids secreted by 
hepatocytes. Sporidesmin inhibits bile acid synthesis and its transport across the plasma 
membrane. Depression of bile acid synthesis may in part account for the decrease in bile 
flow in sporidesmin poisoned animals as flow is coupled to maintenance of hepatic bile 
acid pools. It is not obvious whether the effect of sporidesmin on bile acid transport is 
reflecting general disruption of membrane morphology or specific interaction with bile acid 
transport components. 
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It was decided to extend our studies to look at the role of MDR2 in FE resistance (Chapter 
Seven). MDR1 had been mapped to sheep chromosome 4 and its characterisation in the FE 
outcrossed pedigrees had showed no significant linkage to resistance. The mapping of 
MDR2 using RFLP analysis placed this gene adjacent to MDR1 on sheep chromosome 4. 
Such a gene arrangement is conserved in the human and mouse MDR families which are 
found on chromosomes 7 and 5 respectively, gene members linked within a 600 kb locus. 
The linkage mapping of sheep MDR2 adjacent to MDR1 eliminates changes in MDR2, or 
any other linked MDR gene, per se being responsible for FE resistance. The assumption 
being that the segregation data using MDR1-linked MS markers applies equally to MDR2 
when it is linked to MDRl. 
8.8 MD Rl Expression in Resistant and Susceptible Animals 
Ince and Scotto (1996) in studying MDR1 gene regulation realised that differential 
expression was dependent on chromosomal integration of the transfected MDR1 cDNA. 
The fact that integration was required suggested DNA methylation or chromatin structure 
was important in gene regulation. Methylation of a transcription factor binding site can 
directly lead to transcriptional repression. In addition chromosomal DNA is organised by 
nucleosome proteins which can restrict the access of transcription factors to their promoter 
elements and inhibit transcription. Transient DNA is often not properly methylated 
(Doerfler et al., 1990) nor compacted by nucleosome proteins (Komberg and Lorch, 1995; 
Workman and Buchman, 1993). A number of MDR1 transcriptional factors and promoter 
elements have been identified (Ince and Scotto, 1996; Combates et al., 1994; Raymond and 
Gros, 1990). If such factors acting on MDR1 are differentially expressed or activated in 
resistant and susceptible cells, to confer resistance to sporidesmin, then involvement of 
MDR1 would not be detected by searching for variants in the gene structure. 
To identify any differential effects that transcription factors may be having on MDR1 
mRNA levels in resistant and susceptible cells the expression of MDR1 was analysed using 
a semi-quantitative RT-PCR approach. As the liver is the site of sporidesmin accumulation 
and damage MDR1 expression in hepatocytes was primarily examined. This experiment 
(Chapter Six) involved isolating RNA from the liver of a number of resistant and 
susceptible animals some of which had received a challenge of sporidesmin two days prior 
to culling. 
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Unchallenged cells isolated from resistant and susceptible animals had comparable MORI 
mRNA levels. This suggested basal MORI expression levels had remained constant during 
the selection process. The major difference observed was in MORI expression after 
sporidesmin dosage. Hepatic cells isolated from resistant animals showed higher MORI 
expression after a 0.35 mg/kg dose of sporidesmin than the undosed resistant cells. MORI 
expression levels in dosed susceptible animals (O.I5 mg/kg) were not significantly different 
from undosed susceptible cells. As this lower dosage still elicits FE symptoms in the 
susceptible animals it was known that lack of MORI response in these animals was not due 
to failure of the toxin to cause liver damage. The reason that the same dose could not be 
used on both selection lines was that the high (0.35 mg/kg) dose would have killed animals 
from the susceptible line and the lower (O.I5 mg/kg) dose would not have elicited a disease 
phenotype in resistant animals. Data generated from animals sampled both pre- (biopsy 
sample) and post- dose supported the observation that MORI expression was elevated in 
the cells of resistant animals following exposure to sporidesmin but not in susceptible cells 
exposed to sporidesmin. This analysis suggested resistant cells had the ability to induce 
MDRI overexpression in response to sporidesmin exposure. 
An increase in MDRI expression was also recorded in leukocyte cells following a 5 ng/ml 
dose of sporidesmin. A dose of 50 ng/ml resulted in reduction of MORI expression in the 
resistant cells back to basal levels. It was postulated that at 5 ng/ml an increase in MORI 
expression was associated with cell protection against sporidesmin but that at 50 ng/ml the 
toxin has saturated MORI function leading to sporidesmin build up, cell death and loss in 
protein function. In contrast susceptible leukocyte cells showed no appreciable change in 
MORI levels after either the 5 or 50 ng/ml dose. This differential expression could be 
exploited in the development of an assay to select for animals resistant to FE. 
The differential change in MORI expression in resistant cells without an observed 
concurrent change in the MORI genome structure may be suggestive of a differentially 
expressed transcriptional factor or structural moiety directly affecting MORI gene 
transcription and indirectly regulating resistance to sporidesmin. Our genetic evidence 
would suggest that if such a gene exists to control MDRI expression it is not located in the 
same region of the genome. 
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8.9 Conclusions 
Sporidesrnin is a typical candidate for MDR1 transport and we tentatively suggest that one 
of the toxic compounds MDR1 transports across cell membranes is sporidesrnin. In 
addition we propose the differential MDR1 expression between resistant and susceptible 
cells represents not a structural mutation in the gene encoding MDR1 but a defect in an 
interacting regulatory locus. This regulation of MDR1 protein function appears to be 
correlated with the resistance of cells to sporidesmin. Overexpression of MDR1 seen in 
resistant cells may be depicting the lowering of intracellular sporidesrnin concentration. 
8.10 Future Work 
This research has shown no detectable difference in the primary structure of the MDR 
genes between resistant and susceptible sheep that could be exploited in marker assisted 
selection. However resistant and susceptible animals have shown differential levels of 
MDR1 expression. The resulting hypothesis is that the difference in MDR1 activity stems 
from differentially acting regulatory proteins. To prove this the interacting protein would 
need to be isolated and linkage to FE resistance established. Identification of interacting 
proteins could utilise the two hybrid system, (Chien et al., 1991), to detect protein-protein 
interactions and Dnase footprinting to examine the binding of specific protein factors to 
promoter regions of the gene. In addition functional studies would confirm whether MDR1 
is specifically involved in transportation of sporidesrnin and lowering of toxin 
concentration. Transfection experiments would determine if overexpression of MDR1 
cDNA conferred protection from sporidesrnin toxicity. 
The differential expression of MDR1, detected in leukocytes exposed to sporidesrnin, may 
be developed as a blood test for assessing animal resistance to FE. Repeat experiments 
would first be required with more frequent dosage points between 0 and 50 ng/ml. If 
resistant and susceptible cells were found to display a differentially robust response to the 
toxin, MDR1 expression levels in leukocytes could be used to identify the resistance of an 
animal. The forseen test would involve blood samples taken from the animal, culturing of 
leukocytes, challenging with appropriate pre-determined dosages of sporidesrnin and 
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evaluating the change in MDR1 mRNA levels. This would enable a move away from 
current performance testing that involves exposure of valuable livestock to the toxin. 
With the large number of potential candidate genes for FE the completion of the QTL scan 
may help identify specific chromosomal regions of interest to concentrate future study. A 
recent candidate, glutationie-S-transferase (GST) has displayed increased activity in 
resistant-line mice studied for tall fescue toxicosis that affects beef cattle (Hohenboken and 
Blodgett, 1997). Glutathione-S-conjugates are found within hepatocytes and are selectively 
transported across the canalicular membrane into bile (Ballatori and Truong, 1995). 
Although progress in the alleviation of FE damage has been considerable since its 
recognition the disease still represents a serious threat to susceptible livestock in N.Z. The 
MDR1 gene represents a functional candidate for FE resistance in light of both its 
previously established drug conferring phenotype and the results presented from this 
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The full nucleotide sequence of the 350 bp fragment of sheep MDR1, including a part of 
exon 13 and intron 14, from which the primers for microsatellite OarMEM2 were designed. 
CAGAGTCGGA CACGACTGAA CCACCGCTTC ACTCTCTGTG TCCAGCGCTG 
AGGTGGCCTC ATCCAGCAGG AGGATCTTGG GGTTGCGAAC CAGGGCCCGG 
GCAATGGCGA TTCTCTGCTT CTGTCCACCA CTTAGCTGGG CTCCTCTCTC 
TCCAACCAGG GTGTCAAATT TCTACAACAT CGAAAACGCA GGAGGATTAA 
ATAACAGAAT AAGCAATCTC ACCTAAGATT TTTAAGATGG GAAGTAATCC 
TATAAACAAC CCAAATCTAA CAGGCAGTAT GCTCTAGTTT TGTGTGTGTG 




The full nucleotide sequence of the 1200 bp fragment of sheep genomic DNA from which 
the microsatellite primers for OarMEM3 were designed. 
CCGCCATGGC CGCGGGATTC CCACTCCAGT ACTCTTGCCT GGAAAATCCC 
ATAGACAGGG GAAGCTTGGT GGGTTACATT TCATGGGGTC GCAAAAGTCA 
GACACGACTG AGCACACTAG CACACATGTC TTTTTCTTCA TGGTCTCAGA 
AAGATGGGAA TCTTTCAGCT TCACTGAGTC TTAGTTTCCT CATCTTTAAA 
GGAATCTTTC TAAGAATGTT AAATGAATGT AGAGACGTTA ATCAGTTAAG 
ATCTTCCAAA CTTCTTCTAC AAATGTGGAA TGATGATTCA AAACAAGGAA 
GGCCCAGTAT AAAGAGAGAA AAAGCCAGGG GATGAAACAA CAGTATTAAT 
TTAGCCATTC CTTCATTCAG TAAATATTTA CCGTGTTCAC TATCCTTTCT 
TTGTTTGGGA AACAGAAGAA CAAAGCAGAA ACGGGCTGCC CTTCCAGAGT 
TTATATCTCA ATGGGAAAGA CACATTTTGT AATGAGCAAA ATTGCAATTG 
TGATGTTTAA TAGGAAGGAG AAGTGCAATA TACTCTGTGA ATTACTACTA 
AGATGACAAA ATCTAACCCA GAAGAATAGG GAATATTTCT CTGAGGAACT 
GATGTTTGAA GCAGAAGAAT GAATCAATTA GCCACCTGCT GTTGTGTGTG 
TGTGTGTGTG TGTGTGTGTG TATGTGTGTG TTTCTATGTA AATGCATGTT 
GGCCAGTTGT AAGGGGTAGG AGAGGGTAGA GGGGTAGAGA AAGACCACTC 
CAGGAGGGTG GGCAAGAGGA ACACCATGCA CATGAAAGCT CCAAGGAGCT 
GACAGAGGCC AGCGCGCCTG GATCCTGAAG GAGCAAAGAG AAGCAGCCTG 
TAGCTACAGA GATGAACGGG GAATTGAACC TGAGAGCAAC GGAAAGGCAT 
TGCAAGTCTT TACATAGGTG TGTGACATGG CCATACGTGC ATTTTTACAA 
GGTACTTTCC CTGCTGTGGA GAGTGCATTA TAAGCGTTCT AGAATGGATA 
TGGAGAAGCC AGGTGGGAAT GCTCTGATAG TAACTCAGGT AAGAGAGGAT 
AGTAGATATT ATGGTTTGAC AAAATTGCGT GCCTGCCTGT GTGCTAAGTC 
GCTTCAGTCA TGTCCAACCC TCTGTCCATG AGATTTTCCA GGCAAGAGTA 
CTGGAGTGGG A 
